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 Abstract 
The molecular events that promote or inhibit specific training adaptations (i.e. skeletal muscle 
hypertrophy or mitochondrial biogenesis) are not completely understood. Accordingly, there 
is a need to better define both the acute and chronic responses to divergent exercise stimuli in 
order to elucidate the specific molecular mechanisms that ultimately determine skeletal 
muscle phenotype. Therefore, the primary aims of the studies undertaken for this thesis were to 
examine the acute molecular adaptation responses in skeletal muscle following resistance and 
endurance training.  
In order to determine the acute molecular events following repeated bouts of exercise, 
the study described in Chapter Two compared a high-frequency “stacked” training regimen 
designed to generate a summation of transient exercise-induced signalling responses with a 
conventional-frequency resistance training protocol. Groups (n= 6) of Sprague-Dawley rats 
performed either high-frequency training (four exercise bouts consisting of 3 × 10 repetitions 
separated by 3 h) or conventional-frequency training (three exercise bouts consisting of 4 × 10 
repetitions with 48 h between sessions). Protocols were matched for total work, and 
repetitions were performed at 75% one-repetition maximum with 3 min recovery between 
sets. White quadriceps muscle was extracted 3 h after every training bout, and 24 and 48 h 
following the final exercise session of each protocol. AKT phosphorylation was significantly 
decreased 3 h following the 2nd bout of high-frequency training, an effect that persisted until 
48 h after the final exercise bout (P <0.05), while the phosphorylation state of this kinase was 
unchanged with conventional training. These results suggest that high-frequency training 
suppressed IGF-1 mediated signalling. Furthermore, high-frequency training generated 
sustained and coordinated increases in TNFα and IKK phosphorylation (P <0.05), indicating 
an extended response of inflammatory signalling pathways. Conversely, and irrespective of an 
initial increase after the first bout of exercise, TNFα signalling ultimately returned to control 
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values by DAY 5 of conventional-frequency training, indicative of a rapid adaptation to the 
exercise stimulus. Notably, despite differential AKT activation there were similar increases in 
p70 S6K phosphorylation with both training protocols. These results indicate high-frequency 
resistance training extends the transient activation of inflammatory cytokine-mediated 
signalling and results in a persistent suppression of AKT phosphorylation, but these events do 
not appear to inhibit kinase activity proximal to translation initiation.  
The aim of the study described in Chapter Three was to determine the effect of prior 
training history on selected signalling responses after an acute bout of resistance and 
endurance exercise. Following 24 h diet / exercise control 13 male subjects (7 strength-trained 
and 6 endurance-trained) performed a random order of either resistance (8 x 5 maximal leg 
extensions) or endurance exercise (1 h cycling at 70% peak O2 uptake). Muscle biopsies were 
taken from the vastus lateralis at rest, immediately and 3 h post-exercise. AMPK 
phosphorylation increased after cycling in strength-trained, but not endurance-trained subjects 
(P <0.05). Conversely, AMPK was elevated following resistance exercise in endurance-, but 
not strength-trained subjects (P <0.05). Thus, AMPK was elevated only when subjects 
undertook a bout of exercise in a mode of training to which they were unaccustomed. 
Surprisingly, there was no change in AKT phosphorylation following resistance exercise 
regardless of the training background of the subjects. In the absence of increased AKT 
phosphorylation, resistance exercise induced an increase in p70 S6K and ribosomal S6 protein 
phosphorylation in endurance-trained but not strength-trained subjects (P<0.05). AKT 
phosphorylation was increased in endurance-trained, but not strength-trained subjects after 
cycling (P <0.05). These results show that a degree of signalling “response plasticity” capable 
of diverse adaptive compliance is conserved at opposite ends of the adaptation continuum. 
Furthermore, the adaptive phenotype associated with a prolonged training history alters the 
subsequent signalling responses with divergent exercise stimuli.  
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The third study described in Chapter Four quantified the acute sub-cellular mRNA 
responses in muscle to habitual and unfamiliar exercise modes. This study employed the same 
subjects and protocols outlined in Chapter Three and analysis was performed on muscle 
biopsies taken at rest and 3 h after an exercise bout. Gene expression was analysed using 
Real-Time PCR with changes normalised relative to pre-exercise values. Following cycling 
exercise peroxisome proliferator activated receptor gamma co-activator-1 alpha, pyruvate 
dehydrogenase kinase 4 and vascular endothelial growth factor mRNA abundance was 
significantly increased in both endurance and strength-trained subjects (P <0.05). This finding 
indicates that the adaptive phenotype of these athletes did not produce a disparity in the 
mRNA response of these ‘metabolic genes’. Similarly, muscle atrophy F box protein 
(MAFBx) mRNA increased in both groups (P <0.05) suggesting that a prolonged endurance 
training stimulus may increase the activity of pathways involved in the regulation of muscle 
atrophy. Unexpectedly, MyoD and Myogenin mRNA increased in endurance-trained subjects 
after cycling. Accordingly, it seems plausible to suggest that these regulators of satellite cell 
activity may have additional roles in skeletal muscle metabolism. Finally, high-intensity 
resistance exercise did not induce any change in mRNA abundance of selected ‘myogenic’ 
genes in either group of subjects, despite a decrease in MAFBx and Myostatin mRNA in 
endurance-trained subjects. It may be that in highly-trained athletes a greater volume or 
repeated bout effect is required to initiate anabolic gene expression. Taken collectively, these 
results indicate that prior training history can modify the acute mRNA changes in skeletal 
muscle in response to exercise. Indeed, the data indicate that independent of exercise mode, 
the gene responses in skeletal muscle from endurance-trained athletes are more sensitive to 
alterations in the cellular milieu than strength-trained subjects. 
In summary, the work from the studies undertaken for this thesis provides novel 
information regarding the effects of the frequency of the training stimulus on signalling 
responses in skeletal muscle. Specifically, high-frequency resistance training does not 
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enhance anabolic signal transduction and may exacerbate inflammation and atrophy. In regard 
to the effects of prior contractile history on early signalling and mRNA responses, divergent 
exercise induces a mode specific molecular response that is altered by the training-induced 
phenotype of the muscle, highlighting the need for extensive training overload in highly-
trained athletes.  
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Chapter One 
 
Literature Review 
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1.1 Overview: The Specificity of Exercise Responses 
Skeletal muscle is a malleable tissue capable of altering the type and amount of protein in 
response to disruptions to cellular homeostasis. Contractile activity as a result of physical 
activity (i.e. exercise) represents a potent stimulus that can generate significant disturbance 
within the muscle milieu and elicit substantial changes and adjustment in the cellular 
environment. Indeed, repeated contractile activity produces a cascade of events that ultimately 
alters the adaptive machinery and tissue characteristics resulting in less interference to cell 
homeostasis during subsequent contractions (Figure 1.1).  
 Nerve stimulation
Contractile activity
Primary messengers
Secondary messengers
Regulatory Genes
Functional genes (Proteins)
Fibre specific characteristics
Tissue characteristics
(Phenotype)
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1 Putative steps through which contractile activity leads to alterations of skeletal 
muscle (Williams and Neufer 1996). 
 
Current understanding of the complex process of exercise-induced adaptation in 
skeletal muscle was pioneered in the 1960’s. Notably, Holloszy (1967) was the first exercise 
scientist to utilise conventional biochemistry techniques to investigate the effects of exercise 
on skeletal muscle. Holloszy (1967) established that regular prolonged exercise significantly 
increased skeletal muscle mitochondrial content and enzyme activity, thereby elucidating a 
molecular mechanism for the increase in aerobic work capacity with endurance training. 
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Similarly, Goldberg (1968) pioneered work that identified the capacity of skeletal muscle to 
increase in size in response to physiological overload. He showed that overload-induced 
compensatory hypertrophy occurred via the incorporation of amino acid derived protein 
synthesis, the principal molecular event to increase muscle mass with resistance training. 
Since these early studies advances in biotechnology have enabled the elucidation of specific 
signalling mechanisms that initiate replication of DNA sequences and translation of the 
genetic message into a series of amino acids that create new protein (Bouchard et al. 1997). 
The continuous turnover of cell proteins and alterations in the equilibrium between protein 
synthesis and degradation permits muscle plasticity (Booth and Baldwin 1996). The 
functional consequences of these exercise-induced adaptation processes are determined by the 
volume, intensity and frequency of the stimulus and the half-life of the protein.  Moreover, 
many features of the resultant adaptation after repeated bouts of contractile activity are 
specific to the type of stimulus, such as the mode of exercise (Williamson et al. 2001; 
Izquierdo et al. 2004; Mahoney et al. 2005).  
The early signalling responses elicited by a single bout of exercise generate increases 
in transcription of nuclear / mitochondrial DNA resulting in greater mRNA abundance of 
specific exercise-induced genes. While gene expression and subsequent protein synthesis in 
response to exercise is regulated at multiple steps, the directional change in mRNA is 
generally the same as the protein during early adaptation to a new steady-state level (Booth 
and Baldwin 1996). Contraction generates transient increases in the quantity of mRNA for 
specific exercise-induced genes commonly peaking between 3-12 h post-exercise and 
returning to basal levels within 24 h (Figure 1.2a; Pilegaard et al. 2000; Psilander et al. 2003; 
Bickel et al. 2005; Yang et al. 2005). Therefore, frequent repeated bouts of exercise will result 
in increased transcriptional activity that subsequently amplifies protein synthesis. 
Consequently, chronic adaptation to training is likely due to the cumulative effects of each 
acute exercise bout leading to a change in the steady-state level of specific proteins and a new 
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functional threshold (Figure 1.2b; Widegren et al. 2001; Mahoney et al. 2005; Pilegaard et al. 
2005).  
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Figure 1.2 Schematic of the putative (A) mRNA and (B) protein responses with adaptation to 
repetitive exercise stress. 
 
Diverse exercise stimuli induce specific early gene responses and protein synthesis in 
skeletal muscle (Atherton et al. 2005). Individuals have different genetic capacity to perform 
and adapt to aerobic or anaerobic exercise (Bouchard et al. 2000) and muscle fibre 
composition is an important contributing factor to this process. Nevertheless, while the 
mechanisms that transduce the fibre-type specific effect of contractile activity are 
incompletely understood, numerous signalling proteins and genes have been implicated in 
exercise-induced adaptation (Hawley 2002; Glass 2005; Koulmann and Bigard 2006). 
Prolonged endurance training elicits a variety of metabolic and morphological gene 
expression including those related to mitochondrial biogenesis (Holloszy 1967; Irrcher et al. 
2003), fast-slow fibre-type transformation (Zierath and Hawley 2004) and substrate 
metabolism (Holloszy et al. 1977). In contrast, heavy resistance exercise stimulates adaptive 
machinery responsible for increasing muscle hypertrophy (Rennie et al. 2004) and maximal 
contractile force output (Häkkinen 1989; Ahtiainen et al. 2003).  
Concomitant with the vastly different functional outcomes induced via these diverse 
exercise modes, the genetic and molecular mechanisms of adaptation are distinct and may be 
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regarded as incompatible. Each mode of exercise results in activation and / or repression of 
specific pathways and subsets of genes. Performing multiple bouts of each training mode in 
isolation will ultimately generate a developmental history in the muscle fibres, producing a 
specific exercise-induced phenotype associated with chronic training (Ingalls 2004). 
Therefore, aerobic endurance and heavy resistance training represent opposite ends of an 
adaptation continuum. While the cellular and molecular events associated with endurance and 
resistance exercise adaptations are becoming evident, our current understanding of the 
adaptation process when performing concurrent endurance and resistance training is less 
clear. Previous work (Leveritt et al. 2003) suggests that concurrent endurance and resistance 
training reduces the adaptive response compared to when each exercise mode is undertaken 
alone (Figure 1.3).   
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Figure 1.3 Proposed effect of concurrent training on specific adaptation when compared to 
single mode training. 
 
 
Metabolic and mitochondrial adaptation to aerobic exercise is typically associated 
with resistance to lifestyle related diseases, while increased muscular strength and power may 
prevent musculo-skeletal injury and loss of function. Greater knowledge of the mechanisms 
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and interaction of exercise-induced adaptive pathways in skeletal muscle is important for our 
understanding of the aetiology of disease, maintenance of metabolic and functional capacity 
with aging, and training for athletic performance. This chapter will provide a detailed review 
of adaptive pathways in skeletal muscle and highlight the effects of exercise on genetic and 
molecular mechanisms of adaptation. 
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1.2 Skeletal Muscle Mechanotransduction 
The process of converting a mechanical signal to a biochemical event in a muscle cell has 
been termed mechanotransduction (Hornberger and Esser 2004) and involves the up-
regulation of primary and secondary messengers that initiate a cascade of events that result in 
activation and / or repression of specific signalling pathways regulating exercise-induced gene 
expression and protein synthesis / degradation (Williams and Neufer 1996). One of the most 
potent stimuli for skeletal muscle mechanotransduction is contraction. 
 
1.2.1 Putative Primary Messengers 
Elucidation of the precise mechanisms that enable skeletal muscle cells to interpret and 
respond to contraction has proved elusive. Indeed, the complexity of this process is 
complicated by 1) the proposed mechanoreceptors that connect the neuronal, mechanical and 
biochemical events and 2) the numerous cellular candidates as potential primary messengers 
that transduce the mechanical signal. In addition, it is unlikely that these primary signalling 
messengers act in isolation and probably results in an intricate multifaceted signal with 
redundancy and cross-talk. Nevertheless, a number of putative messengers is emerging 
including, but not limited to, calcium, Na+ / K+, mechanical stretch, pH, hydrogen ions, redox 
state, hypoxia, and phosphorylation state. This review will focus on several important primary 
messengers that have been identified to be altered with exercise-induced contractile activity 
(Williams and Neufer 1996; Sakamoto and Goodyear 2002; Hawley and Zierath 2004). 
Mechanical Stretch 
Mechanical stimuli modulate cell function via membrane distortion and mechanochemical 
conversion, and directly affect tissue form and function (Alenghat and Ingber 2002). Putative 
mechanoreceptors for signal transduction in skeletal muscle include the phospholipid bilayer 
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and surface adhesion receptors (Hornberger and Esser 2004). Movement of intra- and extra-
cellular components via disruption to the lipid membrane and activation of focal adhesion 
kinases through integrin receptors as a result of muscle contraction represent likely candidates 
that activate secondary events (Hornberger and Esser 2004; Rennie et al. 2004). Technical 
limitations currently prevent accurate measurement of the effect of mechanical stimuli on 
mechanotransduction in vivo. However, the use of passive stretch on muscle in vitro and in 
situ demonstrates that mechanical stimuli induce numerous adaptive processes. Passive 
stretch has been shown to alter myogenic regulatory factors (MRF), myosin heavy chain and 
fast-to-slow phenotype gene expression in both innervated and denervated skeletal muscle 
(Loughna et al. 1990; Loughna and Morgan 1999; Rauch and Loughna 2005). Furthermore, 
stretch is capable of generating significant increases in skeletal muscle insulin-like growth 
factor (IGF) mRNA and hypertrophy (Czerwinski et al. 1994).  
 Evidence is emerging that mechanical perturbation of skeletal muscle mediates 
activation of the calcineurin, mitogen activated protein kinase (MAPK) and IGF signalling 
cascades (Kumar et al. 2002; Hornberger et al. 2005a; Rauch and Loughna 2005). Moreover, 
it has become apparent that muscle cells can distinguish between mechanical forces acting on 
the cell. Work by Kumar and colleagues (2002) revealed that axial versus transverse stress 
produced activation of distinct signalling intermediates despite the same magnitude of 
mechanical stress applied to the muscle fibre. Similarly, Hornberger and co-workers (2005a) 
observed unique activation of signalling proteins when comparing cyclic uni- and multi-axial 
stretch. The rapid and differentiated mechanochemical conversion induced by distinct models 
of mechanical stress strongly suggests the existence of mechanotransduction specificity. 
Therefore, the signalling events initiated by mechanical load with exercise (i.e. frequency and 
intensity of contraction) are likely to contribute to the specificity of exercise-induced 
adaptation and implicates mechanical stress / tension as a significant primary messenger. 
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Calcium 
Neural activation of skeletal muscle generates an action potential that results in Ca2+ release 
from the sarcoplasmic reticulum (SR) via Ca2+ release channels triggering a rise in cellular 
[Ca2+] for excitation-contraction coupling (Carroll et al. 1995). Cessation of the action 
potential initiates the transport of Ca2+ out of the cytosol back to the sarcoplasmic reticulum. 
The rate and capacity of Ca2+ release and uptake is altered by contractile activity (Figure 1.4).  
Prolonged moderate intensity (~60-70% VO2max) exercise has been shown to increase 
SR Ca2+ uptake and may increase the number of active pumps resequestering Ca2+ (Schertzer 
et al. 2003; Schertzer et al. 2004). In contrast, a single bout of high-intensity (>100% VO2max) 
or fatiguing exercise generates a 20-50% transient decrease in Ca2+ uptake and release, 
returning to basal levels following 60 min recovery (Byrd et al. 1989; Matsunaga et al. 2002). 
These acute alterations in cytosolic [Ca2+] may elicit secondary events following a return to 
resting / basal values. Interestingly, repeated bouts of exercise have been shown to induce an 
adaptive response resulting in less perturbation in Ca2+ release and uptake, and subsequently 
improved Ca2+ cycling and resistance to fatigue (Holloway et al. 2005). Taken together, these 
findings provide evidence to suggest the amplitude and duration of Ca2+ flux is regulated by 
the duration and frequency of contractile stimulus. For example, endurance exercise likely 
results in extended periods of moderately elevated [Ca2+], while resistance exercise would 
generate short cycles of significantly higher intra-cellular [Ca2+] (Baar et al. 1999). Indeed, it 
is plausible to suggest that the specific cytosolic Ca2+ transient will also determine subsequent 
downstream events such as gene expression and protein synthesis (Chin 2005; Tidball 2005).  
Ca2+ cycling has been implicated in the activation of multiple potential secondary 
messenger complexes including calcineurin, nuclear factor of activated T-cells (NFAT), 
calmodulin, MAPK and protein kinase C (Williams and Neufer 1996; Baar et al. 1999; 
Sakamoto and Goodyear 2002). Elevation of intranuclear [Ca2+] may also result in activation 
of histone deacetylase (HDAC) and myocyte enhancer factor 2 (MEF2) (Liu et al. 2005). 
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However, the precise relationship between alterations in [Ca2+] and initiation of the adaptive 
processes culminating in gene expression and protein synthesis remains elusive. Nevertheless, 
Ca2+ appears to be a compelling regulator in the specificity of exercise-induced adaptive 
events and its effects are likely to be altered by the mode, intensity and volume of exercise.  
 
 
 
 
 
 
 
 
 
 
Ca2+
Ca2+
Ca2+
Ca2+
Ca2+
Ca2+
Ca2+
Ca2+
Ca2+
Ca2+
Ca2+
Ca2+
Ca2+
Ca2+
T-
tu
bu
le
Sarcoplasmic Reticulum
stretch
stretch
ADP + Pi
ATP
CHO + Fat
NAD
NADH
O2
+
+
+
1
2
34
 
Figure 1.4 Metabolic and mechanical signals believed to play key roles as primary 
messengers in mechanotransduction. 1) Mechanical stretch 2) Ca2+ flux 3) redox potential and 
4) phosphorylation potential. Ca2+, calcium; CHO, carbohydrate (Spriet 2002; Hawley and 
Zierath 2004).  
 
Redox Potential 
The process of maintaining redox potential occurs when nicotinamide adenine dinucleotide 
(NAD) is converted to NADH, and to maintain redox homeostasis NADH must be constantly 
re-oxidised via several different pathways (Lin and Guarente 2003). This redox mechanism is 
predominantly a result of the catabolic reactions occurring with glycolytic and lipolytic 
metabolism (Figure 1.4). Therefore, the NAD/NADH ratio regulates intra-cellular redox state 
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and may be considered a marker of skeletal muscle metabolic state (Lin and Guarente 2003). 
Indeed, contractile function in the absence of fatigue and during strenuous exercise to 
exhaustion is modulated moment-to-moment by cellular redox state (Smith and Reid 2006). 
 The maintenance of redox potential produces volatile free oxygen molecules (e.g. 
reactive oxygen species [ROS]) and this oxidant activity is buffered by multiple anti-oxidant 
systems in skeletal muscle (Stofan et al. 2000; Arbogast and Reid 2004). Due to the increase 
in demand for oxygen and activity of metabolic pathways, exercise represents a stimulus 
capable of generating high levels of ROS. While a direct cause and effect relationship has not 
been established, indirect evidence suggests that oxidative stress limits exercise capacity and 
may modulate exercise-induced adaptive signalling. ROS-selective antioxidants have been 
utilised to significantly increase sub-maximal exercise time to exhaustion but do not appear to 
promote any delay in fatigue at high-intensity workloads in human skeletal muscle in vivo 
(Medved et al. 2003; Medved et al. 2004; Matuszczak et al. 2005). Therefore, prolonged 
endurance exercise appears to be a stimulus more likely to promote oxidative stress and ROS 
activity than heavy resistance training. This may characterise a point of diversion in the 
specificity of exercise-induced signalling. 
 Our present understanding indicates that redox potential and resultant free radical 
synthesis with exercise and during recovery may regulate adaptive pathways in two ways. In 
the first instance, redox state may act as a primary messenger through a direct affect on 
transcriptional regulation and DNA binding specificity of immediate early genes (IEG’s) such 
as Fos and Jun, and transcription factors nuclear factor kappa B (NFκB) and activator protein 
1 (AP1; Xanthoudakis et al. 1992; Carrero et al. 2000; Jindra et al. 2004). In addition, due to 
the apparent effect of ROS on numerous elements of cellular function redox state may act 
indirectly on signalling machinery via its effect on intra-cellular Ca2+ regulation and 
mitochondrial metabolism (Smith and Reid 2006). 
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Phosphorylation Potential 
Muscle contraction is an energy consuming process that requires the continual hydrolysis of 
adenosine triphosphate (ATP) to sustain force production. Resynthesis of ATP via restoration 
of its high energy phosphate bonds is generated by oxidative phosphorylation and / or 
glycolysis (Houston 2001). Subsequently, concentrations of metabolites related to the 
maintenance of muscle phosphorylation potential (i.e. [ATP]/[ADP][Pi]) provide feedback 
signals to balance ATP production with ATP consumption (Hawley and Zierath 2004). 
Indeed, intra-cellular concentrations of free adenosine monophosphate (AMP) are an 
important regulator of energy consuming and regenerating pathways (Sakamoto and 
Goodyear 2002).  
Contraction has been clearly shown to alter metabolite concentration in both type I and 
type II muscle fibres (Hintz et al. 1982; Ivy et al. 1987). Strong evidence also exists for the 
relationship between metabolite concentrations and contractile intensity and duration during 
both continuous and intermittent models of electrical stimulation and in vivo exercise (Hintz 
et al. 1982; Ivy et al. 1987; Bangsbo et al. 2001; Ferguson et al. 2001; Krustrup et al. 2003). 
Moreover, the maintenance of phosphorylation potential appears to be inversely related to 
exercise intensity. Work by Krustrup and colleagues (2003) revealed significant differences in 
ATP and creatine phosphate (CP) degradation in response to either low (50% VO2peak) or high 
(110% VO2peak) intensity exercise, in which the more intense exercise generated a 20% 
greater degradation in muscle ATP concentration. Likewise, Ivy and co-workers (1987) have 
shown a concomitant decrease in CP concentration as exercise intensity increases during a 
graded exercise protocol to exhaustion. Exercise duration also results in modulation of 
phosphorylation potential whereby exercise at a constant work rate has been shown to 
increase the rate of ATP turnover, reducing mechanical efficiency with continued exercise 
(Bangsbo et al. 2001). 
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Any cellular stress that inhibits ATP synthesis or accelerates ATP consumption (e.g. 
exercise-induced contraction) and subsequently increases the AMP:ATP ratio potentially 
initiates numerous downstream molecular events in skeletal muscle (Hardie and Sakamoto 
2006). As a primary messenger for adaptive signalling, phosphorylation state appears to 
principally exert its effect via a potent secondary messenger, the 5’adenosine monophosphate 
activated protein kinase (AMPK; Sakamoto and Goodyear 2002; Hawley and Zierath 2004; 
Hardie and Sakamoto 2006). Therefore, phosphorylation potential and subsequent AMPK 
activation may ultimately regulate multiple cell signalling cascades for such diverse processes 
as glucose uptake, fatty acid oxidation, hypertrophy and gene expression (Aschenbach et al. 
2004). This ubiquitous kinase is discussed at greater length in section 1.2.2. 
Summary 
All mechanotransduction events are important in coordinating and transmitting the 
mechanochemical signals produced during exercise. Collectively, and in a coordinated 
manner, these signals provide the mechanistic framework by which exercise initiates and 
regulates intra-cellular signal transduction to the transcriptional machinery in the nucleus, 
modulating gene expression and ultimately protein turnover, generating an exercise specific 
signal.  
 
1.2.2 Secondary Messengers 
Following initiation of the primary signal additional kinases / phosphatases are activated to 
mediate the exercise-induced signal. Numerous signalling cascades exist in mammalian cells 
and these pathways are highly regulated at multiple levels with substantial cross-talk between 
pathways producing a highly sensitive, complex transduction network. This review will 
consider major pathways of contraction and growth factor signalling in skeletal muscle. 
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5’Adenosine Monophosphate Activated Protein Kinase (AMPK) Mediated Signalling 
AMPK is a heterotrimeric protein consisting of three subunits (α, β, γ), and functions as a key 
regulator of energy homeostasis in skeletal muscle (Winder 2001; Aschenbach et al. 2004; 
Hardie and Sakamoto 2006; Witters et al. 2006). Each subunit of AMPK exists in multiple 
isoforms and its presence in skeletal muscle may be unique, in that it appears to be the only 
tissue containing all catalytic α-subunit (α1, α2) and regulatory β- (β1, β2) and γ-subunit (γ1, 
γ2, γ3) isoforms (Hardie and Sakamoto 2006). AMPK is directly activated by 5’AMP and 
consequently is sensitive to changes in cellular AMP:ATP ratios (Carling et al. 1987; Hardie 
et al. 1999). In addition, upstream kinases LKB1 and calcium calmodulin-dependent kinase 
kinase (CAMKK) also converge at threonine172 on the α-subunit to phosphorylate and activate 
AMPK in response to altered cellular AMP and Ca2+, respectively (Hawley et al. 2005; 
Hurley et al. 2005; Sakamoto et al. 2005; Woods et al. 2005; Witters et al. 2006).  
Acute activation of AMPK in response to cellular energy depletion (e.g. skeletal 
muscle contraction) initiates actions to both conserve and generate ATP (Witters et al. 2006). 
AMPK is implicated in enhancing ATP production by stimulating insulin-independent 
glucose uptake (Hayashi et al. 1998; Musi et al. 2001; Nakano et al. 2006) and increasing fat 
oxidation, primarily via inhibition of the β isoform of acetyl-CoA carboxylase (ACC-β) 
thereby reducing the synthesis and inhibitory effects of malonyl-CoA and subsequently 
increasing fatty acyl-CoA translocation into the mitochondria (Merrill et al. 1997; Kaushik et 
al. 2001; Aschenbach et al. 2004; Lee et al. 2006). Additional effects of contraction-mediated 
AMPK activation are less clear but may result in multiple adaptive events including altered 
protein synthesis and gene expression (Figure 1.5). AMPK has been linked to control of gene 
expression by activating transcription factors associated with mitochondrial fatty acid 
oxidation and the inhibition of protein synthesis by down-regulating components of the 
insulin / insulin-like growth factor signalling pathway (Bolster et al. 2002; Zong et al. 2002; 
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Kimura et al. 2003; Terada and Tabata 2003; Jorgensen et al. 2005; Terada et al. 2005; Lee et 
al. 2006). 
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Figure 1.5 Putative contraction-mediated adaptive events associated with 5’Adenosine 
Monophosphate Activated Protein Kinase (AMPK) activation in skeletal muscle. + positive 
effect, – negative effect, V variable positive/negative effect, ? unknown effect; Ca2+, calcium; 
CHO, carbohydrate (adapted from Aschenbach et al. 2004 and Witters et al. 2006). 
 
Activation of AMPK in skeletal muscle has been shown in a variety of systems 
including in vitro / in vivo contraction, pharmacological activators and transgenic animals 
(Nielsen et al. 2003b; Sakamoto et al. 2004b; Atherton et al. 2005; Jorgensen et al. 2005; 
Toyoda et al. 2006). Current evidence suggests that isoform specific AMPK activation occurs 
in a time, intensity, fibre-type and mode-specific manner and exercise-induced contraction of 
skeletal muscle in vivo has been clearly shown to up-regulate AMPK activity (Durante et al. 
2002; Nielsen et al. 2003b; Yu et al. 2003; Frøsig et al. 2004; Atherton et al. 2005; Hurst et al. 
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2005; McConell et al. 2005; Sriwijitkamol et al. 2005; Taylor et al. 2005; Wojtaszewski et al. 
2005; Toyoda et al. 2006). 
In vitro activation of AMPK has revealed that while increased AMPK activity occurs 
in both red and white muscle, α1 and α2 isoform activity is greatest in red fast-twitch muscle 
(Ai et al. 2002). Findings in vivo following treadmill running support the contention that 
AMPK activation is greater in red compared to white muscle (Rasmussen and Winder 1997; 
Durante et al. 2002). Importantly, interpretation of the available literature with regard to fibre-
type specific AMPK activity is limited because most studies have incorporated exercise 
protocols unlikely to significantly recruit white muscle (i.e. endurance running or swimming). 
However, Taylor and colleagues (2005) recently compared the effects of moderate-intensity 
endurance training and high-intensity interval training on AMPK signalling. They found that 
high-intensity interval training induced a significant additive effect to endurance training on 
LKB1 activity in white but not red quadriceps suggesting that white muscle may generate 
substantial AMPK responses when sufficiently stimulated. Nevertheless, our current 
understanding of fibre-type specific AMPK responses is incompletely resolved. 
Commensurate with its proposed role as an ‘energy sensing’ kinase, AMPK activation 
occurs in an intensity-dependent manner and has been shown to increase with increasing 
contraction force, treadmill speed and cycling power (Rasmussen and Winder 1997; Ihlemann 
et al. 1999; Musi et al. 2001; Chen et al. 2003; Wadley et al. 2006). While acute low intensity 
in vitro contraction has been shown to activate AMPK α1 but not α2 isoforms (Toyoda et al. 
2006), sub-maximal aerobic exercise in vivo appears to primarily increase AMPK α2 activity 
(Fujii et al. 2000; Wojtaszewski et al. 2000; Durante et al. 2002; Stephens et al. 2002; Yu et 
al. 2003). Indeed, endurance exercise-induced activation of AMPK is predictable given its 
ability to increase ATP regeneration via fat oxidation to meet the demands of prolonged low-
intensity contraction. Interestingly, this exercise response seems to be dependent on the 
adaptive state of the muscle as evidence exists to demonstrate that short-term and chronic 
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aerobic training reduces the acute AMPK response to prolonged and intermittent sub-maximal 
exercise (Durante et al. 2002; Yu et al. 2003; Hurst et al. 2005; McConell et al. 2005). 
However, the AMPK response in endurance trained athletes may be conserved with adequate 
overload as high-intensity interval training (~90% VO2max) has been shown to increase AMPK 
α1 and α2 in highly trained cyclists (Clark et al. 2004). Furthermore, AMPK α1/α2 isoform 
activity and ACC phosphorylation is also significantly up-regulated following short duration 
(~30 s) supra-maximal sprint cycling, likely due to the extensive and rapid reduction in 
cellular ATP (Chen et al. 2000).  
Few studies investigating AMPK signalling have incorporated resistance training as a 
stimulus. Hence our knowledge of AMPK signalling following this mode of contractile 
activity is limited. Work by Wojtaszewski and colleagues (2005) utilised six wk of 
progressive overload resistance training at 50-80% of one repetition maximum (1-RM) in 
healthy and diabetic subjects. Their data reveal a significant increase in the protein expression 
of AMPK α1, β2 and γ1, but not α2 isoforms independent of the subject’s health status. 
Interestingly, Dreyer et al. (2006) report an increase in AMPK activity after an acute bout of 
resistance training in humans, yet they observed increased α2 but not α1 activity. Koopman 
and co-workers (2006) also observed increased AMPK phosphorylation following an acute 
bout of resistance training, although it should be noted that the training load in that study (16 
sets x 10 reps, 2 min recovery) would likely induce a high metabolic stress typically 
associated with endurance training. Resistance exercise-induced changes in AMPK 
phosphorylation may reflect an increase in insulin-independent cellular glucose uptake and 
transport. However, the physiological significance of increased AMPK following resistance 
training has yet to be determined.  
Information on differences in AMPK responses between endurance and resistance 
training has not been extensively investigated. However, intricate work by Atherton and co-
workers (2005) indicates mode-specific AMPK activation with acute bouts of “endurance-
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like” and “resistance-like” contraction. Using electrical stimulation to mimic endurance or 
resistance loading, these workers show increased AMPK phosphorylation immediately and 3 
h post-exercise following “endurance-like” but not “resistance-like” contraction in slow-
twitch soleus and fast-twitch extensor digitorum longus muscle. Therefore, given the 
dissimilar functional adaptive outcomes with chronic endurance versus resistance training the 
possibility exists that AMPK signalling is a key intermediate for the divergent adaptation with 
these different exercise modes.  
 
Ca2+ calmodulin-dependent kinase (CaMK) / Calcineurin Signalling 
Contraction-stimulated alterations of intra-cellular [Ca2+] induce both direct and hierarchical 
signalling responses in skeletal muscle (Chin 2005; Koulmann and Bigard 2006). 
Specifically, calmodulin (CaM) is an intermediate binding protein sensitive to increases in 
[Ca2+] and acts as a calcium sensing unit that transduces Ca2+ flux (>30 Hz) via 
conformational changes in its protein motifs before subsequently activating downstream 
kinases and phosphatases (Chin 2005). Calcineurin is a Ca2+ / calmodulin-dependent 
phosphatase that acts as a molecular translator of Ca2+ flux activated by a sustained, low 
amplitude signal (~10 Hz) (Olson and Williams 2000; Michel et al. 2004). 
The Ca2+-calmodulin-dependent serine / threonine kinases (CaMK) detect and respond 
to physiologically relevant [Ca2+] and incorporates a group of single and multi-functional 
kinases (Chin 2005). The specific kinases from the CaMK family found in skeletal muscle are 
not well defined but existing evidence indicates that CaMKII and IV are expressed in skeletal 
muscle (Wu et al. 2002; Rose and Hargreaves 2003). CaMKII and IV have been linked with 
activation of gene expression of contractile and mitochondrial proteins, respectively (Fluck et 
al. 2000; Wu et al. 2002). CaMKII activity has been shown to increase with stretch overload 
and wheel running animal models (Fluck et al. 2000) and with cycling exercise in humans 
(Rose and Hargreaves 2003). Indeed, it appears CaMKII is the predominant multifunctional 
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CaMK in response to endurance exercise and is rapidly up-regulated after commencing 
exercise in an intensity-dependent manner (Rose et al. 2006). While transgenic animals 
selectively expressing CaMKIV appear to enhance mitochondrial biogenesis following 
electrical stimulation (Wu et al. 2002), these findings are contentious as other investigators 
have failed to detect CaMKIV protein in skeletal muscle (Rose and Hargreaves 2003; 
Akimoto et al. 2004).  
 
 
 
 
 
 
 
 
 
 
 
Cytoplasm
Nucleus
Ca2+
Ca2+
Ca2+
Ca2+
Ca2+
CaN CaMK
Ca2+
mRNA TranscriptionNFAT GATAMEF2
NFAT
NFAT
P
HDAC
HDAC P
Figure 1.6 Proposed mechanisms for calcium-dependent increases in gene expression with 
skeletal muscle contractile activity. Bars denote inhibition and arrows denote activation. Ca2+, 
calcium; CaN, calcineurin; CaMK, calmodulin kinase; HDAC, histone deacetylase; MEF2, 
myocyte enhancer factor 2; NFAT, nuclear factor of activated T-cells (adapted from Liu et al. 
2005).  
 
Conclusive mechanistic data linking the effect of CaMK activation to cellular 
adaptation is currently lacking but downstream effects may be mediated, at least in part, 
through histone deacetylase nuclear extrusion via calcium signalling (Figure 1.6; Chin 2005; 
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Liu et al. 2005). Prolonged, low-amplitude intra-cellular calcium transients increase 
calcineurin activity that dephosphorylates and activates transcriptional promoters to up-
regulate gene expression (Michel et al. 2004; Koulmann and Bigard 2006). The principle 
substrate targets of calcineurin include the nuclear factor of activated T cells (NFAT) and 
myocyte enhancer factor 2 (MEF2) families of transcription factors (Liu et al. 2005). 
Calcineurin has been implicated in several adaptive responses inducing muscle fibre growth / 
regeneration and slow fibre-type gene expression (Dunn et al. 1999; Musaro et al. 1999; Naya 
et al. 2000; Sakuma et al. 2003). Calcineurin appears to act as a co-regulator of muscle 
hypertrophy with insulin-like growth factor and may also contribute to myogenic proliferation 
and differentiation of satellite cells during skeletal muscle regeneration (Dunn et al. 1999; 
Musaro et al. 1999; Dunn et al. 2000; Sakuma et al. 2003; Scicchitano et al. 2005). The use of 
calcium / calmodulin inhibitors has been shown to suppress growth of overloaded muscle 
fibres while calcineurin over expression reduces disuse atrophy (Dunn et al. 1999; Dunn et al. 
2000). In addition, research suggests calcineurin is also involved in fibre-type plasticity and 
fast-to-slow phenotype transformation (Naya et al. 2000; Michel et al. 2004; Parsons et al. 
2004; Talmadge et al. 2004). Indeed, it has been proposed that calcineurin-induced gene 
expression of slow fibre and oxidative genes may result in the acquisition of a more 
metabolically efficient phenotype (Chin et al. 1998; Wu et al. 2000a; Michel et al. 2004). 
Such diverse calcineurin regulated adaptive pathways appear paradoxical (i.e. hypertrophy 
versus oxidative phenotype) but may represent alternating adaptation responses that are 
specific to the intensity and duration of contractile activity. 
While research investigating Ca2+-calmodulin-calcineurin-dependent signalling has 
provided mechanistic insight into the role of this pathway in skeletal muscle, it should be 
noted our current understanding appears to be limited to cell culture and transgenic animal 
models. Importantly, few works have investigated the role of Ca2+-dependent signalling in 
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humans, and the effect of exercise on calmodulin-calcineurin pathways remains to be 
established. 
 
Insulin / Insulin-like Growth Factor (IGF) Signalling Pathway 
The insulin / IGF signalling pathway incorporates many of the molecular components critical 
to our current understanding of muscle proteolysis and regulation of hypertrophy and atrophy 
processes (Glass 2003; Heszele and Price 2004; Sartorelli and Fulco 2004; Glass 2005; 
Taniguchi et al. 2006). Moreover, many of these components have additional roles for the 
regulation of glucose uptake, glycogen synthesis, and cell growth and differentiation 
(Taniguchi et al. 2006). The expression and importance of IGF-1 in skeletal muscle has been 
demonstrated in a variety of models from cell culture to human in vivo (DeVol et al. 1990; 
Vandenburgh et al. 1991; Adams and McCue 1998; Musaro et al. 1999; Chakravarthy et al. 
2000b; Rommel et al. 2001; Dehoux et al. 2004; Stitt et al. 2004; Latres et al. 2005). 
Contractile activity in skeletal muscle stimulates the secretion of IGF-1 which acts as 
an autocrine / paracrine growth factor, binding to its membrane receptor and initiating a 
cascade of molecular events (Figure 1.7; Glass 2003). IGF-1 binding to the receptor tyrosine 
kinase phosphorylates the insulin receptor substrate-1 (IRS-1) which subsequently activates 
phosphatidylinositol-3-OH kinase (PI3K; Backer et al. 1992). PI3K catalyses phosphate 
transfer (phosphatidylinositol-4, 5 biphosphate [PIP2] / -3, 4, 5 triphosphate [PIP3]) which 
ultimately recruits additional kinases, protein kinase B / AKT and PDK1 (3’ 
phosphoinositide-dependent protein kinase 1) to the cell membrane (Stephens et al. 1998; 
Wick et al. 2000). AKT may be negatively regulated via PIP3 dephosphorylation  by lipid-
binding phosphatase and tensin homologue (PTEN) and SH2-containing inositol 5’-
phosphatase-2 (SHIP2; Sleeman et al. 2005; Tang et al. 2005). Nevertheless, when activated 
AKT phosphorylates multiple substrates mediating important aspects of carbohydrate 
metabolism as well as protein synthesis and degradation. 
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Figure 1.7 Simplified IGF-1 signalling pathway from receptor binding to protein synthesis.  
Dashed arrows designate that phosphorylation activates the substrate and bars denote 
inhibition, whereas grey arrows denote phosphorylation events that result in inactivation of 
the substrate. IGFR, insulin-like growth factor receptor; IGF-1, insulin-like growth factor-1; 
IRS1, insulin receptor substrate 1; PIP2/3, phosphatidylinositol-4, 5 biphosphate / -3, 4, 5 
triphosphate; PI3K, phosphatidylinositol-3-OH kinase; PDK1, 3’ phosphoinositide-dependent 
protein kinase 1; FoxO, forkhead box O; mTOR; mammalian target of rapamycin; GSK3β, 
glycogen synthase kinase 3β; 4EBP1, eukaryotic initiation factor 4E-binding protein; 
eIF2B/4E eukaryotic initiation factor 2B/4E; p70S6K, p70 ribosomal S6 kinase (adapted from 
Sartorelli and Fulco 2004). 
 
AKT / Protein Kinase B 
There are three isoforms of the serine / threonine AKT family, two of which (AKT1 and 2) 
are primarily expressed in skeletal muscle (Glass 2003; Nader 2005). Furthermore, the 
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different AKT isoforms appear to have distinct functions: AKT1 has been associated with 
muscle hypertrophy whereas AKT2 has been implicated in signalling to glucose transport 
(Taniguchi et al. 2006). Following translocation to the cell membrane AKT is phosphorylated 
by PDK1 at threonine308 but requires secondary phosphorylation at serine473 for full 
activation, a role for which the mammalian target of rapamycin-rictor (mTOR-rictor) complex 
has recently been implicated (Sarbassov et al. 2005b; Taniguchi et al. 2006). Of late, a PH 
domain leucine-rich repeat protein phosphatase (PHLPP) has been shown to dephosphorylate 
AKTser473 and suppress growth in cancer cells but this down-regulation of AKT has yet to be 
confirmed in skeletal muscle (Gao et al. 2005). 
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Figure 1.8 Proposed adaptive events associated with activation of AKT in skeletal muscle. 
IGF-1, insulin-like growth factor-1. 
 
AKT has numerous molecular targets commensurate with its varied physiological 
functions including those involved in protein synthesis (mTOR, tuberous sclerosis complex 2 
 [TSC2], glycogen synthase kinase 3 [GSK3]), atrophy (forkhead box O1 [FoxO1]), and 
glucose uptake (AKT substrate of 160 kDa [AS160]) (Figure 1.8; Bodine et al. 2001b; 
Rommel et al. 2001; Inoki et al. 2002; Stitt et al. 2004; Bruss et al. 2005; Cai et al. 2006). 
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While mTOR is considered a down-stream target of AKT via phosphorylation at serine2448 
(Nave et al. 1999; Bodine et al. 2001b), evidence is emerging that mTOR also phosphorylates 
AKT when bound to its associated protein rictor suggesting mutual activation under certain 
conditions (Hresko and Mueckler 2005; Sarbassov et al. 2005b; Sarbassov et al. 2006). 
Regardless, there is strong evidence the PI3K-AKT-mTOR pathway mediates hypertrophy in 
skeletal muscle via activation of translation initiation and increased ribosomal protein content 
(Bodine et al. 2001b; Rommel et al. 2001; Lai et al. 2004; Nader et al. 2005). In addition, 
AKT regulation of AMPK activity and direct phosphorylation of TSC2 and GSK3β may 
suppress their role as inhibitors of protein synthesis (Rommel et al. 2001; Inoki et al. 2002; 
Hahn-Windgassen et al. 2005; Cai et al. 2006). AMPK phosphorylates TSC2 which 
subsequently inhibits the hypertrophic actions of mTOR, while GSK3β prevents activation of 
eukaryotic initiation factor (eIF) 2B (Tee et al. 2002; Vyas et al. 2002; Garami et al. 2003; 
Hahn-Windgassen et al. 2005). Thus, in addition to mTORser2448 phosphorylation, AKT may 
also indirectly enhance translation initiation and protein synthesis through inhibition of 
AMPK-TSC2 and GSKβ. Similarly, phosphorylation of the nuclear transcription factor FoxO 
by PI3K-AKT has been shown to sequester FoxO from the nucleus to the cytosol preventing 
transcription initiation of atrophy genes responsible for degradation of contractile protein, 
thereby mediating a protective effect on skeletal muscle by down-regulating pathways of 
protein degradation (Rena et al. 2002; Stitt et al. 2004; Latres et al. 2005). 
There is conflicting data regarding AKT responses to contractile activity in skeletal 
muscle (Table 1.1). A variety of electrical stimulation and surgical ablation protocols have 
been shown to increase AKT phosphorylation in both red and white rodent skeletal muscle 
(Turinsky and Damrau-Abney 1999; Nader and Esser 2001; Sakamoto et al. 2002; Atherton et 
al. 2005; Bruss et al. 2005; Thomson and Gordon 2006).  
  
 
Table 1.1 Summary of research investigating AKT responses to contractile overload in skeletal muscle. 
P, phosphorylation; A, activity; T, total protein; ES, electrical stimulation; HF, high-frequency; LF, low-frequency. 
Author    Species Stimulus Results
Thomson & Gordon (2006) Rat One wk surgical ablation P + T - >100% increase 
Atherton et al. (2005) Rat 1) HFES – 10 x 6 @ 3 s contractions 2) LFES 3 h P – 1) HFES = 8-fold increase 2) LFES = no change 
Bruss et al. (2005)  Rat In vitro epitrochlearis contractions (5 min) P – 150% increase 
Parkington et al. (2003) Rat HFES – 10 x 10, 3 s contractions  P + T - no change 
Sakamoto et al. (2002) Rat In situ contractions (1, 2.5, 5, 15, 30 min) P – increased in all muscle types (range 1.6-13-fold)  
Bodine et al. (2001) Rat Surgical ablation (7, 14 & 30 d) T – increased 4-fold @ 14 d P – 9-fold @ 14 d 
Nader/Esser (2001) Rat 1) HFES – 10 x 6 @ 3 s contractions 2) LFES 30 min  
3) Treadmill – 30 min @ 83%  VO2max
P – increase 1) HFES= 38%   2) LFES= 40%  
3) Run = no change  
Turinsky/Damrau-Abney (1999) Rat ES of the calf muscle (1 contraction/s 5, 15, 25 min) AKT 1-A – 3-fold increase, AKT 2 + 3-A – no effect 
Sherwood et al (1999) Rat ES of the sciatic nerve (2, 5, 10, 15, 30, 60 min) A – no change 
Lund et al. (1998) Rat In vitro contractions of soleus (5 min) A – no change 
Brozinick/Birnbaum (1998) Rat ES of epitrochlearis/soleus A – no significant increase  
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P, phosphorylation; A, activity; T, total protein; RM, repetition maximum; VO2max, maximum oxygen consumption; ECC, eccentric; CON, concentric. 
Author Species Stimulus Results
Dreyer et al. (2006) Human Resistance 10 x 10 leg extensions @ 70% 1RM P – 100% increase 
Eliasson (2006) Human Resistance 1) 4 x 6 ECC 2) 4 x 6 CON P – no change 
Wilson et al. (2006) Human Cycle 60 min @ ~70%  VO2max P – 50% increase 
Creer et al. (2005) Human Resistance – 3 x 10 @ 70% 1RM P – 1.5-fold increase 
Sakamoto et al. (2004) Human Cycle 1) 30 min @ 75%  VO2max 2) 6 x 60 s @ 125%  
VO2max
A – increase 1) 75%  VO2max = 40% 2) 125%  VO2max  
= 110%  
Thorell et al. (1999) Human Cycle – 60 min @ 70% VO2max P – 180% increase 
Widegren et al. (1998) Human Cycle – 60 min one-leg @ 70% VO2max A – no change 
Williamson et al. (2006) Rat Treadmill – 10% grade 26/m/min for 10, 20, 30 min P – no change 
Reynolds et al. (2004) Rat Voluntary wheel running (3 months) P + T – 45-50% increase 
Krisan et al. (2004) Rat Resistance –  3 x 10 @ 75% 1RM 3/wk (12 wk) A + T – no change 
Bolster et al. (2003) Rat Resistance – 1 x 50 each day for 4 d P –~200% increase 
Sakamoto et al. (2003) Rat Treadmill 1) 60 min @ 20m/min+12% grade 2) 
16m/min, grade increased 1% every 2 min to fatigue 
A – increase 1) 60 min= 80%  - 150%  
                     2) Fatigue= 150%  - 150%  
Markuns et al. (1999) Rat Treadmill – 5, 10, 30, 60 min @ 25m/min (10% gde) A + P = no change  
Wojtaszewski et al (1999) Mice 
(MIRKO)
Treadmill – 60 min @ 22m/min (10%) P – no effect 
Table 1.2 Summary of research investigating AKT responses to exercise in skeletal muscle. 
 
 
 
 
Equally, a number of studies have also observed no change in phosphorylation of AKT 
following electrical stimulation (Brozinick Jr. and Birnbaum 1998; Lund et al. 1998; 
Sherwood et al. 1999; Parkington et al. 2003). Moreover, in vivo contraction after running and 
resistance training in rodents has also produced conflicting findings where AKT has been 
reported to increase (Bolster et al. 2003b; Sakamoto et al. 2003; Reynolds et al. 2004) or 
remain unchanged (Markuns et al. 1999; Nader and Esser 2001; Krisan et al. 2004; Eliasson et 
al. 2006; Williamson et al. 2006b) in response to exercise (Table 1.2). Notably, Bolster et al. 
(2003b) examined the time-course of AKT response to resistance exercise and observed peak 
AKT phosphorylation 5-15 min following a bout of resistance training. Conversely, Dreyer 
and colleagues (2006) observed an increase in AKT phosphorylation 60 min after an acute 
bout of resistance training in humans. Differences in the contractile stimulus, timing of 
muscle tissue collection and isoform specific response may have contributed to the diverse 
and conflicting findings. 
Work by Wilson et al. (2006), Sakamoto and colleagues (2004) and Thorell and co-
workers (1999) has shown that moderate duration (30- 60 min) low- (~70% VO2max) and high-
intensity (~125% VO2max) cycling exercise is sufficient to increase AKT phosphorylation in 
humans. Similarly, Creer et al. (2005) observed a significant increase in AKT 
phosphorylation 10 min after a bout of moderate-intensity resistance training. In contrast, 
Widegren and co-workers (1998) found no change in AKT activity 15 min post-exercise after 
60 min cycling at 70% VO2max. These conflicting results bring into question the specific role 
and functions of AKT in contraction-mediated training responses. However, differences in 
species, experimental design, fibre-type, substrate availability, and mode and intensity / 
duration of contractile activity may partly explain some of these discordant findings.  
While strong evidence exists for AKT as a critical regulator of adaptation in skeletal 
muscle, defining and validating its role with in vivo exercise models remains elusive. Heavy 
resistance training increases muscle tension and hypertrophy while endurance training 
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increases substrate turnover and utilisation. Therefore, the increase in AKT observed with 
diverse exercise modes described previously may be expected considering AKT’s putative 
regulation of protein synthesis and glucose transport, respectively. Indeed, AKT appears to be 
a primary signalling mediator of training-specific adaptation to both endurance and resistance 
training in skeletal muscle.  
Mammalian target of rapamycin (mTOR) 
Protein complexes involving mTOR (also known as FKBP12 rapamycin-associated protein, 
FRAP) are capable of sensing diverse signals and produce a multitude of responses including 
mRNA translation, ribosomal biogenesis and nutrient metabolism (Sarbassov et al. 2005a). 
Two mTOR protein complexes exist where mTOR binds with a G-beta-L protein (GβL) and 
either a rapamycin-sensitive raptor or a rictor protein (Figure 1.9; Kim et al. 2003; Sarbassov 
et al. 2005b; Sarbassov et al. 2006). Work utilising rapamycin to manipulate mTOR activity 
indicates the mTOR-GβL-raptor complex is a positive regulator of cell growth while mTOR-
GβL-rictor appears to have a key role in AKT activation and actin cytoskeleton regulation 
(Takano et al. 2001; Sarbassov et al. 2004; Park et al. 2005; Wang et al. 2005; Sarbassov et al. 
2006). 
Due to mTOR-rictor mediated activation of AKT it appears mTOR bound with rictor 
acts upstream and therefore is involved in regulating mTOR-raptor. In addition to AKT, 
upstream regulators of mTOR-raptor include the Ras homologue enriched in brain (Rheb) G 
protein (Manning and Cantley 2003). Rheb is in turn regulated upstream by the TSC1/2 
complex and has been shown to regulate mTOR signalling and its subsequent downstream 
targets by an unknown mechanism (Tee et al. 2002; Garami et al. 2003). Primary downstream 
targets of mTOR-raptor include p70 ribosomal S6 kinase (p70 S6K), eukaryotic initiation 
factor 4E-binding protein (4E-BP1) and eukaryotic initiation factor 4B (eIF4B) which links 
mTOR with mRNA translation and increased protein synthesis and cell size (Bodine et al. 
2001b; Raught et al. 2004; Ali and Sabatini 2005; Ohanna et al. 2005; Ruvinsky and Meyuhas 
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2006). However, the mechanisms of mTOR-raptor activity in adaptation processes are not 
known and roles for additional kinases in this process cannot be ruled out (Sarbassov et al. 
2005a). Nevertheless, altered mTOR activity has been observed in response to nutrients, 
mechanical stimuli and contraction in skeletal muscle (Hornberger et al. 2004; Parkington et 
al. 2004; Vary and Lynch 2006).  
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Figure 1.9 Model of the regulation and functions of the mammalian target of rapamycin 
(mTOR) complex. Bars denote inhibition and arrows denote activation. AMPK, adenosine 
monophosphate kinase; TSC2, tuberous sclerosis complex 2; Rheb, Ras homologue enriched 
in brain; GβL, G beta L protein; 4E-BP1, eukaryotic initiation factor 4E-binding protein; 
S6K, ribosomal S6 kinase; (adapted from Sabassov 2005). 
 
Overloaded plantaris following surgical ablation has been shown to increase mTOR 
phosphorylation and total protein in both young and aged rodent skeletal muscle (Reynolds et 
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al. 2002; Thomson and Gordon 2006). Work by Parkington and colleagues (Parkington et al. 
2003; Parkington et al. 2004) and Atherton and co-workers (2005) has used intermittent high-
frequency electrical stimulation and induced significant increases in mTOR phosphorylation 
in a number of different muscle groups. Conversely, no change in mTOR phosphorylation 
was seen following sustained low-frequency electrical stimulation, suggesting a tension-
specific contractile response (Atherton et al. 2005). However, these contractile stimuli may 
not represent physiological loading as voluntary wheel running and resistance training in 
rodents have been shown to increase mTOR phosphorylation (Bolster et al. 2003b; Reynolds 
et al. 2004).  
It is difficult to reconcile an increase in mTOR activity following an endurance 
exercise stimulus such as voluntary wheel running, although emerging evidence suggests that 
mTOR may be involved in regulating mitochondrial function (Schieke et al. 2006). However, 
the reported changes in aged rodents following chronic (3 months) wheel running were 
increased total mTOR protein content but not mTOR activity (Reynolds et al. 2004). 
Accordingly, the elevated total mTOR protein in aged rodent muscle relative to sedentary 
control may be the result of exercise-induced maintenance of muscle mass with aging rather 
than stimulating translation initiation and protein synthesis. In contrast, increased mTOR 
activation following resistance training seems plausible given its proposed role in protein 
synthesis in response to a hypertrophy stimulus (Bolster et al. 2003b). Few studies have 
investigated the activation of mTOR in skeletal muscle of humans in vivo. Recently, Dreyer 
and co-workers (2006) have shown an increase in mTOR phosphorylation up to 2 h after 
resistance exercise in humans, providing strong evidence for the role of mTOR in anabolic 
processes following resistance training. Indeed, mTOR appears to be a primary regulator of 
protein synthesis in response to resistance training that may also be modulated by physical 
activity with aging. 
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p70 S6K, 4E-BP1& eIF2B 
The most well-defined effectors of the PI3K-AKT-mTOR signalling pathway are the proteins 
implicated in translational control: ribosomal protein S6 kinase (S6K), eukaryotic initiation 
factor 4E-binding protein (4E-BP1) and eukaryotic initiation factor 2B (eIF2B; Bolster et al. 
2003a; Ruvinsky and Meyuhas 2006). Mammalian cells express two S6K isoforms (S6K1 and 
2) and S6K1 subsequently has duel cytosolic (p70 S6K) and nuclear (p85 S6K) isoforms 
(Ruvinsky & Meyuhas 2006). S6K appears to function downstream of mTOR-raptor and 
rodent knockout models have revealed that of the two isoforms, S6K1 predominantly 
regulates cell size in skeletal muscle (Shima et al. 1998; Ohanna et al. 2005). mTOR-raptor 
also regulates and suppresses 4E-BP1 (also known as phosphorylated heat and acid soluble 
protein stimulated by insulin, PHAS-1) via hyper-phosphorylation to derepress 4E-BP1 
inhibition of translation initiation cap binding protein eIF4E (Richter and Sonenberg 2005; 
Sarbassov et al. 2005a). Alternately, GSK3 regulates eIF2B and inhibits its actions which 
initiate ribosomal translation (Pavitt 2005). GSK3 is a phosphorylation target of AKT, which 
inhibits its negative effect on eIF2B thereby increasing translation and protein synthesis, and 
is therefore controlled to a large extent via insulin / IGF signalling (Welsh et al. 1997; 
Jefferson et al. 1999). 
S6K exerts its effect through multiple substrate targets and has been implicated in 
orchestrating the regulation of numerous cellular functions (Figure 1.10; Ruvinsky and 
Meyuhas 2006). Numerous studies provide compelling support for the fundamental role of 
p70 S6K in skeletal muscle hypertrophy (Baar and Esser 1999; Bodine et al. 2001b; Nader 
and Esser 2001; Karlsson et al. 2004; Lai et al. 2004; Atherton et al. 2005). Early work by 
Baar and Esser (1999) established a strong association between increased p70 S6K activity 
and skeletal muscle hypertrophy following 6 wk of high-frequency electrical stimulation. 
Subsequently, work from Bodine and co-workers (2001b) used surgical ablation and 
pharmacological intervention to highlight the important role for p70 S6K in skeletal muscle 
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hypertrophy processes. Further studies reveal that the exercise-induced p70 S6K response 
occurs with a resistance training-like stimulus and that endurance exercise does not up-
regulate p70 S6K activity (Nader and Esser 2001; Atherton et al. 2005; Kubica et al. 2005). 
Indeed, recent work showing increased p70 S6K phosphorylation with stretch activated 
mechanotransduction in skeletal muscle suggests that eccentric loading may be critical for 
S6K1 activation and therefore hypertrophy (Hornberger et al. 2005a; Hornberger et al. 2005b; 
Spangenburg and McBride 2006).  
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Figure 1.10 Putative downstream targets and functions of ribosomal protein S6K. Bars denote 
inhibition, arrows denote activation, and dashed lines indicate a putative effect. IRS-1, insulin 
receptor substrate-1; mTOR; mammalian target of rapamycin; eIF4B, eukaryotic initiation 
factor 4B; S6K, ribosomal protein S6 kinase; rpS6, ribosomal protein S6; eEF2, eukaryotic 
elongation factor 2; eEF2K, eukaryotic elongation factor 2 kinase. (adapted from Ruvinsky 
and Meyuhas 2006). 
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Studies performed on humans support the results of investigations undertaken in 
rodents in which up-regulation of S6K1 and p70 S6K has been observed following an acute 
bout of resistance training (Karlsson et al. 2004; Eliasson et al. 2006; Koopman et al. 2006). 
The chronic regulation of hypertrophy and other cell processes by S6K1 is less clear 
considering its possible reciprocal effects on protein synthesis and negative feedback to PI3K-
AKT-mTOR signalling through IRS-1 phosphorylation (Ruvinsky and Meyuhas 2006). 
Given the well-documented co-regulation by mTOR-raptor, it is not surprising that 
4E-BP1 phosphorylation in skeletal muscle emulates that of S6K1 to a large extent. Studies 
utilising surgical ablation and high-frequency electrical stimulation consistently show an 
increase in 4E-BP1 phosphorylation in skeletal muscle in rodents (Bodine et al. 2001b; 
Atherton et al. 2005; Funai et al. 2006; Thomson and Gordon 2006). Furthermore, as 
translation initiation cap binding is prevented when dephosphorylated 4E-BP1 is bound to 
eukaryotic initiation factor (eIF) 4E, skeletal muscle overload has also been shown to produce 
a decrease in 4E-BP1-eIF4E binding and subsequent increases in eIF4E-eIF4G association 
(Bodine et al. 2001b; Kubica et al. 2005). Significant increases in phosphorylation of 4E-BP1 
have also been observed following several resistance exercise models (Bolster et al. 2003a; 
Kubica et al. 2005). Conversely, an endurance-like stimulus has been shown to decrease 4E-
BP1 phosphorylation indicating a negative effect of endurance training on translational 
machinery and protein synthesis (Atherton et al. 2005). Interestingly, Koopman and 
colleagues (2006) recently observed reduced 4E-BP1 phosphorylation immediately and 2 h 
after an acute bout of resistance training. However, these authors incorporated an atypical 
resistance training protocol including a high number of contractions with short recovery 
periods generating elevated metabolic stress and AMPK activity. This training stimulus could 
reduce activation of pathways involved in protein synthesis in a manner similar to endurance 
training. 
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Contraction-induced eIF2B activity is predominantly controlled by AKT-GSK3β and 
represents a rate limiting step for translation initiation (Welsh et al. 1997; Jefferson et al. 
1999; Pavitt 2005). Moreover, evidence exists that eIF2B may also be regulated in an mTOR 
dependent manner (Kubica et al. 2005). Nevertheless, of the multiple eIF2B subunits the 
epsilon subunit may represent a principal site for activation with contraction (Kubica et al. 
2005). Contractile activity has been shown to reduce GSK3β phosphorylation of eIF2B 
thereby relieving inhibition and increasing translation (Farrell et al. 2000; Kostyak et al. 2001; 
Vary et al. 2002). In response to resistance exercise significant dephosphorylation of eIF2B 
enhancing its availability for translation initiation and increases in eIF2B total protein and 
mRNA levels have been shown (Farrell et al. 2000; Kostyak et al. 2001; Kubica et al. 2004; 
Kubica et al. 2005). The effect of endurance training on eIF2B is unclear although in view of 
its regulation of glycogen metabolism, GSK3 activity would be expected to increase with 
endurance exercise but may be repressed during recovery with carbohydrate feeding. Indeed, 
Atherton and colleagues (Atherton et al. 2005) employed endurance–like contractile activity 
in rodent skeletal muscle and observed a significant increase in GSK3β and eIF2B 
(deactivation) phosphorylation immediately and following 3 h recovery, respectively. 
However, eIF2B responses to resistance or endurance exercise have not been investigated in 
human skeletal muscle. 
Taken together, these findings provide strong evidence for the resistance training-
induced increase in protein synthesis via IGF signalling, but may also include other currently 
unknown kinases acting directly on mTOR-raptor or its downstream kinases. In addition, 
endurance training appears to have a significant negative effect on the translational 
machinery.  
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Cytokine Signalling 
Cytokines function as inter-cellular signalling molecules and act as facilitators of receptor 
subunit assembly to induce an intra-cellular signal (Cannon and St. Pierre 1998). Cytokines 
are small polypeptides released at the site of inflammation in response to numerous factors 
including cachexia, sepsis, and exercise-induced muscle damage (Cannon and St. Pierre 1998; 
Jackman and Kandarian 2004; Glass 2005; Petersen and Pedersen 2005). Several cytokines 
have been implicated in initiating protein degradation and suppression of protein synthesis 
following injury in skeletal muscle, most notably tumor necrosis factor alpha (Garcia-
Martinez et al. 1993; Glass 2005; Williamson et al. 2005).  
Tumor Necrosis Factor Alpha (TNFα) 
Elevated TNFα concentration generates an increase in the activity of ubiquitin-conjugated 
protein degradation and inhibition of insulin / IGF mediated protein synthesis (Garcia-
Martinez et al. 1993; Garcia-Martinez et al. 1994; Fernandez-Celemin et al. 2002; Plomgaard 
et al. 2005; Williamson et al. 2005; Lang et al. 2006). Furthermore, TNFα has also been 
shown to negatively affect anabolic processes by destabilising myogenic differentiation and 
altering transcriptional activity (Langen et al. 2004; Vashisht Gopal et al. 2006). Suppression 
of the insulin / IGF signalling pathway by TNFα has been shown to induce insulin resistance 
via impaired phosphorylation of IRS-1 and the AKT substrate AS160 kDa (del Aguila et al. 
1999; de Alvaro et al. 2004; Plomgaard et al. 2005), and suppress protein synthesis through a 
decrease in IGF-1 and IGF-binding protein gene expression, subsequently inhibiting 
elongation initiation and mRNA translational efficiency in skeletal muscle (Lang et al. 2002; 
Williamson et al. 2005; Lang et al. 2006). Early studies using intravenous administration of 
TNFα revealed a significant time-dependent increase in free ubiquitin and ubiquitin gene 
expression highlighting the role of TNFα with regard to elevated muscle proteolysis (Garcia-
Martinez et al. 1993; Garcia-Martinez et al. 1994). This effect has subsequently been linked to 
downstream intermediates stimulating ubiquitin ligase gene expression and therefore muscle 
 39
atrophy (Fernandez-Celemin et al. 2002; Li et al. 2003; Cai et al. 2004; Li et al. 2005; Lang et 
al. 2006).   
Work by Sriwijitkamol and colleagues (2006) revealed a 40% decrease in TNFα 
protein content in subjects following eight wk of cycling, indicating a positive effect of low-
intensity aerobic exercise on low-grade inflammation and metabolic status in skeletal muscle. 
Conversely, strenuous exercise, particularly heavy eccentric contractions associated with 
resistance training, would be expected to generate an acute increase in local inflammation and 
rise in TNFα concentration. Indeed, there is a significant increase in circulating systemic 
TNFα after muscle damaging eccentric resistance training and marathon running (Ostrowski 
et al. 1999; Del Aguila et al. 2000). Similarly, Hamada and colleagues (2004) observed an 
increase in TNFα mRNA abundance 3 d after a 45 min bout of downhill running in muscle 
samples of healthy subjects, indicative of an acute inflammatory response associated with 
exercise-induced muscle damage. Thus, it appears that exercise is capable of generating pro- 
and anti-inflammatory effects on skeletal muscle in an intensity- and mode-dependent 
manner, mediated at least in part via TNFα activation. However, the chronic effects of 
repeated bouts of high-intensity exercise and the specific adaptive response with altered 
intensity, duration and frequency of contraction and mode of exercise on TNFα activity 
remain to be established.  
Previous studies have predominantly utilised cell culture, pathological states or 
intravenous administration to identify the effect of TNFα. Hence, our knowledge of 
contraction-induced changes in TNFα and subsequent alterations within skeletal muscle is 
limited. Moreover, most investigations have focused on regulators and effectors of TNFα 
signalling, namely inhibitor of NFκB kinase (IKK), nuclear factor kappa enhancer binding 
protein (NFκB) and p38 mitogen activated protein kinase. 
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Inhibitor Kappa B Kinase (IKK) & Nuclear Factor Kappa B (NFκB) 
The binding of TNFα to its receptor at the cell membrane initiates a cascade of intra-cellular 
events. An important component of this cytokine mediated pathway is the activation of a 
kinase that inhibits IκB (Chen 2005; Chen et al. 2006). When IκB is bound to the nuclear 
transcription factor NFκB, IκB suppresses its role as a promoter of gene expression (Chen 
2005; Natoli et al. 2005; Tergaonkar et al. 2005; Bosisio et al. 2006). TNFα signals through 
the TNF-receptor-associated factor (TRAF) and transforming growth factor beta activated 
kinase 1 (TAK1) proteins to phosphorylate and activate IKK (Chen et al. 2006).  
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Figure 1.11 Simplified TNFα pathway initiating nuclear transcription. TNFR, tumor necrosis 
factor receptor; TRAF2/5, TNF-receptor-associated factor 2/5; TAK1, transforming growth 
factor beta activated kinase 1; IκB, inhibitor of nuclear factor kappa enhancer binding protein; 
IKKα/β, inhibitor kappa B kinase; P, phosphorylation; p50/65, nuclear factor kappa enhancer 
binding protein complex (adapted from Chen 2005 & Chen et al. 2006). 
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Phosphorylation of IκB by IKK targets it for ubiquitination and subsequent 
degradation, releasing the NFκB dimeric complex (p50/p65) to initiate the expression of 
genes involved in multiple cell processes including ubiquitin-mediated protein degradation 
(Figure 1.11; Alkalay et al. 1995; Chen et al. 1995; Scherer et al. 1995; Tergaonkar et al. 
2005). Moreover, while this orthodox regulation of NFκB activity is well-accepted there are 
numerous additional putative mechanisms of activation and transcriptional and post-
translational control (Bae et al. 2003; Duran et al. 2003; Schwabe and Sakurai 2005; 
Steinbrecher et al. 2005; Kearns et al. 2006). Indeed, NFκB exists as multiple complexes 
resulting in altered function and is induced by a diverse array of stimuli with immense 
diversity in the effects and consequence of its activation that can both promote and suppress 
cell growth and metabolic status (Perkins and Gilmore 2006). 
Recently, work by Cai and colleagues (2004) established a mechanistic link between 
IKKβ / NFκB and expression of atrophy genes in skeletal muscle confirming the findings of 
previous investigations that identified a relationship between NFκB activation and muscle 
atrophy in models of disuse and muscular dystrophy (Hunter et al. 2002; Kumar and Boriek 
2003). Cai and co-workers (2004) utilised muscle-specific transgenic expression of IKKβ or 
an IκB repressor to selectively activate or repress NFκB and skeletal muscle wasting, and the 
subsequent gene expression of the atrophy promoting ubiquitin ligase muscle ring finger 
protein (MuRF). Additional work in cell culture provides support for the proposed initiation 
of ubiquitin-proteasome transcriptional machinery in a NFκB-dependent manner (Wyke and 
Tisdale 2005). Collectively, these results indicate that up-regulation of the IKK / NFκB / 
MuRF pathway exacerbates atrophy in skeletal muscle. 
 Given the capacity of contractile activity to induce local and systemic stress / 
inflammation and disturb cell homeostasis, exercise represents a stimulus capable of 
increasing NFκB activity in skeletal muscle. Yet, contractile activity is also of critical 
importance for maintaining cell functions including enhanced protein synthesis and 
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preserving muscle mass. Ex vivo mechanical stretch of diaphragm muscle activates IKK / 
NFκB and promotes IκB degradation with an ensuing increase in NFκB / DNA binding 
(Kumar and Boriek 2003). Likewise, an acute bout of endurance exercise (60 min, ~75% 
VO2max) has been shown to decrease IκB content, and increase IKK and NFκB 
phosphorylation in rodent skeletal muscle (Ji et al. 2004; Ho et al. 2005). In contrast, Durham 
and colleagues (2004) observed a decrease in NFκB activity following a severe bout of 
resistance training in humans and with electrical stimulation in rodents. While the low sample 
numbers (four human, five rodent) necessitate that these results are interpreted cautiously, an 
explanation for these discordant findings is unclear. Indeed, a vigorous resistance training 
session with repeated eccentric contractions would typically be expected to result in muscle 
damage, inflammation and muscle remodelling. To date, only one training study has 
investigated the effects of exercise on TNFα signalling. In that investigation, 14 subjects 
performed 8 wk of sub-maximal cycling (4 x wk, 45 min, 70% VO2peak) and had increased 
IκB and reduced TNFα protein content in skeletal muscle, indicating a decrease in IKK / 
NFκB signalling (Sriwijitkamol et al. 2006). These findings may be interpreted as a protective 
effect of sub-maximal intensity aerobic activity on the inflammatory response, decreasing 
local inflammation and cellular disturbance. 
Altered transcriptional responses through signal transduction to NFκB with exercise-
induced contraction may be an important process in skeletal muscle adaptation. Acute training 
bouts may increase NFκB activity for transient adaptive events such as immune or anti-
apoptotic responses, while chronic training may reduce total NFκB activity and subsequent 
protein degradation enabling net protein synthesis. Regardless, due to the innumerable 
functional outcomes of NFκB transcriptional control much work remains to fully elucidate the 
cause and effect relationship between exercise and NFκB activity. 
 
 
 43
Mitogen Activated Protein Kinase (MAPK) Signalling Pathway 
Of all the secondary messenger systems, the mitogen activated protein kinase pathway may be 
the most complex, induced by a variety of stimuli and regulating numerous diverse functions 
in mammalian cells. The MAPK family is conserved in eukaryotic cells and co-ordinately 
regulates activities including gene expression, mitosis, metabolism, survival and apoptosis 
(Figure 1.12; Roux and Blenis 2004). Of the five distinct MAPK groups, two have been most  
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Figure 1.12 Proposed pathways of activation and molecular targets of MAPK signalling. 
MAPK, mitogen activated protein kinase; MEK, mitogen activated kinase; ERK, extracellular 
regulated kinase; RSK, ribosomal S6 kinase; MSK, mitogen and stress activated kinase; 
MNK, MAPK-interacting kinase; MK, mitogen protein kinase; GSK, glycogen synthase 
kinase; IκB, inhibitor kappa B; NFκB, nuclear factor kappa B; TNFα, tumor necrosis factor 
alpha; eEF, eukaryotic elongation factor; eIF, eukaryotic initiation factor; 4E-BP1, eukaryotic 
initiation factor 4E-binding protein (adapted from Roux and Blenis 2004). 
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characterised with regard to exercise responses, the extracellular signal-regulated kinases 1 
and 2 (ERK1/2) and p38 isoforms α, β, γ, and δ (Sakamoto & Goodyear 2002). ERK1/2 
appear to be preferentially activated in response to growth factors while p38 is more 
responsive to an assortment of stress stimuli (Roux and Blenis 2004). 
Upon activation ERK1/2 and p38 can modulate gene expression and protein synthesis 
via phosphorylation of multiple targets including cytosolic proteins and transcription factors, 
or translocate directly to the nucleus where they can also regulate transcription factor activity 
(Figure 1.12; Sakamoto & Goodyear 2002). Moreover, the capacity of exercise-induced 
contractile activity to induce MAPK activation is undeniable yet determining the specificity 
of response and the resultant physiological outcome remains elusive (Nielsen et al. 2003a; 
Thong et al. 2003; Williamson et al. 2003). 
ERK1/2 
A relatively large number of studies have investigated the effect of exercise on MAPK 
activity in vivo human skeletal muscle (Table 1.3) and increased ERK1/2 activity has been 
consistently observed following exercise regardless of intensity, duration, mode of exercise or 
subject training status. Interestingly, this response may be attenuated with aging (Williamson 
et al. 2003). It has been postulated that ERK1/2 is involved in a “general” response to exercise 
that could include up-regulation of non-specific immediate early response genes or signalling 
pathways important for increasing global rates of transcription and / or translation (Assoian 
2002; Galetic et al. 2003; Atherton et al. 2005; Shahbazian et al. 2006; Williamson et al. 
2006b). Despite the common response of ERK1/2 with diverse exercise stimuli it is 
reasonable to suggest that ERK1/2 mediates divergent adaptation processes. Moreover, the 
role of ERK1/2 in regulating immediate early gene (IEG) responses and the cell cycle 
programme has been shown to be dependent on the strength and duration of the signal (Wu et 
al. 2000b; Assoian 2002; Murphy et al. 2002; Murphy et al. 2004). Signal duration of ERK1/2 
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P ,phosphorylation; A, activity; T, total protein; RM, repetition maximum; PWC, peak work capacity; BCAA, branch chain amino acids; H-CHO, high carbohydrate, L-CHO, low 
carbohydrate; KE, knee extension. 
Author Stimulus Results
Creer et al. (2005) Resistance 3 x 10 @ 70% 1-RM 1) H-CHO 2) L-CHO ERK-P 1) 120% 2) 120% p90 RSK-P 1) 290% 2) 550% 
Richter et al. (2004) Cycle 1) 10 min @ 35, 60, 85% VO2max   
          2) 30 min @ 35% VO2max
ERK-A 1) ~100% @ 35% no further increase @ 60/85% 2) ~100%  
ERK-P 1) 35%VO2 = ~100%; 60%VO2 = ~220%; 85%VO2 = ~500% 2) ~100% 
McGee & Hargreaves (2004) Cycle 60 min @ 70% VO2peak Total p38-P 380% Nuclear p38-P 80% 
Chan et al. (2004) Cycle 60 min @ 70% VO2peak 1) Normal 2) L-CHO Nuclear p38-P 1) ~80% 2) ~110% 
Karlsson et al. (2004) Resistance 4 x 10 @ 80% 1-RM 1) BCAA 2) water ERK-P – 700% p38-P – 400% (no effect with BCAA)  
Nielsen et al. (2003) Cycle 20 min @ 80% VO2peak 1) Sed 2) Trained  ERK-A 1) 40% 2) 38% p38-P 1) 1000% 2) 950% 
Thompson et al. (2003) 1) 50 eccentric contractions 2) 30 min -10% downhill treadmill ERK-P 1) 200% 2) –53% ERK-T 1) 424% 2) no change 
Thong et al. (2003) 60 min 1-leg kicks (alt 5 min @ 75 & 100% PWC) p38-P up 40% compared with rest leg 
Williamson et al. (2003) Resistance 3 x 10 (KE) @ 70% 1-RM 1) old 2) young ERK-P 1) –48% 2) 75% p90-P 1) –60% 2) 100% p38-P 1) –17% 2) 18% 
Yu et al. (2003) Cycle 8 x 5 min @85% VO2peak 1) Untrained 2) Trained ERK-P 1) 171% 2) 42% p38-P 1) 120% 2) 50% 
Yu et al. (2001) Marathon ERK-P 400% p38 400% 
Boppart et al. (2000) Marathon p38γ-P 300%  p38γ-A 50% 
Krook et al. (2000) Cycle 1-leg @ 70% VO2max MSK ½-A 400% &  200% p90 RSK-A 2500% MapKap2-A 330% vs. rest  
Widegren et al. (1998) Cycle 1-leg @ 70% VO2max ERK-P 31 fold @ 30 min (75% 30 min response @ 60 min) p38-P 2.2 fold 
Aronson et al. (1997) Cycle 60 min @ 70% VO2max ERK-P 4-24 fold 
Table 1.3 Summary of research investigating MAPK responses to exercise in vivo human skeletal muscle. 
 
alters the functional activity of gene product and ultimately controls the biological outcome 
(Murphy et al. 2002). Indeed, in regulating progression of the myogenic programme ERK1/2 
appears to initially interfere with differentiation but later enhances myotube formation (Wu et 
al. 2000b). In addition, a high degree of crosstalk may also contribute to regulation of ERK1/2 
activity. Notably, AKT has been shown to regulate components of ERK1/2 signalling, fine-
tuning differentiation and proliferation in the cell cycle (Rommel et al. 1999; Moelling et al. 
2002; Galetic et al. 2003).  
Distinguishing between sustained and transient signal duration and alterations in 
signal strength may significantly alter the role of ERK1/2 in subsequent adaptation processes, 
particularly in satellite cell activation. Collectively, these factors may represent a mechanism 
for the specificity of response with diverse modes of exercise considering the extended 
duration of contraction with endurance training versus the greater contraction intensity during 
heavy resistance training. Evidence exists for a specific role of ERK1/2 in response to 
resistance training, in which ERK1/2 has been implicated as a regulator of hypertrophy in 
skeletal muscle. Phosphorylation of TSC2 by ERK1/2 suppresses TSC2 inhibition of mTOR 
and downstream mediators of translation initiation (Ma et al. 2005). ERK1/2 also directly 
regulates eIF4B phosphorylation via its downstream effector p90 ribosomal protein S6 kinase 
(RSK) increasing translation efficiency (Shahbazian et al. 2006). Regardless, due to the 
common response of ERK1/2 following endurance and resistance exercise the precise 
functions of ERK1/2 have yet to be determined and more work is needed to clearly define the 
role of ERK1/2 in specific exercise-induced adaptation.  
p38 
Activation of p38 MAPK has been observed following both endurance and resistance exercise 
in humans (Yu et al. 2001; Karlsson et al. 2004; McGee and Hargreaves 2004). It seems that 
p38 is responsible for the regulation of multiple cell processes including myogenic and 
mitochondrial gene expression and ubiquitin ligase activity making it difficult to establish a 
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clear role for p38 in the adaptation response to exercise (Akimoto et al. 2005; Li et al. 2005; 
Lluis et al. 2006). Previous findings have established an unequivocal role for p38 MAPK in 
controlling muscle gene expression in the myogenic process (Wu et al. 2000b; Lluis et al. 
2006). This multi-step process that is primarily orchestrated by myogenic regulatory factors is 
in large part regulated by p38 which may also act as a molecular switch for the activation of 
satellite cells (Suelves et al. 2004; Jones et al. 2005; Lluis et al. 2005). In addition, a study by 
Li and colleagues (2005) revealed that p38 was also involved in the regulation of muscle 
atrophy, mediating the TNFα-induced gene expression of muscle atrophy F-box protein. 
Therefore, p38 may be involved in the regulation of both hypertrophy and atrophy processes 
suggesting an important role for p38 in adaptation responses to resistance training. The 
complexity of MAPK-mediated signalling in skeletal muscle is highlighted by the notion that 
p38 has recently been implicated in mitochondrial biogenesis (Akimoto et al. 2005). Akimoto 
and co-workers (2005) initially observed a correlation between the peroxisome proliferator 
activated receptor γ co-activator 1α (PGC-1α), a transcription factor that promotes 
mitochondrial biogenesis, and p38 MAPK activation. In addition, work in cells and transgenic 
mice by these workers revealed PGC-1α and cytochrome oxidase IV (COX IV) protein 
expression occurred in response to p38 activation. Furthermore, p38 activity has also been 
shown to regulate myocyte enhancer factor 2 (MEF2) dependent genes, including PGC-1α 
(Zhao et al. 1999; McGee and Hargreaves 2004). Thus, p38 may promote mitochondrial 
biogenesis and therefore may also have a significant role in adaptation following endurance 
training. The conundrum of MAPK responses to exercise limits our current understanding of 
the potential functions and physiological outcomes that contribute to the specificity of training 
adaptation. Indeed, much of our knowledge regarding MAPK responses with exercise rests on 
correlation data with little information currently available regarding the mechanisms of 
regulation.  
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Summary 
It is apparent that multiple secondary messengers and signalling pathways are activated or 
repressed in response to an exercise stimulus and that these pathways induce a multi-faceted 
adaptation process. While our current understanding of intra-cellular signalling is 
incompletely resolved, it is clear that exercise-induced contractile activity generates activation 
of common and distinct signalling intermediaries in response to the intensity, duration and 
mode of contraction. Ultimately, this complex transduction network produces an increase in 
the transcription of particular genes and subsequent gene product to promote phenotypic 
adaptation in an exercise specific manner. 
 
1.3 Genetic and Molecular Responses to Exercise 
Adaptive events distal to primary and secondary signalling culminate in the synthesis of new 
protein containing genetically determined information to carry out specific functions 
(Bouchard et al. 1997; Flück and Hoppeler 2003). This molecular process is highly regulated 
at numerous sites from DNA copying to the assembly of gene product (Figure 1.13). While 
there is a paucity of evidence showing detailed continuity between specific signalling 
pathways, gene expression and subsequent protein synthesis, signalling proteins have been 
shown to activate numerous immediate early genes, transcription factors and molecular 
machinery responsible for promoting the rate of transcription of target gene messenger RNA 
(Zhao et al. 1999; Cai et al. 2004; Murphy et al. 2004; Sandri et al. 2004; Simone et al. 2004). 
Generally, the directional change of mRNA transcription is the same as the directional change 
of the protein generating a new steady state adaptation in the muscle milieu (Booth and 
Baldwin 1996). Increased mRNA quantity should translate into greater functional protein 
abundance although multiple control mechanisms may alter the end state adaptation. 
 
 49
 Gene
DNA
Transcription
RNA Splicing
Primary RNA Transcript
mRNA
Transport
Nucleus
Cytoplasm
mRNA
Ribosome
Polypeptide
Translation
Functional Protein
Post-translation Modification
Stage 1
Stage 2
Stage 3
Stage 4
Stage 5
A
B
C D
E
F
 
 
 
 
 
 
 
 
 
 
 
Figure 1.13 Five stages of gene expression and sites of regulation (A-F; adapted from 
Bouchard, Melina and Perusse 1997).  
 
Moreover, the balance of mRNA synthesis versus degradation, the baseline abundance of 
each specific protein, and additional translational control mechanisms all contribute to net 
protein synthesis (Flück and Hoppeler 2003). The following sections will highlight important 
genetic and molecular adaptation responses with endurance and resistance exercise, and 
examine the effect of concurrent endurance and resistance training on the specificity of 
adaptation in skeletal muscle. 
 
1.3.1 Endurance Exercise 
Endurance training elicits both central and peripheral adaptations, alters neural recruitment 
patterns, and causes profound changes in muscle bioenergetics and enhanced morphological, 
metabolic substrate and acid-base status in skeletal muscle (Hawley 2002). Briefly, endurance 
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adaptation results in increased muscle glycogen stores and glycogen sparing at submaximal 
workloads via increased fat oxidation, enhanced lactate kinetics and morphological alterations 
including greater type I fibre proportions per muscle area, and increased capillary and 
mitochondrial density. Moreover, repeated bouts of endurance exercise results in altered 
expression of a multiplicity of gene products, resulting in an altered muscle phenotype with 
improved resistance to fatigue (Adhihetty et al. 2003). Mitochondria are the main subcellular 
structures that determine the oxidative capacity and fatigue resistance to prolonged contractile 
activity in skeletal muscle (Hoppeler and Flück 2003). Endurance training can increase steady 
state mitochondrial protein content 50-100% within ~6 wk, but a protein turnover half-life of 
~1 wk means a continuous training stimulus is required to maintain elevated mitochondrial 
content (Hood 2001). While enhanced oxygen kinetics, substrate transport, and buffering 
capacity all contribute to enhanced endurance capability in skeletal muscle, improved 
endurance is most associated with the increase in mitochondrial density and enzyme activity, 
termed mitochondrial biogenesis (Adhihetty et al. 2003; Irrcher et al. 2003). 
Mitochondrial Biogenesis 
The expansion of the mitochondrial reticulum in skeletal muscle is a highly regulated and 
complex process that appears to require the co-ordinated expression of a large number of 
genes (Goffart and Wiesner 2003; Irrcher et al. 2003). Mitochondrial biogenesis requires the 
co-expression of both the nuclear and mitochondrial genomes for assembly and expansion of 
the reticulum and 95% of the genes necessary for biogenesis are encoded in the nucleus 
(Hood 2001; Goffart and Wiesner 2003). Thus, an important aspect of mitochondrial 
biogenesis is the import machinery regulating the transport of nuclear encoded precursor 
proteins into the organelle (Irrcher et al. 2003). However, expression of genes promoting 
mitochondrial biogenesis is predominantly controlled by the global principles of gene 
regulation, that is, transcription initiation and interaction at the gene promoter (Goffart and 
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Wiesner 2003). Therefore, transcription factors and transcriptional co-activators represent 
critical regulators of mitochondrial biogenesis. 
 Numerous transcription factors have been implicated in regulating expression of genes 
involved in mitochondrial biogenesis (Adhihetty et al. 2003). While no single transcription 
factor has been found to be responsible for the co-ordination of mitochondrial gene 
expression, several candidates appear to be important for mitochondrial biogenesis. These 
include the immediate early genes (c-fos, c-jun), early growth response gene-1 (Egr-1) and 
nuclear respiratory factors-1 and -2 (NRF-1/2; Hood et al. 2006). Egr-1 is associated with 
promoting transcription of the electron transport chain protein cytochrome C oxidase (COX; 
(Freyssenet et al. 2004) while NRF-1 and NRF-2 are implicated in the transcriptional control 
of multiple mitochondrial genes including mitochondrial transcription factor A (Tfam) and 
recently identified mitochondrial transcription specificity factors TFB1M and TFB2M 
(Scarpulla 2002; Gleyzer et al. 2005). The Egr and NRF transcription factors increase in 
response to serum stimulation or contractile activity (Connor et al. 2001; Irrcher and Hood 
2004; Gleyzer et al. 2005) and NRF-1 and -2 mRNA have been shown to increase in response 
to both acute and chronic endurance exercise (Baar et al. 2002; Short et al. 2003). 
 The peroxisome proliferator receptor gamma co-activator-1 alpha (PGC-1α) has been 
established as an important regulator of mitochondria content in skeletal muscle due to its 
apparent co-activation of multiple mitochondrial transcription factors (Finck and Kelly 2006; 
Hood et al. 2006). Indeed, PGC-1α is the founding member of a family of transcriptional co-
activators that has been proposed as a potential “master regulator” of mitochondrial 
biogenesis (Adhihetty et al. 2003; Scarpulla 2006). In support of this contention, Lin and co-
workers (2002) over expressed PGC-1α in mice skeletal muscle and observed increased 
proportions of type I fibres and increased resistance to fatigue. In addition, the biogenesis and 
maintenance of mitochondrial architecture is controlled by altered rates of mitochondrial 
protein fusion and fission (Santel and Fuller 2001), a role for which mitofusin (Mfn) 1/2 
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proteins have been strongly implicated (Bach et al. 2003; Santel et al. 2003). Recent evidence 
indicates that PGC-1α mediates a regulatory pathway involving estrogen-related receptor 
alpha (ERRα) and Mfn1/2, and this pathway has been shown to be up-regulated following a 
10-km cycling time trial (Cartoni et al. 2005; Soriano et al. 2006). This suggests that a PGC-
1α activated pathway promotes an increase in mitochondrial content in response to endurance 
exercise through enhanced mitochondrial protein fusion.  
Similarly, PGC-1α also mediates Tfam activation, a key component in mitochondrial 
DNA replication and transcription (Kanki et al. 2004; Maniura-Weber et al. 2004). The NRF-
1 transcription factor has been shown to activate Tfam which enhances the capacity for 
assembly of protein complexes within the mitochondria (Scarpulla 2006). Therefore, as a co-
activator of NRF-1 transcription PGC-1α is involved in regulating Tfam function (Wu et al. 
1999). Importantly, Tfam  activity appears to increase in response to contractile activity and 
exercise suggesting enhanced mitochondrial protein assembly with endurance training 
(Bengtsson et al. 2001; Gordon et al. 2001).  
Most notably, PGC-1α is the co-activator of the peroxisome proliferator activated 
receptor (PPAR) family (Vega et al. 2000; Oberkofler et al. 2002). The three PPAR sub-types 
α, γ and δ have distinct functions but all appear to regulate lipid homeostasis via expression of 
genes involved in mitochondrial fatty acid oxidation (Lee et al. 2003; Finck and Kelly 2006). 
The physiological significance of increased PGC-1α-PPAR activated gene expression with 
endurance training is an enhanced capacity for fat utilisation during prolonged exercise, and 
may also be related to fast-to-slow fibre type conversion (Luquet et al. 2003; Wang et al. 
2004). Indeed, this was highlighted by Wang and colleagues (2004) who generated transgenic 
mice over expressing PPARδ that resulted in a 2.3-fold increase in mitochondrial DNA 
content, significant type I fibre transformation and a 90% increase in running performance 
(Figure 1.14). The small numbers of studies investigating PPAR activation following exercise 
support these findings where both acute (Jorgensen et al. 2005; Russell et al. 2005) and 
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chronic (Luquet et al. 2003; Mahoney et al. 2005; Fritz et al. 2006) endurance exercise 
induces PPAR transcription.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.14 Peroxisome proliferator receptor delta (PPARδ) regulates exercise endurance. A) 
Enhanced exercise performance in the transgenic PPARδ-over expression mice (TG) versus 
wild type (WT) mice. B) Compromised exercise performance in transgenic PPARδ-null mice 
(Null) compared with wild type (WT) mice. C) Putative functions of PPARδ in skeletal 
muscle (reproduced from Wang et al. 2004). 
 
The available evidence suggests that increased PGC-1α-PPAR mediated transcription 
is an important endurance adaptation and imperative for establishing an endurance phenotype. 
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Taken collectively, the results from the studies reviewed here not only implicate PGC-1α in 
the regulation of aerobic metabolism but also mitochondrial architecture and fast-to-slow fibre 
type transformation. The upstream signalling events that activate PGC-1α gene expression are 
not well defined and various pathways have been implicated including AMPK, calcineurin, 
p38 MAPK and FoxO1 (Zong et al. 2002; Akimoto et al. 2005; Southgate et al. 2005; Finck 
and Kelly 2006). Intriguingly, PGC-1α activation may be complicated by the fact that some 
transcription factors that are co-activated by PGC-1α may also be responsible for its up-
regulation (Hood et al. 2006).  
Endurance exercise has been routinely shown as a potent stimulator of PGC-1α gene 
and protein expression (Pilegaard et al. 2000; Baar et al. 2002; Norrbom et al. 2003; Psilander 
et al. 2003; Terada and Tabata 2003; Cluberton et al. 2005; Jorgensen et al. 2005; Terada et 
al. 2005). In contrast, due to its specific role in mitochondrial biogenesis, no studies have 
investigated the role of PGC-1α following resistance training. However, as might be expected, 
a significant decrease in PGC-1α protein was observed after high-frequency electrical 
stimulation to mimic the effects of resistance training (Atherton et al. 2005). Accordingly, 
exercise-induced up-regulation of PGC-1α represents an essential molecular response in our 
current understanding of mitochondrial biogenesis and exercise specific adaptation to 
endurance but not resistance training in skeletal muscle. 
Metabolic Gene Expression 
In addition to mitochondrial biogenesis, increased gene expression of metabolic proteins 
following endurance exercise contributes to promoting an enhanced endurance phenotype 
(Mahoney et al. 2005). These include genes encoding enzymes and transporters involved in 
carbohydrate and fat metabolism such as hexokinase, lipoprotein lipase and carnitine 
palmitoyltransferase (Pilegaard et al. 2000; Tunstall et al. 2002). Endurance exercise has been 
shown to increase the mRNA abundance and transcription of a variety of metabolic genes in 
the post-exercise recovery period (Pilegaard et al. 2000; Tunstall et al. 2002; Hildebrandt et 
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al. 2003; Pilegaard et al. 2005; Yang et al. 2005). This up-regulation of metabolic genes 
following exercise appears to peak in the initial hours of recovery and generally returns to 
resting levels within 24 h (Pilegaard et al. 2005; Yang et al. 2005). It has been postulated that 
the cumulative effect of this transient up-regulation with repeated bouts of exercise may be an 
underlying mechanism for exercise-induced adaptation with endurance training (Pilegaard et 
al. 2000). However, in contrast to PGC-1α activity resistance training may also alter the 
expression of a number of metabolic genes (e.g. PDK4), but this moderate effect may be 
restricted to those proteins involved in carbohydrate metabolism (Yang et al. 2005). In 
addition, evidence suggests that nutrient availability has a significant effect on the exercise 
response of a variety of metabolic genes. Therefore, nutrient-gene interactions represent a 
variable that may promote or suppress metabolic exercise-induced adaptation in skeletal 
muscle (Vissing et al. 2004; Pilegaard et al. 2005; Hawley et al. 2006). 
 
1.3.2 Resistance Exercise 
Increased muscle cross-sectional area and altered neural recruitment patterns represent the 
principal adaptations to repeated bouts of heavy resistance exercise (Häkkinen 1989). 
Increased cross-sectional area (i.e. hypertrophy) following resistance training is a result of an 
increase in protein mass per cross-sectional area of tissue which occurs when the rate of 
protein synthesis is greater than protein degradation (Chesley et al. 1992; Phillips et al. 1997). 
Fundamentally, the hypertrophy response to overload is qualitatively and quantitatively 
controlled via the production of cellular proteins and new muscle cells. Adaptation to 
resistance training includes increased protein synthesis via regulatory changes in 
transcriptional and translational mechanisms, and in the production of muscle cells that are 
added to existing myofibres or combine and form new contractile filaments, each providing 
additional contractile machinery with which to generate force (Bolster et al. 2003a; Rennie et 
al. 2004; Sartorelli and Fulco 2004). In addition, while a degree of protein degradation is 
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required for muscle remodelling resistance training may also decrease chronic activation of 
atrophy pathways resulting in supplementary net protein synthesis (Jones et al. 2004).  
Hypertrophy 
Compensatory hypertrophy in skeletal muscle following resistance training involves an 
increase in ribosomal protein synthesis (Bolster et al. 2003a). Regulation of ribosomal protein 
synthesis is controlled by phosphorylation events altering mRNA translation initiation, 
elongation and termination, and the cellular ribosome content which determines the synthesis 
of protein per mRNA (Farrell et al. 2000; Wang et al. 2001; Hannan et al. 2003; Richter and 
Sonenberg 2005). Modulation of translation initiation is a particularly important regulatory 
site for global protein synthesis in response to a resistance exercise stimulus and is the rate 
limiting step and most frequent target for translational control (Baar et al. 1999; Richter and 
Sonenberg 2005). The initiation step in translation is regulated by phosphorylation of 
eukaryotic initiation factors (eIFs) that mediate 40S ribosomal subunit binding to mRNA 
(Bolster et al. 2003a). The binding of 40S ribosome-mRNA is mediated by the interaction of 
multiple eIFs and ribosomal S6 protein that are the most distal components of the insulin / 
IGF-1 and MAPK signalling cascades (Glass 2005; Kubica et al. 2005; Shahbazian et al. 
2006). Given its ability to ultimately enhance protein synthesis through translation initiation 
IGF-1 and IGF-binding protein gene expression following an exercise stimulus has been the 
focus of extensive investigation.  
Over expression and localised infusion of IGF-1 have both been shown to induce 
significant skeletal muscle hypertrophy (Adams and McCue 1998; Musaro et al. 2001; Song 
et al. 2005). While a number of IGF isoforms and splice variants exist there is growing 
evidence elucidating the potential mechanisms that directly promote IGF-1 induced 
hypertrophy. Musaro and co-workers (1999) have demonstrated that IGF-1 mediated protein 
synthesis and hypertrophy involves IGF-1 induced calcineurin activation of GATA-2 and 
nuclear factor of activated T-cell (NFAT) transcription factors generating an increase in gene 
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expression. Moreover, there is compelling mechanistic data showing IGF-1 regulates 
increases in PI3K-AKT-mTOR signalling (Shen et al. 2005; Vary 2006). Importantly, these 
studies show p70 S6K and 4E-BP1 phosphorylation and eIF4E-eIF4G association, indicating 
IGF-1 activation of kinases proximal to the translational machinery. IGF-1 has also been 
shown to enhance satellite cell recruitment, proliferative potential and life span (Chakravarthy 
et al. 2000a; Chakravarthy et al. 2000b; Jacquemin et al. 2004). Thus, IGF-1 appears capable 
of inducing hypertrophy via an enhanced programme of gene expression, increased 
ribosomal-mediated translation, and satellite cell activation. Collectively, this strongly 
implicates IGF-1 as a potent multi-factorial regulator of hypertrophy. The co-ordination of the 
alternate adaptive machinery responsible for IGF-1 mediated hypertrophy responses is unclear 
but is likely to be specific to the intensity and duration of the overload stimulus.  
Skeletal muscle IGF-1 and IGF-binding protein mRNA and protein content increases 
in response to contractile activity in a variety of overload models (Adams et al. 1999; 
Spangenburg et al. 2002; Hameed et al. 2003; Adams et al. 2004; Bickel et al. 2005). 
However, the effect of resistance exercise on IGF-1 in vivo in humans is equivocal, as IGF-1 
mRNA has been reported to increase (Bamman et al. 2001; Kim et al. 2005; Petrella et al. 
2006), decrease (Psilander et al. 2003; Bickel et al. 2005) and remain unchanged (Bickel et al. 
2003; Hameed et al. 2003). Differences in exercise stimuli, individual variability and the 
unknown time course of expression for the IGF-1 response may provide some explanation for 
these discordant findings. Nonetheless, the IGF-1 genotype appears to enhance the strength 
response to resistance exercise in humans as the IGF-1 promoter polymorphism has been 
associated with greater strength gains following 10 wk of resistance training (Kostek et al. 
2005). Therefore, despite only partial clarity of in vivo human data the available evidence 
implicates IGF-1 gene expression in exercise-induced muscle hypertrophy in response to 
resistance training.  
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Activation and differentiation of non-specialised satellite cells into new muscle cells is an 
additional mechanism that contributes to compensatory hypertrophy (Sartorelli and Fulco 
2004). Eccentric contraction during resistance exercise is capable of inducing substantial 
damage to contractile and structural components of skeletal muscle (McCully and Faulkner 
1985; MacPherson et al. 1997). Satellite cells located at the basal lamina that surrounds a 
myofibre are activated for the repair and maintenance of the muscle milieu and addition of 
myonuclei, both important components for muscle regeneration and hypertrophy (Zammit et 
al. 2004; Petrella et al. 2006). During the course of regeneration satellite cells first exit their 
quiescent state and proliferate until secondary molecular signals arrest the mitotic activity and 
initiate the differentiation of non-specialised cells to muscle precursor cells that migrate to the 
site of regeneration (Figure 1.15; Charge and Rudnicki 2004).  
 
Figure 1.15 Schematic representations of events regulating satellite cell activation. Following 
muscle damage (A) quiescent satellite cells are activated to enter the cell cycle and proliferate 
and (B) is followed by terminal differentiation. (C-E) Cells then combine with damaged 
myofibres for repair or each other for new myofibre formation. (F) A subset of cells return to 
quiescent state to replenish the satellite cell pool. (G) Repaired or new fibres resemble 
original myofibres (adapted from Charge and Rudnicki 2004). 
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Primary regulators of satellite cell activation include the myogenic regulatory factor 
(MRF) family of transcription factors and cell cycle kinases, which provide molecular 
landmarks for the transition from satellite cell quiescence to activation, proliferation and 
differentiation (Zammit et al. 2004). The best characterised of the MRF’s are the myogenic 
differentiation (MyoD) and myogenin (MyoG) transcription factors. Activation of satellite 
cells in skeletal muscle is associated with rapid up-regulation of MyoD prior to cell 
proliferation and continues through differentiation, while MyoG up-regulation occurs in cells 
initiating the terminal differentiation programme (Cornelison and Wold 1997; Cornelison et 
al. 2000).  
Expression patterns from functionally overloaded skeletal muscle reveal that satellite 
cells express both MyoD and MyoG during the hypertrophy process and activated satellite 
cells can significantly contribute to activity-dependent muscle growth (Ishido et al. 2004b; Li 
et al. 2006; Petrella et al. 2006). A single bout of contractile activity is sufficient to increase 
cell cycle kinases and MyoD and MyoG mRNA abundance in skeletal muscle of both rodents 
and humans (Adams et al. 1999; Haddad and Adams 2002; Willoughby and Nelson 2002; 
Psilander et al. 2003; Bickel et al. 2005; Vissing et al. 2005; Yang et al. 2005). Moreover, this 
response does not appear to be attenuated with chronic resistance training (3 d/wk for 16 wk) 
which induced MyoD and MyoG mRNA responses equal to a single resistance training bout 
(Kosek et al. 2006). This implicates the MRF’s in contributing to the myogenic programme 
and resultant compensatory hypertrophy response with resistance training. However, 
increased MyoD and MyoG expression has also been observed following low-frequency 
electrical stimulation and endurance exercise (Kadi et al. 2004; Siu et al. 2004; Vissing et al. 
2005; Yang et al. 2005). Endurance cycling / swimming is unlikely to induce muscle damage 
and subsequent satellite cell activation; hence the MyoD / MyoG response to an endurance 
exercise stimulus has been postulated to regulate a pathway for exercise-induced changes in 
mitochondrial enzymes and / or muscle fibre type transformation (Kadi et al. 2004; Siu et al. 
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2004; Vissing et al. 2005). While there is an established role for MRF’s in satellite cell 
activation and subsequent increases in myonuclei number and myofibre size, it appears these 
transcription factors have additional and as yet undefined roles in skeletal muscle adaptation 
to exercise. 
Atrophy 
Skeletal muscle atrophy is characterised by a decrease in structural and contractile protein 
content and fibre diameter (Jackman and Kandarian 2004; Bassel-Duby and Olson 2006). 
Moreover, while hypertrophy pathways may suppress the activity of some mediators of 
protein breakdown, atrophy is not simply the reversal of hypertrophy but comprises unique 
mechanisms in a series of pathways regulating proteolysis (Sacheck et al. 2004; Glass 2005). 
Atrophy occurs when protein degradation exceeds protein resynthesis and is often prevalent in 
conditions such as inactivity, aging and disease (Jackman and Kandarian 2004; Reid 2005). 
The variety of conditions that generate a common outcome suggests that both reciprocal and 
distinct molecular signalling pathways contribute to the skeletal muscle atrophy programme 
(Jackman and Kandarian 2004).  
 Current understanding of skeletal muscle atrophy implicates at least three systems in 
the regulation of proteolysis. The calcium-dependent protease calpain family and proteolytic 
caspase class of proteins have been proposed to mediate skeletal muscle myofibrillar 
disassembly and cleavage of actomyosin protein, respectively (Tischler et al. 1990; Du et al. 
2004). Similarly, cathepsin, a proteolytic enzyme involved in lysosomal proteolysis has been 
implicated in the degradation of membrane proteins such as receptors, channels and 
transporters (Jackman and Kandarian 2004). While the initial fragmentation of structural and 
contractile protein via calpain, caspase or lysosomal pathways is required to enable 
degradation, the destruction of the protein fragments appears to be co-ordinated by a common 
system (Bodine et al. 2001a; Lecker et al. 2004).  
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The destruction of myofibrillar protein is primarily carried out by the ATP-dependent 
ubiquitin proteasome pathway (Kandarian and Jackman 2006). This pathway labels proteins 
by conjugation with ubiquitin and this composite protein is subsequently recognised and 
degraded via zinc-finger domain protein ZNF216 association with the 26S proteasome 
enzyme complex (Reid 2005; Hishiya et al. 2006). In addition, ubiquitin ligases may also 
degrade MyoD and inhibit subsequent satellite cell activation (Abu Hatoum et al. 1998; 
Mitchell and Pavlath 2004; Tintignac et al. 2005). Work by Bodine and colleagues (2001) and 
Gomes and co-workers (2001) has identified important ubiquitin ligase proteins that are up-
regulated during skeletal muscle atrophy; the muscle-specific atrophy F box (MAFBx, also 
known as atrogin-1) and muscle ring finger (MuRF) proteins. The evidence supporting their 
proposed role in muscle atrophy is compelling as the increase in gene expression of these 
ubiquitin proteins has been systematically induced with fasting, cachexia, diabetes, uremia, 
denervation, glucocorticoid release and disuse atrophy models (Bodine et al. 2001a; Jones et 
al. 2004; Lecker et al. 2004; Sacheck et al. 2004). The results from these studies suggest that 
the MAFBx and MuRF proteins are valid and reliable markers of skeletal muscle atrophy. 
However, the molecular proteins that initiate MAFBx and MuRF gene expression are still 
largely unknown (Figure 1.16). 
Principle candidates implicated in MAFBx and MuRF activation include the forkhead 
(FoxO) transcription factors and TNFα via p38 MAPK and NFκB (Glass 2005). FoxO has 
numerous regulatory sites mediated by AKT phosphorylation which stimulates the nuclear 
exclusion and inactivation of this transcription factor (Rena et al. 2002). Constitutively active 
FoxO acts on the MAFBx promoter to initiate MAFBx transcription and results in dramatic 
atrophy of myotubes and myofibres (Sandri et al. 2004). Moreover, in the absence of IGF-1 
signalling MAFBx and MuRF gene expression and muscle atrophy is increased, implicating 
AKT-FoxO interactions in mediating regulation of ubiquitin ligases (Sacheck et al. 2004; Stitt 
et al. 2004). Similarly, activation of NFκB through transgenic expression of IKKβ, and  
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Figure 1.16 Putative pathways regulating signalling to MAFBx / MuRF ubiquitin ligases. 
MAFBx, muscle atrophy F box protein; MuRF, muscle ring finger protein; IKK, inhibitor 
kappa B kinase; NFκB, nuclear factor kappa B; TNFα, tumor necrosis factor alpha; FoxO, 
forkhead box O; p38, p38 mitogen activated protein kinase (adapted from Cai et al. 2004).  
 
reactive oxygen species stimulated p38 MAPK activity, have been shown to increase MuRF 
and MAFBx gene expression, respectively (Cai et al. 2004; Li et al. 2005). Pharmalogical 
inhibition of IKKβ / NFκB and p38 results in inhibition of MuRF and MAFBx up-regulation 
and reverses muscle atrophy, providing further evidence for NFκB and p38 regulation of 
MuRF and MAFBx activation in the atrophy programme, respectively (Cai et al. 2004; Li et 
al. 2005).  
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Myostatin (or growth and differentiation factor 8) is a transforming growth factor-β 
family member that may not be classified as an atrophy-inducing factor per se but functions 
as an inhibitor of muscle hypertrophy (McNally 2004; Wagner et al. 2005). The role of 
myostatin as a negative regulator of hypertrophy is highlighted by the extraordinary increase 
in muscle mass of myostatin-deficient animals and humans (McPherron and Lee 1997; Lee 
and McPherron 2001; Schuelke et al. 2004). Furthermore, transgenic over expression of 
myostatin has been shown to reduce muscle mass, fibre size and myonuclei number, 
suggesting that increased myostatin expression may have the capacity to exacerbate atrophy 
(Reisz-Porszasz et al. 2003). Myostatin appears to exert its regulatory effect on muscle mass 
via inhibition of satellite cell proliferation, differentiation and self-renewal (Thomas et al. 
2000; Langley et al. 2002; McCroskery et al. 2003). Therefore, down-regulation of myostatin 
gene expression can result in hypertrophy and hyperplasia following skeletal muscle 
regeneration (Lee and McPherron 2001). 
The capacity of muscle contraction to repress, reverse or exacerbate various atrophy 
signalling pathways and catabolic states is still unclear. Early work by Sandri et al. (1997) 
showed that ubiquitin protein and associated apoptosis in mice increased following one night 
of voluntary wheel running. Their findings were later corroborated by other studies 
incorporating repeated bouts of resistance training that also induced a post-exercise increase 
in skeletal muscle ubiquitin protein content (Stupka et al. 2001; Willoughby et al. 2003). 
Indeed, Yang and colleagues (2006) observed an increase in MAFBx and MuRF mRNA 
abundance following a single bout of resistance exercise. Conversely, resistance training has 
also been shown to reduce MuRF and MAFBx gene expression and restore muscle mass and 
strength following 2-6 wk disuse atrophy, decreasing ubiquitin ligase mRNA abundance by a 
minimum ~40% (Jones et al. 2004; Dupont-Versteegden et al. 2006). Myostatin gene 
expression also appears to be reduced following resistance exercise in humans (Roth et al. 
2003; Kim et al. 2005; Raue et al. 2006), although a single study has reported an increase in 
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myostatin mRNA abundance after 12 wk resistance training (Willoughby 2004). Moreover, 
Matsakas and co-workers (2005) observed a decrease in myostatin mRNA in rodents 
following one and three days (2 x 60 min/d) of swimming training. The authors attributed this 
somewhat unexpected finding to the need for skeletal muscle remodelling with repeated 
concentric contractile activity (Matsakas et al. 2005).  
Interestingly, Haddad and colleagues (2006) provide evidence that an isometric 
training programme previously shown to induce hypertrophy (Adams et al. 2004) failed to 
maintain myofibril protein content during hind limb suspension, despite completely abating 
the increase in MAFBx, MuRF and myostatin mRNA. These workers suggest that to prevent 
muscle atrophy, maintaining optimal activity of hypertrophy pathways is required in addition 
to inhibiting the catabolic stimulus. Furthermore, training history is likely to alter the response 
of atrophic gene expression where acute bouts of resistance exercise in untrained muscle may 
induce an atrophy programme due to muscle damage, but may also be required for 
regeneration remodelling. Indeed, chronic resistance training may ultimately produce a 
decrease in atrophy gene expression thereby enhancing the capacity for compensatory 
hypertrophy. 
Collectively, these findings suggest that exercise-induced skeletal muscle contraction 
is capable of altering regulators of skeletal muscle atrophy including pathways regulating 
ubiquitin ligase and satellite cell activation. However, the interaction of mode of contraction, 
duration and intensity of exercise likely modifies the specific response of atrophy and / or 
hypertrophy pathways. In addition, exercise interventions in models of disease or disuse may 
induce molecular responses that do not accurately reflect changes in atrophy / hypertrophy 
pathways that occur with resistance training in healthy or athletic populations. Regardless, the 
proteolytic status in skeletal muscle is the result of the interactions between integrated atrophy 
and hypertrophy pathways generating a specific time-course of events determining net protein 
balance that may promote or inhibit protein synthesis (Figure 1.17). 
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Figure 1.17 Schematic providing an example of the integration of hypertrophy (IGF-1) and 
atrophy (TNFα) pathways in skeletal muscle. Bars denote inhibition and arrows denote 
activation. IRS1, insulin receptor substrate 1; PI3K, phosphatidylinositol-3-OH kinase; 
PDK1, 3’ phosphoinositide-dependent protein kinase 1; FoxO, forkhead box O; mTOR; 
mammalian target of rapamycin; GSK3, glycogen synthase kinase 3; TSC1/2, tuberous 
sclerosis complex 1/2; 4EBP1, eukaryotic initiation factor 4E-binding protein; eIF2B 
eukaryotic initiation factor 2B; p70 S6K, p70 ribosomal S6 kinase; MAFBx, muscle atrophy 
F box protein; MuRF, muscle ring finger protein; IKK, inhibitor kappa B kinase; NFκB, 
nuclear factor kappa B; TNFα, tumor necrosis factor alpha; p38, p38 mitogen activated 
protein kinase (adapted from Glass 2005). 
 
1.3.3 Concurrent Training 
The concomitant integration of endurance and resistance training in a periodised training plan is 
termed concurrent training. To date, few animal studies have attempted to elucidate mechanisms 
of adaptation in skeletal muscle with concomitant aerobic and hypertrophic stimuli. Furthermore, 
the results of studies investigating adaptation and performance changes in humans undertaking 
concurrent strength and endurance training have been equivocal (Millet et al. 2002; Balabinis et 
al. 2003; Häkkinen et al. 2003; Glowacki et al. 2004). There are several possible reasons for this 
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discrepancy, including differences in the design of the concurrent training interventions, the 
training status of the subjects, the influence of dependent variable selection, small sample sizes 
and inadequate statistical power (Leveritt et al. 2003). Most concurrent training studies have 
involved cycling, with only a few studies using running or swimming protocols, and have 
typically employed untrained or moderately trained male volunteers, who undergo short-term (8 
to 16 wk) training interventions in which the training volume and intensity is low. Nevertheless, 
since the classic investigative work of Hickson (1980) numerous studies have reported a 
variety of adaptive consequences when combining resistance and endurance training (Table 
1.4; Leveritt et al. 1999).  
The conundrum of variable results arising from concurrent training research is not 
surprising given the complexity of signalling and gene expression with endurance and 
resistance training described previously. Indeed, it is reasonable to suggest that the specific 
adaptations to the divergent exercise modes appear to be incompatible, at least at the cellular / 
molecular level. Heavy resistance training does not lead to mitochondrial biogenesis, and the 
larger myofibril cross sectional area increases diffusion distances for oxygen and substrates 
(Hood 2001). Therefore, with respect to alterations in the muscle milieu, this does not induce 
a favourable adaptation for endurance capacity. Likewise, chronic endurance training does not 
have a marked effect on myofibril size and the muscles altered [AMP/Ca2+] and subsequent 
residual fatigue may have a negative effect on muscle protein synthesis and the ability to 
generate force. Accordingly, this does not produce an adaptation conducive for increased 
muscular size and strength.  
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Table 1.4 Summary of research investigating the effect of concurrent strength and endurance training on skeletal muscle adaptation. 
S, strength training; E endurance training; C, concurrent strength and endurance training
Author WK Training Concurrent Training Interference? 
Izquierdo et al. (2005) 16  (S) 2 d/wk (E) 2 d/wk (C)  1 x S + 1 x E once weekly Yes – lower leg strength development 
Glowacki et al. (2004) 12  (S) 2-3 x wk (E) 2-3 x wk (C) 5 x wk  Yes – reduced increase of maximum oxygen consumption in C vs. E 
Häkkinen et al. (2003) 21 (S) 2 d/wk (C) 2 x S + 2 x E Yes – impaired explosive strength development 
Balabinis et al. (2003) 7  (S) 4 d/wk (E) 4 d/wk (C) S + E regimens / same day No 
Millet et al. (2002) 14 (E) triathlon precondition phase (C) E + S-2 x wk No 
McCarthy et al. (2002) 10  (S) 3 d/wk (E) 3 d/wk (C) combined S + E in same session No 
Bell et al. (2000) 12  (S) 3 d/wk (E) 3 d/wk (C)  S + E regimens / alternate day Yes -  impaired strength gains in C compared with S 
Horne et al. (1997) 12  (S) 3 d/wk (E) 3 d/wk (C)  S + E regimens / alternate day Yes -  impaired strength gains in C compared with S 
Kraemer et al. (1995) 12  (S) 4 d/wk (E) 4 d/wk (C) S + E regimens / same day Yes -  impaired strength gains in C compared with S 
McCarthy et al. (1995) 10  (S) 3 d/wk (E) 3 d/wk (C) combined S + E in same session No 
Hennessy & Watson (1994) 8  (S) 3 d/wk (E) 4 d/wk(C) random S+E combined & separate 5 d/wk Yes – impaired strength gains in C compared with S 
Nelson et al. (1990) 20  (S) 4 d/wk (E) 4 d/wk (C) S + E regimens / same day Yes – reduced increase of maximum oxygen consumption in C vs. E 
Hunter et al. (1987) 12  (S) 4 d/wk (E) 4 d/wk (C)  S + E regimens / same day Yes – reduced vertical jump in C compared with S 
Dudley & Djamil (1985) 7  (S) 3 x wk (E) 3 x wk (C) S + E regimens / alternate day Yes – reduced maximum torque at high velocities in C vs. S 
Hickson (1980) 10  (S) 5 d/wk (E) 6 d/wk (C) S + E regimens / same day Yes – impaired strength gains in C compared with S group 
 
The majority of research aimed at elucidating the adaptive responses to concurrent 
training has been confined to “end state” measures such as maximum strength / power or 
maximal aerobic capacity. Consequently, it is not possible to deduce the timing and identity of 
the regulatory events that orchestrated the observed “end-point” adaptations. As a result there 
has been little or no elucidation of the mechanisms underlying the specificity of training 
adaptation or interference to these pathways during concurrent training. Early work by Riedy 
and colleagues (1985) examined whether enlarged rodent skeletal muscle following 30 d 
surgical ablation responded to endurance training similar to control muscle. They observed 
comparable increases in succinate dehydrogenase activity in enlarged versus normal muscle 
and concluded that the response to endurance training was unaltered in hypertrophied muscle. 
Conversely, Stone and co-workers (1996) assessed the effect of 6 wk concurrent surgical 
overload and endurance training on citrate synthase and observed compromised oxidative 
enzyme content with concomitant hypertrophy. Finally, Putman and colleagues (2004; 
Putman et al. 2004) employed 12 wk concurrent training to determine changes in myosin 
heavy chain isoform content. These workers reported reduced strength development with 
concurrent compared to strength training alone and greater fast-to-slow fibre-type transition 
and attenuated hypertrophy of type I fibres following concurrent training. Accordingly, these 
inconclusive findings provide little mechanistic insight regarding the possible interference and 
/ or incompatibility of adaptation with concurrent strength and endurance training. However, 
emerging evidence provides a number of possible mechanisms that may, in part, offer a 
rationale for adaptation specificity and an “interference” phenomenon with concurrent 
training. 
The elongation phase of translation is mediated by eukaryotic elongation factors which 
represent a rate limiting step in protein synthesis (Bouchard et al. 1997). A key component of 
this translational machinery is eukaryotic elongation factor 2 (eEF2) which mediates 
translocation of the ribosome along the mRNA. eEF2 is phosphorylated and inactivated by 
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eEF2K in response to stimuli that increase energy demand or reduce energy supply (Browne 
and Proud 2002). Moreover, the activation of eEF2K appears to be regulated upstream via 
calmodulin and AMPK mediated signalling, kinases activated in response to endurance 
exercise (Nairn and Palfrey 1987; Ryazanov 1987; Horman et al. 2002). Indeed, Rose and 
colleagues (2005) provide strong evidence for the phosphorylation and inactivation of eEF2 in 
a calcium-calmodulin dependent manner in response to 90 min submaximal cycling (~67% 
VO2peak). Atherton and co-workers (2005) likewise observed an increase in eEF2 
phosphorylation immediately after, and 3 h following an endurance-like stimulus. This 
suggests that inhibition of eEF2 activity by endurance exercise results in a decrease in 
translation elongation and protein synthesis (Figure 1.18). Conversely, IGF-1 signalling has 
been implicated in the phosphorylation and inhibition of eEF2K and subsequent activation of 
eEF2 (Browne and Proud 2002). Data exists showing phosphorylation at serine366 by p70 S6K 
inactivates eEF2K, while mTOR has also been shown to phosphorylate serine78 on eEF2K 
decreasing kinase activity (Wang et al. 2001; Browne and Proud 2004). Therefore, in addition 
to its established role in translation initiation these findings also implicate mTOR-p70 S6K in 
the regulation of eEF2 and translation elongation. Increased mTOR and p70 S6K activity 
following resistance training would be expected to promote hypertrophy in part via increased 
eEF2 activity (Figure 1.18). In support of this contention a resistance-like stimulus has been 
demonstrated to decrease eEF2 phosphorylation likely enhancing elongation and protein 
synthesis (Atherton et al. 2005), but this effect has yet to be investigated in humans. 
Nonetheless, contrasting regulation of eEF2 mediated elongation by endurance and resistance 
training may represent a point of divergence for control of protein synthesis. 
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Figure 1.18 Putative divergent regulation of eukaryotic elongation factor 2 (eEF2) by (1) 
endurance and (2) resistance exercise. Bars denote inhibition and arrows denote activation. 
CaMK, calmodulin-dependent kinase; S6K, ribosomal protein S6 kinase; eEF2K, eukaryotic 
elongation factor 2 kinase (based on findings of Atherton et al. 2005; Rose et al. 2005; and 
Wang et al. 2001).  
 
The FoxO transcription factor has been implicated in promoting mRNA abundance of 
genes involved in processes as varied as mitochondrial biogenesis and myofibrillar protein 
degradation (Glass 2005; Hood et al. 2006). FoxO functions on the promoter regions and 
initiates transcription of a number of genes including PGC-1α and MAFBx, and the activity 
and nuclear abundance of FoxO is regulated by AKT (Daitoku et al. 2003; Sandri et al. 2004; 
Nader 2005). When AKT phosphorylates FoxO it translocates from the nucleus to the cytosol 
and is prevented from promoting transcription and may also be subject to cytosolic 
proteasomal degradation (Matsuzaki et al. 2003). AKT activation following resistance 
exercise would likely result in phosphorylation of FoxO and subsequent inhibition of 
 71
ubiquitin ligase gene expression (Figure 1.19). While these events would be expected to 
promote hypertrophy, work by Southgate and co-workers (2005) suggests that this results in 
the concomitant down-regulation of PGC-1α gene expression (Figure 1.19). Equally, 
endurance exercise is associated with increased PGC-1α gene expression and mitochondrial 
biogenesis promoting an oxidative phenotype (Irrcher et al. 2003). However, the nuclear 
location of FoxO with endurance exercise may suppress net protein synthesis due to increased 
activity of ubiquitin gene expression and subsequent protein degradation. Therefore, altered 
regulation of FoxO activity with contrasting modes of exercise may generate contradictory 
gene expression profiles ultimately reducing the specificity of adaptation. 
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Figure 1.19 Proposed effects of acute endurance and resistance training on forkhead box O1 
(FoxO1) mediated transcription. PGC-1α, peroxisome proliferator activated receptor gamma 
co-activator-1 alpha; MAFBx, muscle atrophy F box protein (based on findings of Hoffman 
& Nader 2004 and Southgate et al. 2005). 
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 Figure 1.20 Putative adaptive pathways in response to endurance- and resistance-like stimuli. 
Bars denote inhibition and arrows denote activation. AMPK, adenosine monophosphate 
kinase; PGC-1α, peroxisome proliferator activated receptor gamma co-activator-1 alpha; IGF, 
insulin-like growth factor; PI3K, phosphatidylinositol-3-OH kinase; mTOR, mammalian 
target of rapamycin; GSK3, glycogen synthase kinase 3; TSC1/2, tuberous sclerosis complex 
1/2; 4E-BP1, eukaryotic initiation factor 4E-binding protein; eIF2B eukaryotic initiation 
factor 2B; p70S6K, p70 ribosomal S6 kinase; eEF2, eukaryotic elongation factor (adapted 
from Atherton et al. 2005). 
 
The most compelling mechanism proposed to mediate the specificity of training and 
subsequent interference effect with concurrent training may be the AMPK-AKT “master-
switch” hypothesis of Atherton and colleagues (Figure 1.20). In a rodent model in which 
muscle fibres were electrically stimulated for prolonged periods at low frequency (to mimic 
endurance training) or for short periods with high-frequency (to mimic resistance training) 
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they observed a reciprocal relationship in the activation of AMPK and AKT pathways in 
response to these extreme divergent stimuli. Specifically, after low-frequency stimulation they 
observed increased AMPK-TSC2 activity, PGC-1α gene expression and an inhibition of 
mTOR mediated translation initiation. Conversely, after high-frequency stimulation there was 
increased AKT-mediated hypertrophy signalling concomitant with a decrease in AMPK and 
suppression of TSC2 activity. Based on these findings in a single muscle electrical stimulation 
model to mimic exercise, these workers proposed that the AMPK and AKT signalling may 
represent divergent pathways that when activated direct skeletal muscle adaptation to either 
an aerobic or hypertrophic phenotype (Figure 1.20). 
Collectively, the current literature provides a number of possible mechanisms to 
explain the specificity of training adaptation in response to strength and endurance exercise. 
However, as it appears that divergent adaptive phenotypes are induced via the complex 
manipulation of numerous common signalling and gene expression pathways this highlights 
the intricacy of adaptation to exercise stimuli. Regardless, alternating exercise modes during 
concurrent training may reduce the capacity for the simultaneous acquisition of hypertrophy 
and / or mitochondrial training-induced adaptation responses compared with single mode 
training. 
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 1.4 Summary & aims of this thesis 
The specificity of training adaptation is highlighted by comparing the distinct adaptive 
responses in skeletal muscle to endurance versus heavy resistance training. Heavy resistance 
training increases muscle size and strength while regular endurance training results in 
enhanced oxygen kinetics and improved resistance to fatigue. It would appear that skeletal 
muscle adaptive responses are reduced when incorporating concurrent endurance and 
resistance exercise stimuli, producing moderate alterations in muscle phenotype when 
compared to single mode training. However, the molecular events that promote or inhibit the 
specificity of training adaptation are incompletely resolved and determining the interaction of 
adaptive pathways when undertaking concurrent strength and endurance training remains 
elusive. Moreover, the current understanding of intracellular signalling and gene expression 
with various modes of training is limited due to the specific transient and time-dependent 
molecular responses to exercise. Accordingly, there is a need to better define the acute and 
chronic responses to exercise by manipulating the mode, volume, intensity and frequency of 
training thereby elucidating the specific molecular and genetic mechanisms that ultimately 
determine the specificity of training adaptation.  
 The aims of this thesis were to 1) systematically evaluate the time-course of a spectrum 
of cellular and molecular markers specific to the regulation of muscle contractile protein and 
subsequent hypertrophy, after the imposition of different resistance training protocols and 2) to 
quantify the early response to divergent training stimuli in competitive athletes who are 
highly specialised / adapted to a single discipline, and to establish the degree of “signalling 
specificity” in these athletes. 
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 Chapter Two 
 
 
High-frequency training stimulus attenuates AKT and 
exacerbates TNFα signalling responses in skeletal muscle 
 
 
Adapted from: Coffey, V.G., Reeder, D.W., Lancaster, G.I., Yeo, W.K., Febbraio, M.A., 
Yaspelkis III, B.B., Hawley, J.A. American Journal of Physiology Endocrinology and 
Metabolism (In Review). 
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2.1 Introduction 
Skeletal muscle is the most abundant tissue in the human body and its normal physiology 
plays a fundamental role in health and disease. During many disease states, a dramatic loss of 
skeletal muscle mass (atrophy) is observed. In contrast, chronic resistance training results in 
increased skeletal muscle size (hypertrophy) and changes in muscle contractile properties that 
ultimately lead to gains in strength and power (Fry et al. 2003). While such adaptations 
involve multiple factors including nutrient availability, genetic predisposition and 
environmental factors etc, they are likely to be the result of the cumulative effect of repeated 
training bouts, with the cellular responses leading to these long-term adaptations occurring 
during and after each training session (Widegren et al. 1998; Atherton et al. 2005; Yang et al. 
2005). Indeed, many contraction-induced signalling events in muscle appear to be maximally 
activated in the initial (0-4 h) period post-exercise, returning to basal levels within 24 h 
(Widegren et al. 1998; Nader and Esser 2001). This short-term, transient increase in signalling 
activation following contraction represents a stimulus capable of initiating downstream events 
co-ordinating an increase in gene expression and subsequent protein synthesis (Atherton et al. 
2005; Cuthbertson et al. 2005).  
 The signalling pathways that initiate adaptive processes in skeletal muscle constitute a 
complex network of kinases and phosphatases that are often subject to a high degree of 
feedback regulation, cross-talk, and transient activation (Glass 2005). While our current 
understanding of the signal transduction pathways controlling skeletal muscle hypertrophy 
and atrophy are incompletely resolved, a growing body of evidence identifies several key 
signalling cascades that are pivotal to these adaptation processes (Glass 2005). For example, 
activation of insulin-like growth factor-1 (IGF-1) and AKT / mammalian target of rapamycin / 
p70 S6 kinase is sufficient to induce skeletal muscle hypertrophy (Adams and McCue 1998; 
Bodine et al. 2001b), while this signalling cascade can also block the transcriptional up-
regulation of key mediators of skeletal muscle atrophy (Latres et al. 2005), the ubiquitin-
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ligases MuRF1 and MAFBx (also called Atrogin-1). Activation of the NFκB transcription 
pathway, by cachectic factors such as TNFα and inhibitor NFκB kinase, is sufficient to induce 
skeletal muscle atrophy, in part via NFκB-mediated up-regulation of MuRF1 (Cai et al. 2004).  
 Much of the work that has attempted to elucidate the signalling pathways regulating 
hypertrophy / atrophy in skeletal muscle has utilised transgenic manipulation, chronic 
unloading or electrical stimulation. Such models may not be typical of the loading patterns 
encountered with daily physical activity. To date, few studies have incorporated in vivo 
exercise-induced contractile activity as a stimulus to examine changes in growth factor and 
inflammatory signalling cascades. The present study compared a conventional-frequency 
resistance training regimen with a novel high-frequency “stacking” protocol designed to 
generate a summation of transient exercise-induced signalling responses in order to identify 
the discrete cellular and molecular responses that take place following repetitive overload. 
The hypothesis was that when high-frequency resistance training sessions were performed 
with short (i.e. 3 h) recovery periods, the transient response of key signalling pathways 
initiating hypertrophy may be extended and additive compared to when the same work was 
undertaken with longer (i.e. 48 h) recovery.  
 
2.2 Methods 
Experimental Design 
Seventy-two male Sprague-Dawley rats ~6 wk of age (mass 351 ± 17 g) were obtained from 
Harlan (San Diego, CA) and housed four per cage in an environment maintained at ~21 °C 
with an artificial 12:12 h light-dark cycle. All animals received a standard chow diet (63% 
carbohydrate, 17% fat and 20% protein, no. 112386, Dyets, Bethlehem, PA) for the duration 
of the study and had ad libitum access to food and water. Animals were assigned to one of 
three treatment groups: control (Con, n = 6); high-frequency “stacked” training protocol (HF; 
n = 36) or conventional-frequency training protocol (CF; n = 30). Exercise-trained groups (HF 
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and CF) were further subdivided into “stacked” training that completed either one, two, three 
or four exercise sessions on the same day (1×, 2×, 3× or 4×, n = 6 per group) or conventional 
training, that completed up to three exercise sessions over 5 d (DAY 1, DAY 3 or DAY 5 n = 
6 per group). Following the completion of both HF and CF, two groups of animals were 
sacrificed 24 h and 48 h after their last training bout (n = 6 per group). CF and HF training 
protocols were matched for total work. HF “stacked” training comprised four bouts of 3 sets × 
10 repetitions separated by 3 h recovery while CF training consisted of three bouts of 4 sets × 
10 repetitions with 48 h recovery between resistance training bouts (Figure 2.1). All 
experimental and training procedures were approved by the Institutional Animal Care and Use 
Committee at California State University, Northridge and conformed to the guidelines for the 
use of laboratory animals published by the US Department of Health and Human Resources. 
 
Figure 2.1 Representative schematic of high-frequency “stacking” and conventional-
frequency resistance training protocols. The stacked protocol was comprised of four bouts of 
3 × 10 repetitions separated by 3 h recovery and completed within 10 h on a single day. 
Conventional training consisted of three bouts of 4 × 10 repetitions with 48 h between 
resistance training bouts completed over 5 d. Protocols were matched for total work and 
repetitions were performed at 75% one-repetition maximum with 3 min recovery between 
sets. Animal groups (n = 6) were sacrificed and white quadriceps muscle extracted 3 h after 
every training bout (arrows), and 24 and 48 h following the final exercise session of each 
protocol. 
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 Resistance Training Protocols and Animal Sacrifice 
One repetition maximum (1-RM) was determined for all animals a minimum of 5 d prior to 
commencement of a training period. The 1-RM established the physical load that could be 
lifted once but not a second time with the same squat-training equipment that was utilised 
during all training sessions. Mean 1-RM for all animals was 998 ± 215 g. All subsequent 
resistance-training protocols were performed at 75% of 1-RM. The core components of the 
training protocol and apparatus utilised in the present study have been described in detail 
previously (Krisan et al. 2004).  Briefly, the apparatus consisted of two 45 cm vertical metal 
rods 0.5 cm in diameter set 31 cm apart on a 15 cm × 20 cm stainless steel metal base securely 
inserted into a 2.54 cm thick wood platform. A 33 cm × 2.54 cm wood crossbeam was 
outfitted with two brass sleeves and placed on the two vertical rods, allowing for uninhibited 
vertical movement. An aluminium holder, moulded to accommodate the rats, was attached to 
the centre of the crossbeam at a 90° angle relative to the base. Animals were strapped into a 
nylon vest and attached to the aluminium holder with Velcro straps before being placed in a 
squat position using safety stoppers on each rod to support the load. Two 5 cm metal pegs 
attached vertically on opposite ends of the crossbeam were used to mount calibrated miniature 
weight plates. A brief low-voltage electrical stimulus (10 V, 0.3-s duration) was delivered by 
manually depressing a switch that allowed current to flow through an electrode attached to the 
tail of the animals to initiate each repetition. After each repetition, the animals were 
repositioned on the apparatus such that their legs were beneath the torso. A repetition was 
initiated as soon as practicable following each prior repetition (i.e. cessation of movement and 
re-positioning – mean interval approximately 2 s) and repeated until 10 repetitions were 
completed. The animals were allowed to rest for 3 min between each set and were removed 
from the apparatus and returned to their cage during the recovery period. Group sacrifice (n = 
6) was conducted 3 h after every resistance training session for both CF and HF training 
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protocols, and 24 and 48 h following the final exercise session of each protocol, respectively. 
Animals were sacrificed via cervical dislocation and prepared for hind limb muscle collection. 
Portions of the white quadriceps (WQ) were surgically removed from the left and right hind 
limbs in sequence and freeze clamped in liquid N2. Muscle samples were stored at –80 oC 
until subsequent analysis.  
 
Analytical Procedures 
Muscle Glycogen Concentration 
Muscle samples (~40-50 mg) were freeze-dried with visible connective tissue removed during 
powdering. Aliquots (~3 mg) of freeze-dried muscle were extracted with 250 µL of 2 M 
hydrochloric acid, incubated at 100 ºC for 2 h and then neutralised with 750 µL of 0.67 M 
sodium hydroxide for subsequent determination of glycogen concentration via enzymatic 
analyses (50mM Tris, 25mM HCL, 1mM MgCl2, 0.5 mM DTT, 0.3mM ATP, 0.05mM 
NADP and 1U/ml HK, 0.1 U/ml G-6-PDH) with NADH and glucose standards by 
fluorometric detection. Glycogen concentration was expressed as millimoles of glycogen⋅kg-1 
d.w.  
 
Western Blotting  
Materials 
Monoclonal anti-phospho-AKTSer473 (#4058), polyclonal anti-phospho-mTORSer2448 (#2971), -
p70 S6 kinaseThr389 (#9205), -4EBP1Thr70 (#9455), -p38 MAP kinaseThr180/Tyr182 (#9211), -
FKHRSer256 (#9461) -IKKα/βser176/180 (#2681) and polyclonal anti-AKT (#9272), -p70 S6 
kinase (#9202), -p38 MAP kinase (#9212), and -TNFα (#3707) were from Cell Signalling 
Technology, Inc. (Beverly, MA, U.S.A.). Polyclonal anti-mTOR (#07-231) was from Upstate 
Signalling Solutions (Charlottesville, Va, U.S.A.). Anti-phospho-AMPKthr172 was raised 
against AMPK alpha peptide (KDGEFLRpTSCGAPNY) as described previously (Clark et al. 
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2004). Anti-rabbit secondary antibody and enhanced chemiluminescence reagents were from 
Amersham Biosciences (Buckinghamshire, U.K.) and Pierce Biotechnology (Rockford, IL, 
U.S.A.).  
 
Procedure 
Samples were homogenised in ice cold homogenisation buffer containing 50 mM Tris-HCL, 
pH 7.5, 1 mM EDTA, 1 mM EGTA, 10% glycerol, 1% triton-X, 50 mM NaF, 5 mM Na 
pyrophosphate, 1 mM DTT, 10 µg/mL trypsin inhibitor, 2 µg/mL aprotinin, 1 mM 
benzamidine and 1 mM phenylmethylsulfonyl fluoride. The lysate was kept on ice at all times 
then centrifuged at 12 000 g for 20 min at 4 oC. The supernatant was transferred to a sterile 
tube and subsequently aliquoted to determine protein concentration (Pierce, Rockford, IL, 
U.S.A.). Aliquots were stored at –80 oC until analysis. Aliquots of lysate (60-80 µg of protein) 
were re-suspended in Laemmli sample buffer. Proteins were then separated by SDS/PAGE, 
transferred to polyvinylidenedifluoride membranes (Bio-Rad, Hercules, CA, U.S.A.), blocked 
with 5% non-fat milk for 90 min, washed with TBST (10 mM Tris HCl, 100 mM NaCl, 
0.02% Tween) and incubated with appropriate primary antibodies overnight at 4 oC. 
Membranes were washed with TBST and incubated with an appropriate secondary antibody 
for 60 min. Proteins were visualised by chemiluminescence and quantified by densitometry. 
Samples from each training group were run on the same gel and the amount of protein from 
the densitometric quantification is expressed as arbitrary units. 
 
Statistical Analysis 
Immunoblot phosphorylation and total protein data are expressed in arbitrary units relative to 
non-exercise controls. Differences between means were determined by a one-way analysis of 
variance (ANOVA) with Newman-Keuls post-hoc test (SigmaStat for windows version 3.11). 
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All values are expressed as means and standard error (SE) with the critical level of 
significance established at P <0.05. 
2.3 Results 
Muscle Glycogen  
Muscle glycogen content in HF was decreased ~30-35% 3 h after the initial training session 
and remained below non-exercise control values for each subsequent bout (P<0.05, Figure 
2.2A). Muscle glycogen levels were restored to control values after 24 and 48 h of recovery. 
CF resulted in a decline in muscle glycogen 3 h after training on DAY 1 (NS, Figure 2.2B). 
After DAY 3 there was an increase in glycogen content compared to control and all time 
points (P<0.05), but thereafter muscle glycogen levels were not different to non-exercise 
control values.  
 
Signalling Responses 
5’ Adenosine Monophosphate Activated Protein Kinase (AMPK) 
As might be expected with the decline in muscle glycogen after the initial training bout, 
phosphorylation of AMPKthr172 increased gradually after the HF training bouts (~25-40%) 
reaching significance 3 h after bout 4 compared to 48 h post-exercise (~55%, P<0.05, Figure 
2.2C). In contrast, there were no differences in phosphorylated AMPK thr172 over time with the 
CF training protocol (Figure 2.2D). 
 
AKT / Mammalian Target of Rapamycin (mTOR) / Forkhead Box O1 (FoxO1) 
Phosphorylation of AKTser473 was significantly decreased following the second bout of HF 
training (P <0.05) and remained suppressed for the remainder of this regimen. This 
suppression of AKT persisted for up to 48 h after completion of the HF training protocol 
(Figure 2.3A). In contrast, CF training had little effect on AKT phosphorylation (Figure 
2.3B). mTOR was not significantly altered following either training protocol (Figure 2.3C and 
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2.3D). FoxO1ser256 phosphorylation was decreased by ~24% (2× and 3×, NS) and ~26% (24 h, 
NS) with HF and CF resistance training, respectively, but these changes were not significant 
(Figure 2.3E and 2.3F).  
 
Figure 2.2 Muscle glycogen content (A, B) and 5’ adenosine monophosphate activated 
protein kinase  (AMPK) phosphorylation (C, D)thr172  following either high-frequency 
“stacked” resistance training comprising four bouts of 3 × 10 repetitions separated by 3 h 
recovery (A, C; n = 6 per group) or conventional-frequency training consisting of three bouts 
of 4 × 10 repetitions with 48 h between resistance training bouts (B, D; n = 6 per group). 
Protocols were matched for total work and repetitions were performed at 75% one-repetition 
maximum with 3 min recovery between sets. White quadriceps muscle was extracted 3 h after 
every training bout, and 24 and 48 h following the final exercise session of each protocol, 
respectively. Results are group means (± SE) and p-AMPK arbitrary values are expressed 
relative to control. Significant difference (One-way ANOVA, P<0.05) vs. *control; § 48 h; ╫ 
all. 
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Figure 2.3 Phosphorylated AKT  (A, B) and mammalian target of rapamycin  
(mTOR; C, D) relative to total, and FKHR  (FoxO1) phosphorylation (E, F)
ser473 ser2448
ser256  following 
either high-frequency “stacked” resistance training comprising four bouts of 3 × 10 repetitions 
separated by 3 h recovery (A, C, E; n = 6 per group) or conventional-frequency training 
consisting of three bouts of 4 × 10 repetitions with 48 h between resistance training bouts (B, 
D, F; n = 6 per group). Protocols were matched for total work and repetitions were performed 
at 75% one-repetition maximum with 3 min recovery between sets. White quadriceps muscle 
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was extracted 3 h after every training bout, and 24 and 48 h following the final exercise 
session of each protocol, respectively. Results are group means (± SE) and data are arbitrary 
values expressed relative to control. Significant difference (One-way ANOVA, P<0.05) vs. 
*control; † 1×. 
 
p70 S6 Kinase (p70 S6K) / Eukaryotic Initiation Factor 4E-binding Protein (4E-BP1) 
No difference in 4E-BP1thr70 phosphorylation was observed following HF and CF resistance 
training (~15-25%, NS, Figure 2.4A and 2.4B). In contrast, p70 S6K phosphorylation was 
increased significantly after both HF and CF resistance training. Phosphorylation of p70 
S6Kthr389 was increased 3 h post-exercise with HF compared with control values, reaching 
significance after 3× and 4× bouts of training (~500%, P<0.05, Figure 2.4C). Likewise, p70 
S6K increased 3 h after CF training, an increase that was significantly different from control 
on DAY 1 and DAY 5 (~500-700%, P<0.05, Figure 2.4D). Phosphorylation of p70 S6K had 
returned to control levels 24 and 48 h after the final training bout for both training protocols. 
 
 Cytokines and Mitogen Activated Protein Kinase (MAPK) 
HF resistance training resulted in increased expression of tumor necrosis factor alpha (TNFα) 
at all post-exercise time points (~13-54%) but was only significantly different from control 3 
h after the fourth training bout (P<0.05, Figure 2.5A). TNFα content significantly increased 
after DAY 1 of CF (~38%, P<0.05) but had returned to control values by DAY 5 (Figure 
2.5B). Significant increases in p38thr180 MAPK phosphorylation were consistently observed 
after each bout with HF training and 24 h after the last exercise bout (~67-100%, P<0.05, 
Figure 2.5C), while CF training increased p38 compared to control on DAY 1 and DAY 3 
(~65-118%, P<0.05, Figure 2.5D). Inhibitor kappa B kinase alpha/beta (IKKα/βser180/181) 
phosphorylation was significantly higher than control following 3 h recovery after all HF 
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training bouts (~65-75%, P<0.05, Figure 2.5E) but was only increased following exercise on 
DAY 1 with CF resistance training (~63%, P<0.05, Figure 2.5F).  
 
 
Figure 2.4 Eukaryotic initiation factor 4E-binding protein  (4E-BP1; A, B) 
phosphorylation and ribosomal p70 S6 kinase  (p70 S6K) phosphorylation relative to total 
(C, D) 
thr70
thr389
following either high-frequency “stacked” resistance training comprising four bouts of 
3 × 10 repetitions separated by 3 h recovery (A, C; n = 6 per group) or conventional-
frequency training consisting of three bouts of 4 × 10 repetitions with 48 h between resistance 
training bouts (B, D; n = 6 per group). Protocols were matched for total work and repetitions 
were performed at 75% one-repetition maximum with 3 min recovery between sets. White 
quadriceps muscle was extracted 3 h after every training bout, and 24 and 48 h following the 
final exercise session of each protocol, respectively. Results are group means (± SE) and data 
are arbitrary values expressed relative to control. Significant difference (One-way ANOVA, 
P<0.05) vs. *control, ‡ 2×, # 24 h, § 48 h, ╫ all. 
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Figure 2.5 Total tumor necrosis factor alpha (TNFα) content (A, B), phosphorylated p38  
mitogen activated protein kinase (MAPK) relative to total (C, D), and inhibitor kappa B 
kinase  (IKK) phosphorylation (E, F)
thr180
ser180/181  following either high-frequency “stacked” 
resistance training comprising four bouts of 3 × 10 repetitions separated by 3 h recovery (A, 
C, E; n = 6 per group) or conventional-frequency training consisting of three bouts of 4 × 10 
repetitions with 48 h between resistance training bouts (B, D, F; n = 6 per group). Protocols 
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were matched for total work and repetitions were performed at 75% one-repetition maximum 
with 3 min recovery between sets. White quadriceps muscle was extracted 3 h after every 
training bout, and 24 and 48 h following the final exercise session of each protocol, 
respectively. Results are group means (± SE) and data are arbitrary values expressed relative 
to control. Significant difference (One-way ANOVA, P<0.05) vs. *control, # 24 h, § 48 h, ╫ 
all. 
 
2.4 Discussion 
The key components of any training programme are the volume, intensity and frequency of 
exercise sessions (Hawley 2002). The sum of these inputs can be termed the training stimulus 
that either enhances or impairs adaptation. Initially, training adaptations are directly related to 
the volume of work performed. However, the control mechanisms signalling adaptive 
responses are eventually titrated by exercise duration (Booth and Watson 1985) indicating 
that a maximal duration exists beyond which additional stimulus will not induce significant 
adaptation. If continually increasing exercise volume is insufficient for driving the adaptive 
response this suggests that the intensity and frequency of the overload stimulus are important 
for disruption to homeostasis and subsequent adaptation in skeletal muscle. The present study 
compared a conventional resistance training regimen with a novel “stacking” protocol in an 
attempt to identify the effects of training frequency on discrete cellular and molecular events 
following repetitive overload. It was hypothesised that compared to a conventional resistance 
training protocol, high-frequency training sessions would extend the transient response of key 
signalling pathways leading to an additive or “stacked” effect and a concomitant up-
regulation of signalling pathways involved in hypertrophy. In contrast to the original 
hypothesis, this study provides novel evidence to demonstrate that high-frequency overload 
suppressed AKT phosphorylation and exacerbated expression of TNFα, IKK activity and p38 
MAPK phosphorylation compared to a conventional training regimen. Nevertheless, both 
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training protocols resulted in increases in p70 S6K phosphorylation independent of the 
activation states of AKT and mTOR.  
High-frequency training bouts resulted in a persistent suppression of muscle glycogen 
content, whereas the longer recovery time (and greater nutrient intake) between conventional 
training sessions was sufficient to replenish glycogen levels (Figure 2.2). Indeed, with the 
conventional training regimen there was moderate ‘supercompensation’ on DAY 3 whereby 
glycogen levels were increased above resting basal values. It has been proposed that AMPK 
acts as a “fuel gauge” in muscle cells, switching off ATP-consuming pathways when cellular 
energy is low, while concomitantly turning on alternative pathways for ATP regeneration. 
Accordingly, the suppressed glycogen content in the working muscles throughout the high-
frequency training protocol was associated with a gradual increase in AMPK phosphorylation 
with each successive bout (Figure 2.2). In contrast, with longer recovery between training 
bouts and fuel status restored, AMPKthr172 responses were blunted throughout the 
conventional-frequency training protocol. 
AKT is a critical mediator of insulin / IGF signalling that when activated 
phosphorylates multiple substrates mediating important aspects of carbohydrate metabolism, 
and protein synthesis and degradation (Taniguchi et al. 2006). This study shows a systematic 
down-regulation in the phosphorylation state of AKT following repeated bouts of exercise, an 
effect that persisted for up to 48 h following multiple bouts undertaken in a single day (Figure 
2.3). Given the proposed role for AKT in compensatory hypertrophy (Bodine et al. 2001b; Lai 
et al. 2004) the original hypothesis was that a cumulative increase in the phosphorylation of 
AKTser473 would occur following high-frequency resistance training. Nevertheless, AKT 
activity has previously been shown to both increase (Nader and Esser 2001; Bolster et al. 
2003b; Sakamoto et al. 2004a; Creer et al. 2005) or remain unchanged (Widegren et al. 1998; 
Krisan et al. 2004) in response to a variety of contractile stimuli. There are a number of 
possible explanations for the dephosphorylation of AKT in response to stacked resistance 
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training bouts. The most likely relates to the suppression and / or activation of kinases and 
phosphatases involved in the direct regulation of AKT activity. In this regard, Gao and 
colleagues (Gao et al. 2005) have shown that the pH domain leucine-rich repeat protein 
phosphatase (PHLPP) specifically controls the phosphorylation state of serine473 and catalyses 
its dephosphorylation in vivo significantly reducing AKT activity. Importantly, this 
dephosphorylation can lead to an increase in apoptosis and suppression of cell growth, effects 
that have yet to be confirmed in skeletal muscle (Gao et al. 2005). Nevertheless, the 
possibility exists that the demanding stimulus provided by stacked resistance training bouts 
resulted in PHLPP mediated down-regulation of AKT and increased apoptosis.  
In addition, phosphorylation of the activation loops on threonine308 and the 
hydrophobic motif on serine473 is required for full activation of AKT (Alessi et al. 1997; 
Sarbassov et al. 2005b). Insulin receptor substrate-1 (IRS-1) phosphorylation and insulin 
signalling has been shown to be impaired by increases in TNFα (del Aguila et al. 1999; 
Plomgaard et al. 2005). In the current study a sustained and consistent increase in TNFα 
following high-frequency overload was observed. TNFα appears to exert its effect on IRS-1 
by activation of IKK in a p38 MAPK-dependent manner (Del Aguila et al. 2000; Gao et al. 
2002; de Alvaro et al. 2004). In support of this contention, the present findings show 
corresponding IKK and p38 phosphorylation concomitant with AKT dephosphorylation, 
indicating a possible TNFα-mediated effect on AKT activity. Del Aguila and colleagues (Del 
Aguila et al. 2000) have previously reported that IRS-1 signalling and AKT kinase activation 
is impaired by muscle damage-induced TNFα production. Taken together, these findings 
indicate the muscle damage following high-frequency resistance training and subsequent 
increases in TNFα signalling may have exacerbated the persistent decrease in phosphorylation 
of AKT. 
AKT is involved in the regulation of numerous cellular processes including protein 
synthesis and degradation (Nader 2005). AKT has been shown to mediate protein synthesis 
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and degradation via the AKT-mTOR and AKT-FoxO1 pathways respectively (Nave et al. 
1999; Sandri et al. 2004; Stitt et al. 2004; Latres et al. 2005), yet mTORser2448 and FoxO1ser256 
phosphorylation was largely unaffected by either resistance training regimen or changes in 
AKT phosphorylation (Figure 2.3). Two mTOR protein complexes exist where mTOR binds 
with a G-beta-L protein (GβL) and either a rapamycin-sensitive raptor or a rictor protein 
(Sarbassov et al. 2005b; Sarbassov et al. 2006). The mTOR-raptor complex appears to 
regulate cell growth through p70 S6K and 4E-BP1 while mTOR-rictor phosphorylates and 
activates AKTser473 (Sarbassov et al. 2005a). While the mechanism(s) responsible for the 
regulation of the mTOR-rictor complex is currently unknown, a decrease in mTOR-rictor with 
high-frequency training may have contributed to the down-regulation of AKT 
phosphorylation. Furthermore, mTOR-raptor has been shown to be negatively regulated by 
the tuberous sclerosis complex 1/2 (TSC1/2)-Ras homologue enriched in brain (Rheb) 
pathway and AMPK appears to promote TSC2-Rheb mediated inhibition of mTOR-raptor 
activity (Garami et al. 2003; Williamson et al. 2006a). The increase in AMPK 
phosphorylation with the high-frequency training stimulus may have contributed to the lack of 
response in mTOR activity following this protocol. Indeed, Williamson and colleagues 
(Williamson et al. 2006a) have shown AMPK activation suppresses protein synthesis through 
repression of mTOR signalling. In the present study a modest decrease in phosphorylation of 
the FoxO1 transcription factor following resistance training was also observed (Figure 2.3). 
This suggests that increased transcriptional activity of atrophy proteins may occur after 
strenuous exercise-induced contraction. However, further work is required to establish the 
effect of in vivo contractile activity on FoxO1 activation as previous investigations have 
shown AKT regulation of FoxO1 and subsequent ubiquitin ligase activity in cell culture and 
transgenic animals (Sandri et al. 2004; Stitt et al. 2004). 
Several p70 S6K substrates exist but essentially phosphorylated p70 S6K activates 
processes increasing translation efficiency and protein synthesis while 4E-BP1 is deactivated 
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with phosphorylation inhibiting its role as a repressor of the translational machinery (Bodine 
et al. 2001b; Ruvinsky and Meyuhas 2006). A novel finding of the present study was the 
pronounced summation in p70 S6K phosphorylation with both “stacked” and conventional 
resistance training protocols that occurred independent of AKT or mTOR phosphorylation 
(Figure 2.4). Phosphorylation of p70 S6K and 4E-BP1 has been shown to be regulated by 
AKT (Bodine et al. 2001b; Lai et al. 2004) and mTOR (Burnett et al. 1998; Ali and Sabatini 
2005) and evidence suggests these kinases may be fundamental for the control of cell size 
(Ohanna et al. 2005). It is difficult to reconcile the increased p70 S6K phosphorylation in the 
absence of the activation of its upstream kinases. However, these findings support those of 
others showing the activation of p70 S6K with a resistance training-like stimulus in rodents 
and humans (Bodine et al. 2001b; Atherton et al. 2005; Cuthbertson et al. 2005). The decrease 
in 4E-BP1 phosphorylation in the present study suggests a lack of mTOR mediated 
downstream effects that would abolish its role in p70 S6K activation supporting the 
contention that p70 S6K phosphorylation may occur independent of AKT / mTOR under 
certain conditions (Hornberger et al. 2004; Song et al. 2005). PDK1 has been implicated as 
having a role in regulating  p70 S6K activation, but it does not appear to phosphorylate p70 
S6Kthr389 (Alessi et al. 1998; Pullen et al. 1998). Although evidence suggests that p70 S6K 
and 4E-BP1 are direct substrates of mTOR-raptor it cannot be ruled out that other unique 
kinases regulate p70 S6K / 4E-BP1 phosphorylation.  
TNFα is an inflammatory cytokine shown to negatively affect anabolic processes by 
increasing activity of protein degradation pathways, destabilising myogenic differentiation 
and altering transcriptional activity (Garcia-Martinez et al. 1994; Lang et al. 2002; Langen et 
al. 2004). Primary targets of TNFα signalling include the inhibitor kappa B kinase (IKK) and 
p38 MAPK (Li et al. 2005; Chen et al. 2006). A fundamental role of IKK is phosphorylation 
of the nuclear factor kappa B (NFκB) inhibitor (IκB) which designates IκB for ubiquitination 
and subsequent degradation, releasing the transcription factor NFκB to translocate to the 
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nucleus and initiate the expression of a number of genes, including those involved in 
regulation of skeletal muscle protein degradation such as muscle ring finger 1 protein 
(MuRF1; Cai et al. 2004). Similarly, TNFα stimulated p38 phosphorylation also appears to 
induce gene expression of the E3 ubiquitin ligase muscle atrophy F box (MAFBx) protein 
promoting protein degradation in skeletal muscle (Li et al. 2005). The in vivo data from this 
study show that changes in IKK and p38 phosphorylation were highly coordinated with the 
responses of TNFα (Figure 2.5). Specifically, the repeated stimulus during the stacked 
training protocol induced a significant increase in IKK and p38 phosphorylation following 
each discrete exercise bout.  In contrast, a single exercise bout increased phosphorylation of 
IKK and p38 after 3 h recovery on DAY 1 of conventional training, but this response was 
diminished with subsequent training bouts. The present findings are in agreement with recent 
work by Sriwijitkamol and colleagues (Sriwijitkamol et al. 2006) that showed reduced TNFα 
and increased IκB content in human skeletal muscle following an 8 wk exercise programme. 
Taken together, these results suggest that chronic exercise is capable of promoting anti-
inflammatory effects that may be protective against stress-induced damage in skeletal muscle. 
The initial and sustained increase in IKK / TNFα pathway signalling with high-
frequency overload suggests that resistance exercise generates significant alterations in 
cellular homeostasis and a substantial pro-inflammatory response in skeletal muscle. 
Moreover, it is likely that the increases in IKK and TNFα in the present study were the result 
of muscle damage per se, as a subgroup of animals subjected to an acute bout of prolonged 
swimming showed no alterations in IKK phosphorylation or IκBα degradation (data not 
shown). 
In conclusion, this study compared a high-frequency resistance training protocol 
(matched for total work) with a conventional-frequency training regimen in order to elucidate 
the discrete signalling events following divergent overload stimuli. The data show that the 
frequency of overload is an important factor determining subsequent signalling events that 
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underlie the adaptation processes. Specifically, this work provides novel evidence to 
demonstrate that high-frequency overload suppressed AKT phosphorylation and exacerbated 
the expression of TNFα, IKKα/β activity and p38 MAPK phosphorylation. In contrast, 
conventional-frequency resistance training attenuated these pro-inflammatory signalling 
events. Both training protocols resulted in increases in p70 S6K phosphorylation independent 
of the activation states of AKT and mTOR. These data provide the first information on the 
time-course of events regarding the effects of exercise frequency on signal transduction 
pathways governing hypertrophy / atrophy regulatory responses in skeletal muscle in vivo. 
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Chapter Three  
 
 
 
Early signalling responses to divergent exercise stimuli in 
skeletal muscle from well-trained humans  
 
 
Adapted from: Coffey V.G., Zhong Z., Shield A., Canny B.J., Chibalin A.V., Zierath J.R, 
Hawley J.A. The FASEB Journal 20(1): 190-2, 2006. 
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3.1 Introduction 
Conventional endurance and strength training exercise induce diverse adaptive responses. 
Endurance training elicits a variety of metabolic and morphological responses that function to 
minimise cellular disturbances during subsequent training sessions (Hawley 2002), including 
mitochondrial biogenesis (Holloszy 1967), a fast-to-slow twitch fibre phenotype 
transformation (Zierath and Hawley 2004), a decreased reliance on carbohydrate-based fuels 
during sub-maximal exercise (Holloszy et al. 1977) and improved whole-body aerobic 
capacity (VO2max; Saltin 1969). In contrast, strength / resistance training has minimal effect on 
the muscle fibre phenotype (Williamson et al. 2001), VO2max (Allen et al. 1976), or patterns of 
substrate utilisation during sub-maximal exercise. Strength / resistance training and some 
forms of high-intensity intermittent stimulation are associated with an increase in protein 
synthesis (Nader and Esser 2001; Rennie et al. 2004) and substantial muscle hypertrophy 
(Rennie and Tipton 2000) that promotes gains in maximal force output, whereas endurance 
training does not promote muscle hypertrophy or increase the force-output ability of muscle 
(Hickson 1980). 
Although the molecular signalling mechanisms that transduce the effects of contractile 
activity to modify the skeletal muscle phenotype and function are incompletely understood, a 
number of pathways have been implicated. For example, activation of the 5’ AMP-activated 
protein kinase (AMPK)- peroxisome proliferator activated receptor gamma co-activator-1α 
(PGC-1α) signalling pathway may partly explain some of the adaptations to endurance 
training, while selective up-regulation of the AKT-tuberous sclerosis complex 2 (TSC2)-
mammalian target of rapamycin (mTOR) cascade may underlie the increase in skeletal muscle 
protein synthesis and growth observed after resistance training (Atherton et al. 2005).  While 
the chronic, training-induced adaptations in skeletal muscle are the result of the cumulative 
effect of repeated bouts of exercise, the initial signalling responses that promote long-term 
adaptations are likely to occur after each training session (Widegren et al. 2001). Accordingly, 
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this study investigated the early signalling events in skeletal muscle that are elicited in 
response to different types of contractile stimuli (e.g. endurance and strength training). 
Utilising a unique design in which athletes from different training backgrounds (i.e. 
chronically endurance- or strength-trained) undertook exercise in their habitual training mode, 
and “crossed over” to perform an acute bout in a non-familiar exercise discipline, the results 
are expected to characterise the acute signalling events underlying the specific adaptations to 
diverse modes of contractile activity associated with endurance and strength training. 
 
3.2 Methods 
Materials 
Monoclonal anti-phospho-extracellular regulating kinase 1/2 (ERK1/2Thr202/Tyr204), polyclonal 
anti-AKTSer473/Thr308, were from New England BioLabs (Beverly, MA, U.S.A.). Polyclonal 
anti-p-Tuberin/TSC2Thr1462, Phospho-AMPKThr172, polyclonal anti-ribosomal protein S6 
kinase 70 kDa (p70 S6KThr389) kinase, polyclonal anti-phospho- eukaryotic translation 
initiation factor 2 beta (eIF2BSer540) and polyclonal anti-phospho-p38Tyr188/182 were from Cell 
Signaling Technology, Inc. (Beverly, MA, U.S.A.). Enhanced chemiluminescence reagents 
were from Amersham Biosciences (Buckinghamshire, U.K.). Other reagents are from Sigma 
Chemicals (St. Louis, MO, U.S.A.). 
 
Subjects 
Thirteen trained male volunteers participated in this investigation. Six subjects were cyclists 
who had been participating in regular endurance training (ET) for 8 yr. These subjects did not 
undertake any form of resistance training. The other 7 subjects were power-lifters who had 
been participating in regular strength / resistance training (ST) for 9 yr and did not participate 
in any kind of endurance training. Characteristics of subjects from the two diverse training 
backgrounds are displayed in Table 3.1. The experimental procedures and possible risks 
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associated with the study were explained to each subject, who gave written informed consent 
prior to participation. The study was approved by the Human Research Ethics Committee of 
RMIT University.  
 
Table 3.1 Subject characteristics. 
 Endurance Trained  
(n= 6) 
Strength Trained  
(n= 7) 
Mass (kg) 
Age (yr) 
Training History (yr) 
VO2peak (ml·kg-1·min-1) 
Maximum Strength (N·m) 
Concentric 
Eccentric 
74.7 ± 7.6 
28.7 ± 6.1 
8.5 ± 2.7 
65.2 ± 6.4 
 
214 ± 40 
243 ± 53 
96.9 ± 15.5* 
30.7 ± 8.4 
9.0 ± 7.3 
36.9 ± 7.4* 
 
309 ± 45* 
389 ± 60* 
 
All values are means ± standard deviation. * Significant difference between endurance-trained 
and strength-trained groups (Students t-test, P <0.05). 
 
Overview of Study Design 
The study consisted of a crossover design. All subjects performed two different exercise-
testing protocols in randomised order: one experimental trial was undertaken in the subject’s 
habitual training discipline, while the other trial was performed in a non-familiar exercise 
mode.   
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Preliminary Tests  
Peak Oxygen Uptake (VO2peak)  
Peak oxygen uptake (VO2peak) was determined during an incremental maximal cycling test to 
volitional fatigue on an isokinetic Lode bicycle ergometer (Groningen, The Netherlands). 
Briefly, the test protocol commenced at an intensity equivalent to 3.33 W·kg-1 or 2.5 W·kg-1 
of body mass (BM) for endurance- and strength-trained subjects, respectively. This workload 
was maintained for 150 s then increased by 50 W for the second workload and 25 W every 
150 s thereafter until subjects reached volitional fatigue, defined as the inability to maintain a 
cadence >70 rev·min-1. Throughout the maximal test breath-by-breath expired gas was passed 
through a flowmeter, an O2 analyser, and a CO2 analyser (Med Graphics, Minnesota) that was 
calibrated before testing using a 3-L Hans-Rudolph syringe and gases of known concentration 
(4.00% CO2 and 16.00% O2). The flowmeter and gas analysers were connected to a computer 
that calculated minute ventilation, oxygen uptake (VO2), CO2 production (VCO2), and 
respiratory exchange ratio (RER) from conventional equations.  
 
Maximal Strength 
Maximal concentric and eccentric strength was determined using seated leg extensions, 
performed on a Kin-Com isokinetic dynamometer (Chattanooga, Tennessee, U.S.A.). The 
subject’s right leg was strapped to the actuator arm immediately superior to the lateral 
malleolus of the lower leg with the lateral condyle of the femur visually aligned to the 
fulcrum of the actuator arm. Contractions were performed at 30°·s-1 and subjects were 
instructed to extend their leg and resist the actuator arm with maximal effort during 
repetitions. Exercise range of motion was 85°, with leg extension endpoint set at -5° from full 
extension. Real time visual feedback was provided for all repetitions. Quadriceps strength was 
determined during a series of 3-repetition maximal leg extension sets with each set separated 
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by 120 s. Each individual 1-RM was defined as the peak torque (N·m) recorded during the 
concentric and eccentric contraction phases of the test protocol.  
 
Diet/Exercise Control 
Twenty-four hours before each exercise testing session (described subsequently), subjects 
refrained from vigorous physical activity and were provided with standardised pre-packed 
meals that consisted of 3 g CHO·kg-1 body mass (BM), 0.5 g protein·kg-1 BM, and 0.3 g 
fat·kg-1 BM, to be consumed as the final intake the evening prior to reporting for an exercise 
testing session. 
 
Exercise Testing Session 
On the morning of a testing session subjects reported to the laboratory in a 10-12 h overnight 
fasted state. After resting quietly in a supine position for 10 min local anaesthesia (2-3 ml of 
1% Xylocaine (lignocaine)) was administered to the skin, subcutaneous tissue and fascia of 
the vastus lateralis in preparation for muscle sampling. A resting biopsy was taken by using a 
6 mm Bergstrom needle with suction applied (Evans et al. 1982). Approximately 100 mg of 
skeletal muscle was removed and immediately frozen in liquid N2. At this time, separate sites 
on the same leg (~5 cm distal) were prepared for subsequent sampling. Biopsies were taken 
from the left leg when subjects performed the cycling exercise session and the right leg for the 
resistance training session. Immediately upon completion of each exercise testing session, a 
second biopsy was taken and then subjects rested in a supine position for 3 h. At the end of 
the 3 h recovery period, during which time the subjects were only allowed access to water, a 
third biopsy was taken. Every attempt was made to extract tissue from approximately the 
same depth in the muscle and to freeze the sample in liquid N2 within 10 s. Samples were 
stored at –80 oC until subsequent analysis. 
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 Cycling Exercise Session 
Subjects performed 60 min of continuous cycling at a power output that elicited ∼70% of 
individual VO2peak.  
 
Resistance Exercise Session 
Maximal voluntary isokinetic single leg extensions were performed on a Kin-Com 
dynamometer (as described previously). Subjects performed 8 sets of 5 repetitions at maximal 
intensity, separated by a 3 min recovery period. Peak and mean torque were recorded for each 
leg extension set.  
 
Analytical Procedures 
Total RNA Isolation and Reverse Transcription 
Total RNA from ~20 mg of wet muscle was isolated using the ToTALLY RNA Kit (Ambion 
Inc., Austin, TX, U.S.A.) protocol and reagents. Total RNA concentration was determined 
spectrophotometrically at 260 and 280 nm. RNA was reverse transcribed to synthesise first-
strand cDNA using AMV reverse transcriptase (Promega, Madison, WI, U.S.A.) as described 
previously (Wadley et al. 2001). The cDNA was stored at -20 οC for subsequent analysis. 
 
Primer Design and mRNA Quantification  
Peroxisome proliferator activated receptor gamma co-activator-1α (PGC-1α) primers were 
designed using Primer Express software version 2.0 (Applied Biosystems, Foster City, CA.) 
from GenBank sequence accession no. NM_013261. Primer specificity was confirmed using 
BLAST (Altschul et al. 1990). Primers were purchased from GeneWorks (Adelaide, SA, 
Australia). Primer efficiency (E) of each target amplification for a series of dilutions was 
calculated using E = (10-1/slope)-1. Primers demonstrated efficient amplification. 
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Real-time PCR was performed using the GeneAmp® 5700 Sequence Detection System 
(Applied Biosystems). Reaction volumes (20 µl) contained 2 × SYBR Green PCR Master Mix 
(Applied Biosystems), forward and reverse primers and cDNA template (diluted 1:40). 
Samples were run in duplicate for 1 cycle (50 °C 2 min, 95 °C 10 min) followed by 40 cycles 
(95 °C 15 s, 60 °C 60 s) and fluorescence emissions were measured after each cycle. A 
melting point dissociation curve was generated to confirm single product amplification. 
Expression of the gene of interest was calculated by subtracting the CT of the target gene for a 
given sample from the CT of the appropriate control sample. Expression of the gene of interest 
relative to control was calculated using the expression 2-∆CT.  
 
Western Blot Analysis  
Skeletal muscle biopsies were freeze-dried overnight and dissected under a microscope to 
remove visible blood, fat and connective tissue. Skeletal muscles were homogenised in ice-
cold homogenisation buffer containing 50 mM HEPES, pH 7.5, 150 mM NaCl, 5 mM EDTA, 
10 mM sodium pyrophosphate, 2 mM sodium vanadate, and a protease inhibitor cocktail (1 
mM phenylmethylsulfonyl fluoride, and 10 µg/mL each of aprotinin, leupeptin, and 
pepstatin). The lysate was kept on ice for 30 min and subjected to centrifugation at 12,000 g 
for 10 min at 4 ºC. Protein concentration was determined with a BCA Protein Assay (Pierce, 
Rockford, IL, U.S.A.). Aliquots of lysate (20 µg of protein) were re-suspended in Laemmli 
sample buffer. Proteins were then separated by SDS/PAGE, transferred to 
polyvinylidenedifluoride membranes (Millipore, MA), blocked with 7.5% non-fat milk, 
washed with TBST (10 mM Tris HCl, 100 mM NaCl, 0.02% Tween 20) and incubated with 
appropriate primary antibodies overnight at 4 ºC. Membranes were washed with TBST and 
incubated with an appropriate secondary antibody. Both training groups were run on the same 
gel. Proteins were visualised by chemiluminescence and quantified by densitometry. The 
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amount of phosphorylated proteins of the densitometric quantification is expressed as 
arbitrary units.  
 
Statistical Analysis 
Differences in subject characteristics and exercise performance were determined using two-
tailed t-test assuming unequal variances. Real-time PCR mRNA, and immunoblot 
phosphorylation and protein data are expressed in arbitrary units. Differences between means 
were determined by a one-way analysis of variance (ANOVA) with Newman-Keuls post-hoc 
test (GraphPad Prism version 3.0). All values are expressed as means and standard error (SE) 
with the critical level of significance established at P <0.05.  
 
3.3 Results 
Exercise Performance   
The average power output corresponding to ~70% of VO2peak for the 60 min cycling exercise 
session was 242 ± 11 vs. 168 ± 10 W for endurance- and strength-trained subjects, 
respectively (P <0.001). Four strength-trained subjects were unable to complete the prescribed 
workload during the cycling bout. In these cases, power output was reduced to 60% of VO2peak 
after 30 min for the remainder of the prescribed exercise time. Peak force during the 
isokinetic resistance exercise session was 263 ± 10 vs. 190 ± 4 N for strength- and endurance-
trained subjects, respectively (P <0.001).  
 
Signalling Responses  
AMPK 
Phosphorylation of AMPK increased immediately following cycling exercise in strength-
trained (54%; P <0.05, Figure 3.1A), but not endurance-trained subjects. Conversely, AMPK 
phosphorylation was increased immediately post-exercise in endurance- (114%; P <0.05, 
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Figure 3.1B), but not strength-trained subjects after resistance exercise. Effects on AMPK 
phosphorylation were lost within 3 h recovery following both exercise modes. 
 
Figure 3.1 ‘5 adenosine monophosphate kinase (AMPK) phosphorylation in vastus lateralis 
muscle of strength-trained (ST; n = 7) and endurance-trained (ET; n = 6) subjects in response 
to 60 min cycling at ~70% VO2peak (A) and 8 × 5 maximal isokinetic leg extensions (B). 
Values are group means (± SE) at rest, immediately post-exercise (Post) and 3 h post-exercise 
(3 h). *Significant difference (One-way ANOVA) rest vs. post (*P <0.05); †Significant 
difference post vs. 3 h (†P <0.05). 
 
AKT-TSC2 
Following cycling exercise, AKTSer473 phosphorylation was increased in endurance- (50%; P 
<0.05), but not strength-trained subjects (Figure 3.2A). The level of AKTThr308 
phosphorylation was unchanged (data not shown). After 3 h of recovery, AKT 
phosphorylation decreased below resting values in endurance-trained subjects (67%; P <0.01). 
AKT phosphorylation was similar between strength- and endurance-trained subjects following 
resistance exercise (Figure 3.2B). TSC2 phosphorylation was unaltered after cycle exercise in 
either strength- or endurance-trained subjects (Figure 3.2C). However, following resistance 
exercise, TSC2 phosphorylation was decreased in endurance-trained subjects immediately 
post-exercise (47%; P <0.05), an effect that persisted for 3 h recovery (40%; P <0.05, Figure 
3.2D). 
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 Figure 3.2 AKT (A, B) and tuberous sclerosis complex-2 (TSC2; C, D) phosphorylation in 
vastus lateralis muscle of strength-trained (ST; n = 7) and endurance-trained (ET; n = 6) 
subjects in response to 60 min cycling at ~70% VO2peak (A, C) and 8 × 5 maximal isokinetic 
leg extensions (B, D). Values are group means (± SE) at rest, immediately post-exercise 
(Post) and 3 h post-exercise (3 h). *Significant difference (One-way ANOVA) rest vs. post 
(*P <0.05); ‡Significant difference rest vs. 3 h (‡P <0.05, ‡‡P <0.01); †Significant difference 
post vs. 3 h (†††P <0.001). 
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Figure 3.3 Eukaryotic initiation factor 2B (eIF2B; A, B) and ribosomal p70 S6 kinase (p70 
S6K; C, D) phosphorylation, and ribosomal S6 protein abundance (S6; E, F) in vastus lateralis 
muscle of strength-trained (ST; n = 7) and endurance-trained (ET; n = 6) subjects in response 
to 60 min cycling at ~70% VO2peak (A, C, E) and 8 × 5 maximal isokinetic leg extensions (B, 
D, F). Values are group means (± SE) at rest, immediately post-exercise (Post) and 3 h post-
exercise (3 h). *Significant difference (One-way ANOVA) rest vs. post (*P <0.05, **P 
<0.01); ‡Significant difference rest vs. 3 h (‡P <0.05, ‡‡P <0.01); †Significant difference post 
vs. 3 h (†P <0.05). 
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eIF2B-p70 S6K 
Cycling exercise induced a significant decrease in eIF2B phosphorylation in strength-trained 
(P <0.01, Figure 3.3A), but not endurance-trained subjects. eIF2B phosphorylation in 
strength-trained subjects was decreased immediately post-exercise (78% P <0.01) and this 
effect was maintained after 3 h recovery (63%; P <0.01, Figure 3.3A). eIF2B phosphorylation 
was similar after resistance exercise in strength- and endurance-trained subjects following 3 h 
recovery (Figure 3.3B). Likewise, p70 S6K phosphorylation was similar between strength- 
and endurance-trained subjects after 60 min cycling exercise (Figure 3.3C). However, 
resistance exercise elicited a significant increase in p70 S6K phosphorylation in endurance-
trained subjects after 3 h of recovery (118%; P<0.05, Figure 3.3D). Phosphorylation of S6 
protein, a substrate for p70 S6K, was increased immediately following resistance exercise in 
endurance-trained (129%; P <0.05; Figure 3.3F), but not strength-trained subjects. 
 
ERK1/2-p38  
ERK phosphorylation after cycling or resistance exercise was similar between strength- and 
endurance-trained subjects (Figure 3.4A and 3.4B). p38 phosphorylation was increased in 
strength- (74%; P <0.001), but not endurance-trained subjects immediately after cycling 
exercise (Figure 3.4C). In contrast, p38 phosphorylation was significantly increased in 
endurance-, but not strength-trained subjects after resistance exercise (28%; P <0.05, Figure 
3.4D). All exercise-induced phosphorylation effects were lost after 3 h recovery following 
both exercise modes. 
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 Figure 3.4 Extracellular regulating kinase (ERK; A, B) and p38 (C, D) MAPK 
phosphorylation in vastus lateralis muscle of strength-trained (ST; n = 7) and endurance-
trained (ET; n = 6) subjects in response to 60 min cycling at ~70% VO2peak (A, C) and 8 × 5 
maximal isokinetic leg extensions (B, D). Values are group means (± SE) at rest, immediately 
post-exercise (Post) and 3 h post-exercise (3 h). *Significant difference (One-way ANOVA) 
rest vs. post (*P <0.05, ***P <0.001); †Significant difference post vs. 3 h (†P < 0.05, ††P 
<0.01). 
 
PGC-1α mRNA and Protein Expression Responses to Exercise 
PGC-1α mRNA was increased to a similar extent after cycling in both endurance-trained 
(~8.5-fold, P <0.001) and strength-trained subjects (~10-fold increase, P <0.001). However, 
there was little effect of resistance exercise on the mRNA expression of PGC-1α. PGC-1α 
protein content after 3 h recovery from cycling or resistance exercise was unchanged in 
strength- and endurance-trained subjects (data not shown).  
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3.4 Discussion 
Contractile activity associated with physical exercise stimulates multiple signalling events and 
induces transient changes in gene transcription (Widegren et al. 2001; Sakamoto and 
Goodyear 2002). These acute alterations in cellular homeostasis may be responsible for the 
chronic adaptations that occur in skeletal muscle in response to repeated bouts of exercise (i.e. 
training). The disparity between the adaptations observed after chronic resistance or 
endurance training suggests these two types of contractile stimuli induce differential 
signalling and gene regulatory responses (Booth and Thomason 1991). To test this hypothesis, 
the current study utilised a unique design in which habitually strength-trained and endurance-
trained athletes undertook an acute bout of exercise in each of these training modes in order to 
characterise the specific signalling events associated with diverse modes of contraction. The 
results provide evidence for the highly specialised nature of training adaptation and 
demonstrate that a degree of “response plasticity” capable of diverse adaptive compliance is 
conserved at opposite ends of the endurance-hypertrophy adaptation continuum.  
AMPK is involved in the regulation of numerous adaptive responses including 
mitochondrial biogenesis, muscle hypertrophy and protein synthesis (Aschenbach et al. 2004). 
In response to exercise, isoform-specific and intensity-dependent changes in AMPK activity 
have been observed in human skeletal muscle (Yu et al. 2003). AMPK has been implicated as 
part of a metabolic ‘switch’ that, in concert with PGC-1α (Terada et al. 2002; Jorgensen et al. 
2005), promotes mitochondrial biogenesis and an ‘endurance-training like’ profile (Atherton 
et al. 2005). AMPK phosphorylation was increased in skeletal muscle from strength-trained 
subjects when non-habitual cycling exercise was performed and from endurance-trained 
subjects who undertook non-habitual resistance exercise (Figure 3.1). These changes in 
AMPK phosphorylation in human skeletal muscle in vivo contrast with the recent results in 
rodent skeletal muscle (Atherton et al. 2005), whereby signalling responses were determined 
in response to in vitro electrical stimulation. Compared to rest, low-frequency electrical 
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stimulation to mimic endurance training increased AMPKThr172 phosphorylation (relative to 
total AMPK), while high-frequency electrical stimulation (to mimic resistance training) 
decreased AMPK phosphorylation (Atherton et al. 2005).   
There are a number of possible explanations for the discordant findings between these 
studies. The most obvious relates to the use of different loads and stimulation patterns to 
induce muscle contraction. In vitro electrical stimulation represents an extreme stimulus, 
likely to exceed any stress that would be encountered by human skeletal muscle in vivo. 
However, an alternative explanation might be that [AMP] only increased sufficiently to 
activate AMPK when subjects performed exercise in their unfamiliar discipline (i.e. when 
endurance-trained subjects undertook resistance exercise, or when strength-trained individuals 
undertook sub-maximal cycling). In support of this contention, all strength-trained subjects 
reported experiencing extreme difficulty completing 60 min of continuous cycling at the 
prescribed power output, whereas all endurance-trained individuals coped with the demands 
of this exercise task effortlessly. If, in the case of the strength-trained subjects, part of the 
cycling exercise bout was undertaken at an intensity above the individual lactate threshold, 
then aerobic and glycolytic ATP resynthesis rates would be insufficient to maintain steady-
state [phosphocreatine] and the concentrations of AMP would rise. Indeed, Yu and co-
workers (2003) and Neilsen and colleagues (2003a) have previously shown that during 
cycling exercise performed at the same relative intensity, activation of several signalling 
intermediates (including AMPK) was greater in skeletal muscle from untrained subjects than 
from highly-trained cyclists with a prolonged history of endurance training, probably due to a 
better maintenance of the energy charge and a less pronounced exercise-induced acidification 
in exercise-trained muscle.  
With regard to the increase in AMPK phosphorylation in endurance-trained subjects 
following resistance exercise, the recovery between maximal work-bouts was possibly too 
short to allow for complete resynthesis of [phosphocreatine]. This would lead to an increase in 
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[AMP] to a level that is sufficient for AMPK activation. Finally, as AMPK has a glycogen 
binding domain (Hudson et al. 2003) and activity of AMPK is greater when skeletal muscle 
[glycogen] is low (Wojtaszewski et al. 2003), the possibility exists that greater net glycogen 
depletion occurred when subjects performed the unfamiliar exercise bout, compared to the 
habitual discipline. Unfortunately, adequate muscle sample was unavailable for analyses of 
glycogen and metabolite concentrations.  
Along with AMPK, activation of PGC-1α has recently been proposed to partially 
mediate specific adaptations to endurance training (Atherton et al. 2005). Indeed, evidence for 
increased expression of PGC-1α in rodent skeletal muscle 12-18 h after a single bout of 
prolonged swimming exercise (Baar et al. 2002) and within 3 h of low frequency electrical 
stimulation in vitro (Atherton et al. 2005) has been provided, suggesting that increases in 
PGC-1α protein expression represents a key regulatory component of the stimulation of 
mitochondrial biogenesis by exercise. In the present study, cycling resulted in marked 
increases in PGC-1α mRNA in endurance- and strength-trained subjects, whereas resistance 
exercise had little effect on the mRNA expression. While endurance exercise undoubtedly 
enhances PGC-1α mRNA expression, possibly through an AMPK-related mechanism (Terada 
et al. 2002), further work is required to directly link AMPK-PGC-1α signalling with chronic 
adaptations to exercise. 
AKT is a critical signalling mediator of cellular growth and metabolism in skeletal 
muscle (Glass 2003). AKT directly phosphorylates TSC2, activating mTOR, in part by 
deactivating TSC2 (Inoki et al. 2002). AKT can also directly phosphorylate (Nave et al. 1999) 
and activate mTOR (Scott et al. 1998) and phosphorylation of both AKT and mTOR are 
increased during skeletal muscle hypertrophy (Reynolds et al. 2002). Inhibition of mTOR 
activity blocks compensatory skeletal muscle hypertrophy in vivo (Bodine et al. 2001b), while 
ablation or inhibition of p70 S6K results in decreases in cell size (Montagne et al. 1999). 
Eukaryotic initiation factor eIF2 and its “exchange factor” eIF2B also play key roles in the 
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regulation of protein synthesis and cell growth: phosphorylation of eIF2 inhibits eIF2B and 
thus translation initiation. While phosphorylation of eIF2 serves to impair protein synthesis, it 
causes up-regulation of the translation of specific mRNAs that encode transcription factors, 
therefore exerting effects on gene expression at multiple levels.  
In agreement with others (Thorell et al. 1999; Sakamoto et al. 2004a), an increase in 
AKTSer473 phosphorylation was observed following cycling exercise in endurance-trained 
subjects. However, AKTThr308 phosphorylation was unchanged. At present, there is little data 
on the response of AKT after an acute bout of resistance exercise undertaken by strength-
trained subjects, although a recent report provides evidence for increased AKT 
phosphorylation in endurance-trained cyclists after moderate-intensity resistance exercise 
(Creer et al. 2005). Interestingly, the increase in AKT phosphorylation in that study was 
observed only when subjects commenced exercise with high (~600 mmol/kg dry mass) 
skeletal muscle glycogen content and not when pre-exercise glycogen levels were low (~200 
mmol/kg dry mass). Phosphorylation of AKT deactivates GSK3, which under basal 
conditions is thought to promote activation of glycogen synthase (Cross et al. 1995) and 
inhibit eIF2B activity (Vyas et al. 2002). The current results show a moderate increase in 
eIF2B phosphorylation in skeletal muscle 3 h after strength-trained subjects performed 
resistance exercise, and a concomitant decrease in phosphorylation after these subjects 
undertook endurance exercise. These findings are perplexing and suggest that strength trained 
subjects activated a prolonged translation initiation following endurance exercise, although 
the mechanism underlying this effect remains unknown. 
The involvement of p70 S6K in skeletal muscle hypertrophy has been implicated from 
a variety of work / force overload models(Baar et al. 1999; Bodine et al. 2001b; Nader and 
Esser 2001; Rommel et al. 2001). Phosphorylation of p70 S6K and subsequent activation of 
ribosomal protein S6 enhances translation of mRNAs encoding elongation factors and 
ribosomal proteins, thereby increasing translational capacity (Kubica et al. 2005). Resistance 
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exercise in endurance- but not strength-trained subjects elicited a significant increase in p70 
S6K phosphorylation after 3 h recovery (Figure 3.3D) and in ribosomal S6 protein 
phosphorylation immediately post-exercise (Figure 3.3F). This finding is in agreement with 
previous work in humans (Karlsson et al. 2004), which showed that p70 S6K phosphorylation 
was increased following resistance training in healthy untrained men 2 h post-exercise when 
branch chain amino acids were administered. p70 S6K phosphorylation is also increased with 
high-frequency electrical stimulation and resistance training to induce cell growth and 
hypertrophy in rodents (Baar et al. 1999; Nader and Esser 2001; Kubica et al. 2005). An 
explanation for the lack of change in p70 S6K and S6 protein in the strength-trained subjects 
following resistance exercise is that these proteins are already sufficiently up-regulated to 
accommodate any further strength gains that may occur after subsequent bouts of resistance 
exercise (i.e. negative feedback). This theory may also explain why phosphorylation of p70 
S6K, a translational regulator, was only increased in endurance-trained subjects 3 h following 
resistance exercise. The increase in p70 S6K phosphorylation is consistent with the 
observation that phosphorylation of this protein and subsequent protein synthesis in skeletal 
muscle are only elevated in the long-term recovery period after an acute bout of resistance 
exercise undertaken by untrained subjects (Karlsson et al. 2004) and after in vitro electrical 
stimulation (Baar et al. 1999; Nader and Esser 2001). These models are representative of 
skeletal muscle with large potential for plasticity to adapt (i.e. the malleability of structure and 
function has yet to be determined). 
The specific responses of mitogen activated protein kinases (MAPK) to different 
forms of exercise / contraction are incompletely understood. Indeed, previous investigations 
have established variable MAPK signalling responses with altered metabolic and mechanical 
stress, contraction modes, and training status following a variety of exercise stimuli 
(Widegren et al. 1998; Wretman et al. 2001; Nielsen et al. 2003a; Thompson et al. 2003; Yu 
et al. 2003). In accordance with some (Nader and Esser 2001), but in contrast with other 
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studies (Wretman et al. 2001), findings from the current study provide no evidence for 
exercise-specific or training-specific effects on either ERK1/2 and p38 phosphorylation 
(Figure 3.4). The ERK1/2 pathway has been proposed to play a role in the formation of slow 
muscle fibres and to inhibit the formation of fast muscle fibres (Murgia et al. 2000; Higginson 
et al. 2002). While both forms of contraction were associated with a transient increase in ERK 
phosphorylation immediately post-exercise and a return to resting values after 3 h of recovery, 
these changes failed to reach statistical significance. Both low- and high-frequency electrical 
stimulation of rodent skeletal muscle leads to increased ERK1/2 phosphorylation (Atherton et 
al. 2005), suggesting that this pathway is involved in a general response to contractile activity. 
With regard to the responses of the p38 MAPK pathway to different exercise modalities, 
when subjects undertook exercise in their non-familiar activity, p38 MAPK phosphorylation 
was increased. Contraction-induced phosphorylation of p38 MAPK is induced by high 
mechanical stress, which might partly explain the increase in phosphorylation after 
endurance-trained subjects performed heavy resistance exercise (i.e. mechanical loading to 
which the muscle was unaccustomed or poorly adapted) (Wretman et al. 2001). However, in 
rodent skeletal muscle, p38 MAPK phosphorylation was unaltered in response to either low- 
or high-frequency electrical stimulation (Atherton et al. 2005). Data from this study supports 
the contention that p38 MAPK is not always phosphorylated in response to contractile activity 
(Wretman et al. 2001; Atherton et al. 2005).  
In conclusion, linking specific signalling cascades to specialised metabolic and gene 
regulatory responses that occur in response to different modes of exercise is complicated by 
the fact that signalling pathways are non-linear and often constitute a complex and 
incompletely resolved network with a high degree of cross-talk, feedback regulation, transient 
activation and redundancy (Zierath and Hawley 2004). While information pertaining to the 
subsets of genes and putative signalling pathways activated in response to different modes of 
contraction in humans is emerging (Yu et al. 2003; Yang et al. 2005), the mechanism for 
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adaptive changes in skeletal muscle in response to training is incompletely resolved. 
Moreover, whether prior contractile activity (i.e. training history) affects the acute responses 
to divergent exercise stimuli is unknown. The results from the current study provide evidence 
that chronic endurance or strength training attenuates some of the exercise specific signalling 
responses involved in single mode adaptations to training. Although there is a possibility that 
pre-existing (genetic) differences between the two groups may also contribute to the acute 
exercise responses, this study demonstrates that human skeletal muscle retains the capacity to 
respond to divergent contractile stimuli and that a degree of “response plasticity” is conserved 
at opposite ends of the endurance-hypertrophy adaptation continuum. Although selective 
activation of the AMPK-PGC-1α or AKT-TSC2-mTOR signalling pathways has been 
proposed to explain many of the specific adaptive responses to endurance or resistance 
training during in vitro electrically stimulated muscle contractions (Atherton et al. 2005), the 
in vivo findings from this study provide little evidence for the putative AMPK-AKT switch. 
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Chapter Four  
 
 
 
Interaction of contractile activity and training history on 
mRNA abundance in skeletal muscle from trained athletes  
 
 
Adapted from: Coffey V.G., Shield A., Canny B.J., Carey K.A., Cameron-Smith D., Hawley 
J.A. American Journal of Physiology Endocrinology and Metabolism 290(5): E849-855, 
2006. 
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4.1 Introduction 
Skeletal muscle displays an enormous plasticity to respond to contractile activity and loading 
conditions, with muscle from strength- and endurance-trained athletes representing diverse 
states of the “adaptation continuum.” Endurance training of sufficient volume and intensity 
results in an increased whole-body maximal oxygen uptake and shifts in substrate utilisation 
from carbohydrate- to lipid-based fuels, largely as a result of an expanded mitochondrial 
density and volume (Irrcher et al. 2003). Such changes are brought about by the coordinated 
co-expression of both the nuclear and mitochondrial genomes that, together, ensure proper 
assembly and expansion of the mitochondrial reticulum (Adhihetty et al. 2003). Thus, 
endurance training-induced adaptations culminate in mitochondrial biogenesis and an 
organelle capable of improved ATP provision (Irrcher et al. 2003) and a concomitant 
enhancement of endurance capacity (Holloszy and Coyle 1984). In contrast, resistance 
exercise, comprising high-intensity, low volume loading, results in increased cross-sectional 
area of the trained musculature, mainly due to an increase in muscle contractile protein (Flück 
and Hoppeler 2003). Modulation of transcription and translation events contribute to changes 
in gene expression and subsequent protein synthesis in response to this mode of training 
(Bolster et al. 2003a). Accordingly, resistance training-induced adaptations that culminate in 
muscle hypertrophy are the result of integrated gene responses and coordinated molecular 
events that support the enlargement of pre-existing muscle cells via the incorporation of 
additional myonuclei (Flück and Hoppeler 2003). 
Training adaptation can merely be viewed as the accumulation of specific proteins 
(Hansen et al. 2005). Hence, the altered gene expression that allows for these changes in 
protein concentration is of major importance for any subsequent training adaptation. The 
chronic adaptations to any training regimen are likely to be the result of the cumulative effects 
of repeated bouts of exercise (Sanders Williams and Neufer 1996; Pilegaard et al. 2000), with 
the initial cellular responses that lead to these long-term adaptations occurring after each 
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(acute) training session (Widegren et al. 2001). Previous works have demonstrated the 
importance of a wide range of gene expression consistent with their central role in defining 
the adaptive phenotype with differing modes of training (Teran-Garcia et al. 2005; Vissing et 
al. 2005). However, for many genes the transcriptional activation and translational responses 
occur during the first few hours of recovery, returning to basal levels within 24 h of the 
exercise stimulus (Neufer and Dohm 1993; Pilegaard et al. 2000). Although much data is 
available describing the cellular and molecular mechanisms underlying the transcriptional 
regulation of gene expression after exercise the effects of prior training on the acute response 
to different types of contraction has not been investigated. Accordingly, the present study was 
undertaken to determine the early gene responses after an acute bout of endurance and 
resistance training. Utilising a design in which chronically endurance- or strength-trained 
athletes undertook exercise in their customary training mode and “crossed over” to perform an 
acute bout of exercise in their non-familiar discipline, this study should provide novel data on 
subsets of metabolic and myogenic genes that are likely to be fundamental to the specific 
exercise-induced adaptation in skeletal muscle. 
 
4.2 Methods 
Subjects 
Thirteen trained male volunteers participated in this investigation. Six subjects were cyclists 
who had been participating in regular endurance training (ET) for an average of 8 ±3 yr. 
These subjects were not undertaking any form of resistance training, nor had they performed 
such training during the past 2 yr. The other 7 subjects were power-lifters who had been 
participating in regular strength / resistance training (ST) for 9 ±7 yr and had not participated 
in any kind of endurance training for the past 2 yr. The characteristics of the two training 
populations are the same as those described in Chapter Two (page 98). The experimental 
procedures and possible risks associated with the study were explained to each subject who 
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gave written informed consent prior to participation. The study was approved by the Human 
Research Ethics Committees of RMIT University.  
 
Overview of Study Design 
The study consisted of a crossover design. All subjects performed two different exercise-
training protocols to enable within subject comparisons. One experimental trial was 
undertaken in the subject’s habitual training discipline, while the other trial was performed in 
their non-familiar exercise mode. Exercise testing sessions were separated by a minimum of 
10 d.  
 
Preliminary Tests  
Peak Oxygen Uptake (VO2peak)  
Peak oxygen uptake (VO2peak) was determined during an incremental maximal cycling test to 
volitional fatigue on an isokinetic Lode bicycle ergometer (Groningen, Netherlands) as 
described in detail previously (Hawley and Noakes 1992). 
 
Maximal Strength 
Maximal concentric and eccentric strength was determined using seated leg extensions 
performed on a Kin-Com isokinetic dynamometer (Chattanooga, Tennessee). The subject’s 
right leg was strapped to the actuator arm immediately superior to the lateral malleolus of the 
lower leg with the lateral condyle of the femur visually aligned to the fulcrum of the actuator 
arm. Contractions were performed at 30°·s-1 and subjects were instructed to extend their leg 
and resist the actuator arm with maximal effort during concentric and eccentric leg extension 
repetitions, respectively. Exercise range of motion was 85° with leg extension endpoint set at 
-5° from full extension. Quadriceps strength was determined during a series of 3 x 3-
repetition leg extensions with each set separated by 120 s. Each individual 1-RM was defined 
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as the peak torque (N·m) recorded during the concentric and eccentric contraction phases of 
the test protocol.  
 
Diet/Exercise Control 
Before each exercise testing session subjects were required to refrain from vigorous physical 
activity for a minimum of 24 h and were provided with standardised pre-packed meals that 
consisted of 3 g CHO·kg-1 body mass (BM), 0.5 g protein·kg-1 BM, and 0.3 g fat·kg-1 BM to 
be consumed as the final caloric intake the evening prior to reporting to the laboratory. 
 
Exercise Testing Session 
On the morning of a testing session subjects reported to the laboratory in a 10-12 h overnight 
fasted state. After resting for 10 min local anaesthesia (2-3 ml of 1% Xylocaine (lignocaine)) 
was administered to the skin, subcutaneous tissue and fascia of the vastus lateralis in 
preparation for muscle biopsies. A resting biopsy (~100 mg) was taken by using a 6 mm 
Bergstrom needle with suction applied (Evans et al. 1982), removed and immediately frozen 
in liquid N2. At this time a separate site on the same leg (~5 cm distal) was prepared for a 
second biopsy. Biopsies were taken from the left leg when performing the cycling exercise 
session and the right leg for the resistance training session. Upon completion of each exercise 
testing session subjects rested in a supine position for 3 h and during this time water was 
consumed ad libitum. At the end of the recovery period a second muscle biopsy was taken. 
Every attempt was made to extract tissue from approximately the same depth in the muscle 
and to immediately freeze the sample in liquid N2. Samples were stored at –80 ºC until 
subsequent analysis. 
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Cycling Exercise Session 
Subjects performed 60 min of continuous cycling at a power output that elicited ∼70% of 
individual VO2peak.  
 
Resistance Exercise Session 
Subjects performed maximal concentric and eccentric leg extensor contractions with their 
right leg on a Kin-Com dynamometer (as described previously). Subjects performed 8 sets of 
5 maximal effort repetitions with 3 min recovery between sets. Peak and mean torque were 
recorded for each set.  
 
Analytical Procedures 
Total RNA Isolation and Reverse Transcription 
Total RNA from ~20 mg of wet muscle was isolated using the ToTALLY RNA Kit (Ambion 
Inc., Austin, TX) protocol and reagents. Total RNA concentration was determined 
spectrophotometrically at 260 and 280 nm. RNA was reverse transcribed to synthesize first-
strand cDNA using AMV reverse transcriptase (Promega, Madison, WI). Extracted RNA (1 
µg) was heated at 65 °C for 10 min immediately prior to first strand cDNA being generated 
using AMV reverse transcriptase (kit A3500; Promega, Madison, WI) with Oligo(dT)15 
primer, in the presence of 1mM of each dNTP and 20 U of recombinant RNasin ribonuclease 
inhibitor. The reaction was incubated at 42 °C for 60 min and then terminated at 99 °C for 10 
min and 4 °C for 5 min. The cDNA was stored at -20 ºC for subsequent analysis. Reverse 
transcription was performed for all samples simultaneously. Previous work from this 
laboratory has demonstrated minimal variation in efficiency when performed under these 
conditions (Murphy et al. 2003). 
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Primer Design and mRNA Quantification  
PCR primers were designed using Primer Express software version 2.0 (Applied Biosystems, 
Foster City, CA.) from gene sequences obtained from GenBank (Table 4.2). Primer 
specificity was confirmed using BLAST (Altschul et al. 1990). Primers were purchased from 
GeneWorks (Adelaide, SA, Australia). Efficiency of PCR primers was confirmed by 
examining the dynamic range of responses for a series of dilutions of cDNA. Using the slopes 
of the lines, the efficiency (E) of each target amplification was calculated using the equation E 
= (10-1/slope)-1. All primers used in this study demonstrated efficient amplification. 
Real-time PCR was performed using the GeneAmp® 5700 Sequence Detection 
System (Applied Biosystems). For the PCR step, reaction volumes of 20 µl contained 2 × 
SYBR Green PCR Master Mix (Applied Biosystems), forward and reverse primers and cDNA 
template (diluted 1:40). All samples were run in duplicate. The real-time PCR reaction was 
run for 1 cycle (50 °C 2 min, 95 °C 10 min) followed by 40 cycles (95 °C 15 s, 60 °C 60 s) 
and fluorescence emissions was measured after each of the repetitive cycles. Because SYBR 
green indiscriminately binds to double-stranded DNA, a melting point dissociation curve was 
generated to confirm that only a single product was amplified. Heat dissociation of 
oligonucleotides detects differences in melting temperature and produces a single dissociation 
peak for each nucleotide within a 2 ºC difference in melting temperature (Ririe et al. 1997). 
The selection of endogenous control to normalise for input RNA (housekeeping gene) was 
confounded by training history (strength or endurance trained) and / or exercise mode (cycling 
or resistance training) which generated significant variance in all of the commonly used 
exercise housekeeping genes (β-actin, β 2-microglobulin, GAPDH; Jemiolo and Trappe 2004; 
Mahoney et al. 2004). The expression of the gene of interest in a given sample was calculated 
by subtracting the CT of the target gene for a given sample from the CT of the same gene 
from the appropriate control sample, for that individual. The relative expression of the gene of 
interest relative to control was then calculated using the expression 2-∆CT.  
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Table 4.2 Primer sequences and concentrations used for real-time PCR. 
Gene GenBank 
Number 
Forward Primer (5’ ? 3’) Reverse Primer (5’ ? 3’) 
MAFBx NM_058229 CATCCTTATGTACACTGGTCCAAAGA TCCGATACACCCACATGTTAATG 
MyoD NM_002478 CCGCCTGAGCAAAGTAAATGA GCAACCGCTGGTTTGGAT 
Myogenin NM_002479 GGTGCCCAGCGAATGC TGATGCTGTCCACGATGGA 
Myostatin NM_005259 CCAGGAGAAGATGGGCTGAA CAAGACCAAAATCCCTTCTGGAT 
PGC-1α NM_013261 CAAGCCAAACCAACAACTTTATCTCT CACACTTAAGGTGCGTTCAATAGTC 
PDK4 NM_002612 ATGGATAATTCCCGGAATGCT ACTTGGCATACAGACGAGAAATTG 
VEGF NM_003376.3 GCGCAAGAAATCCCGGTATA GCTTTCTCCGCTGAGCAA 
 
PGC-1α, peroxisome proliferator activated receptor gamma co-activator 1α; PDK4, pyruvate 
dehydrogenase kinase 4; VEGF, vascular endothelial growth factor; MAFBx, muscle atrophy 
F-box protein. 
 
Statistical Analysis 
Differences in subject characteristics and exercise performance were determined using two-
tailed t-test assuming unequal variances. Data for mRNA abundance with each exercise 
session are expressed in relative units after individual samples were normalised relative to 
mean values at rest. Data were subjected to repeated measures ANOVA and log-
transformation was performed when significant deviations from homogeneity occurred (SPSS 
for Windows Version 12.0.1). Differences between individual means were compared using 
Fisher’s LSD test. All values are expressed as means and standard deviation (SD) with the 
critical level of significance established at P <0.05.  
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4.3 Results 
Exercise Performance   
The power output corresponding to ~70% VO2peak for the 60 min cycling bout was 242 ± 11 
vs. 168 ± 10 W for ET and ST subjects, respectively (P <0.001). The mean peak force during 
the isokinetic resistance exercise session was 263 ± 10 vs. 190 ± 4 N for ST and ET subjects, 
respectively (P <0.001). 
 
Changes in mRNA Abundance after Cycling Exercise 
Relative changes in mRNA abundance of metabolic genes in muscle sampled 3 h following 
60 min of cycling exercise were observed for both ST and ET subjects (Figure 4.1A, 1B). 
Peroxisome proliferator activated receptor gamma co-activator 1α (PGC-1α) mRNA was 
increased to a similar extent after cycling in both ET (~8.5-fold, P <0.001) and ST subjects 
(~10-fold increase, P <0.001). There were also large increases in pyruvate dehydrogenase 
kinase 4 (PDK4) mRNA in both groups of subjects after cycling (ET ~26-fold, P <0.05; ST 
~39-fold, P <0.05). Likewise, the increase in vascular endothelial growth factor (VEGF) 
mRNA was similar in ET (~4.5-fold, P <0.01) and ST subjects (~4-fold, P <0.01) in response 
to cycling exercise. 
Cycling exercise produced diverse responses between ET and ST subjects for the 
myogenic regulatory factors (MRF’s) MyoD and Myogenin (Figure 4.2A, 2B). There was an 
increase in both MyoD (~3-fold, P <0.05) and Myogenin mRNA (~0.9-fold, P <0.05) in ET 
subjects after cycling. In contrast, cycling decreased MyoD (~0.4-fold: NS) and Myogenin 
(~0.4-fold: NS) in ST subjects. Muscle atrophy F-box protein (MAFBx) mRNA abundance 
was increased in both subject groups following cycling (ET ~2-fold, P <0.01; ST ~0.4-fold, P 
<0.01) while Myostatin mRNA was significantly increased by cycling exercise in ET (~2-
fold, P <0.05) but not ST subjects. 
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Changes in mRNA Abundance after Resistance Exercise 
There was little effect of resistance exercise on the mRNA abundance of PGC-1α or VEGF 
(Figure 4.3A, 3B). In contrast, PDK4 was significantly increased in ET (~7-fold, P <0.01) but 
not ST subjects after resistance exercise. There were divergent responses of genes associated 
with myogenic regulation in ET subjects in response to resistance exercise (Figure 4.4A). In 
ET subjects, MyoD increased (~0.7-fold: NS) but MAFBx (~0.7-fold: NS) and myostatin 
(~0.6-fold: NS) both decreased after resistance exercise. In ST subjects, the mRNA 
abundance of the myogenic genes under investigation was not significantly altered by a single 
bout of resistance exercise (Figure 4.4B). 
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Figure 4.1 Changes in mRNA abundance for genes associated with endurance responses in 
(A) endurance-trained (ET; n = 6) and (B) strength-trained (ST; n = 7) subject vastus lateralis 
muscle sampled 3 h after 60 min cycling at ~70% VO2peak. All values are mean ±SD. PGC-1α, 
peroxisome proliferator activated receptor gamma co-activator 1α; PDK4, pyruvate 
dehydrogenase kinase 4; VEGF, vascular endothelial growth factor. * Significant difference 
from rest (Repeated measures ANOVA, *P <0.05, **P <0.01, ***P <0.001). 
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Figure 4.2 Changes in mRNA abundance for genes associated with myogenic responses in 
(A) endurance-trained (ET; n = 6) and (B) strength-trained (ST; n = 7) subject vastus lateralis 
muscle sampled 3 h after 60 min cycling at ~70% VO2peak. All values are mean ±SD. MAFBx, 
muscle atrophy F-box protein. * Significant difference from rest (Repeated measures 
ANOVA, *P <0.05, **P <0.01). 
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Figure 4.3 Changes in mRNA abundance for genes associated with endurance responses in 
(A) endurance-trained (ET; n = 6) and (B) strength-trained (ST; n = 7) subject vastus lateralis 
muscle sampled 3 h after 8 × 5 maximal effort leg extensions. All values are mean ±SD. PGC-
1α, peroxisome proliferator activated receptor gamma co-activator 1α; PDK4, pyruvate 
dehydrogenase kinase 4; VEGF, vascular endothelial growth factor. * Significant difference 
from rest (Repeated measures ANOVA, P <0.05). 
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Figure 4.4 Changes in mRNA abundance for genes associated with myogenic responses in 
(A) endurance-trained (ET; n = 6) and (B) strength-trained (ST; n = 7) subject vastus lateralis 
muscle sampled 3 h after 8 × 5 maximal effort leg extensions. All values are mean ±SD. 
MAFBx, muscle atrophy F-box protein. 
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4.4 Discussion 
Differences in muscle phenotype and subsequent function occur by activating and / or 
repressing different subsets of genes. A rate-limiting step for protein synthesis in response to 
exercise is the level of transcription and the quantity of mRNA abundance (Booth and 
Baldwin 1996; Sanders Williams and Neufer 1996), with the level of mRNA determined by 
the rates of mRNA synthesis and decay. New steady state protein synthesis via chronic and 
load-specific stimuli can optimise muscle tissue for such diverse physiological function as 
strength or endurance capabilities (Goldspink 2003; Grifone et al. 2004). 
Previous studies have shown that diverse exercise stimuli induce specific early gene 
responses in skeletal muscle (Altschul et al. 1990; Pilegaard et al. 2000; Adams et al. 2004; 
Mahoney et al. 2005). However, the degree of specificity in gene responses to divergent 
modes of exercise when undertaken by athletes with an extensive history of single mode 
training has not been investigated. The methods of the present study employed exercise of the 
same relative rather than absolute exercise intensity in an attempt to mimic the habitual 
training practices of the two groups of athletes. For the first time, these data provide evidence 
demonstrating that divergent forms of exercise undertaken in habitually trained athletes 
results in the selective up-regulation / repression of specific gene sets that are likely to 
mediate some of the chronic exercise-induced adaptations to training.   
The first novel finding of the present study was that a single bout of endurance 
exercise undertaken by both strength- and endurance-trained athletes elicited similar changes 
in the mRNA abundance of a subset of metabolic genes, namely PGC-1α, PDK4 and VEGF 
(Figure 4.1A, 1B). The results showing an up-regulation of these genes in endurance-trained 
subjects are in agreement with previous findings (Pilegaard et al. 2000; Gavin et al. 2004; 
Cartoni et al. 2005; Mahoney et al. 2005) and provide further support for their proposed roles 
in exercise-induced regulation of mitochondrial biogenesis, carbohydrate metabolism and 
angiogenesis, respectively (Pilegaard et al. 2000; Baar et al. 2002; Psilander et al. 2003; 
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Gavin et al. 2004; LeBlanc et al. 2004). It has been proposed that adaptation to chronic 
resistance training does not create a favourable cellular environment with respect to oxidative 
potential (Tseng et al. 1994; Tseng et al. 1995; Hood 2001). The chronic training history of 
strength-trained athletes results in an increased cross-sectional area and fibre diameter of the 
trained musculature (MacDougall et al. 1982) and it has been suggested that this adaptation 
may limit nuclear and mitochondrial transcriptional capacity due to an increase in the 
cytoplasm to myonucleus ratio of the cell (Tseng et al. 1994). Furthermore, the mitochondrial 
density of enlarged fibres may be diluted, thus increasing diffusion distances for oxygen and 
substrates (Hood 2001). Notwithstanding these observations, such conditions did not preclude 
an endurance exercise-induced increase in “metabolic genes” in this subject population. 
With regard to the acute mRNA responses of “myogenic genes” after a bout of cycling 
exercise, the present results demonstrate that MyoD and Myogenin increased in ET but not 
ST subjects (Figure 4.2A, 2B). MyoD and Myogenin are expressed in muscle satellite cells 
and mature myofibres and have been implicated in mediating the processes of cell 
proliferation and differentiation, and in defining muscle phenotype (Willoughby and Nelson 
2002; Charge and Rudnicki 2004; Ishido et al. 2004b). Cycling involves minimal eccentric 
work for force production suggesting that the divergent responses of MyoD in the present 
study were not the result of disparity in the activation of satellite cell populations. The 
expression of MyoD is highly induced following resistance exercise, surgical ablation, 
denervation and muscle damage (Willoughby and Nelson 2002; Psilander et al. 2003; Ishido 
et al. 2004a; Ishido et al. 2004b; Bickel et al. 2005), but an increase in MyoD expression has 
not previously been reported after cycling exercise in humans. MyoD expression is increased 
after endurance treadmill running in rodents and humans (Armand et al. 2003; Yang et al. 
2005). Yang and co workers (2005) observed increased MyoD mRNA abundance in 
physically active human subjects following 30 min of treadmill running, and attributed this to 
the eccentric component with foot strike and suggested that increased MyoD expression may 
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indicate transcriptional regulation of fibre-specific alterations in myosin heavy chain 
expression. Previously, Kadi et al. (2004) have shown Myogenin accumulation following 
endurance cycling and this may represent an early signal mediating the control of myofibre 
oxidative metabolic properties. In support of this contention a significant increase in the 
mRNA abundance of myogenin following cycling exercise in ET subjects was observed. 
However, it is unclear why a decrease in Myogenin was observed in strength-trained subjects 
following cycling exercise.  
If expression of myogenic regulatory factors occurs in mature myofibres as a result of 
endurance adaptation the decrease in MyoD and Myogenin mRNA in ST subjects following 
cycling may suggest a repressed response due to the adaptive phenotype of the muscle. 
However, although fibre-type specific responses are likely to contribute to the discrepancy in 
MyoD and Myogenin mRNA abundance following cycling exercise, the precise mechanism 
for such unique divergent responses in diversely trained athletic populations remains elusive.  
A novel finding of the present study was the significant increase in mRNA abundance 
of several ‘negative regulators’ of muscle mass in both ET and ST subjects following cycling 
exercise. Increases in MAFBx and Myostatin after cycling exercise has not previously been 
reported (Figure 4.2A, 2B). MAFBx (also known as Atrogin-1) is an ubiquitin E3 ligase 
involved in the regulation of proteolysis (Lecker et al. 1999). The induction of MAFBx 
expression prior to muscle loss and its high expression during accelerated protein degradation 
strongly suggest that this plays an important role in initiating and maintaining proteolysis 
(Lecker et al. 1999; Gomes et al. 2001). Important regulators of MAFBx expression have 
been identified downstream of insulin and insulin-like growth factor signalling including 
AKT and the Forkhead box O (FoxO) class of transcription factors, and mammalian target of 
rapamycin (mTOR; Sandri et al. 2004; Glass 2005). Stimuli that have been shown to generate 
proteolysis in skeletal muscle include fasting and diabetes (Gomes et al. 2001; Dehoux et al. 
2004). In the current study, it seems reasonable to conclude that the metabolic stress produced 
 133
during 60 min endurance exercise performed in a fasted state contributed to the increase in 
MAFBx mRNA abundance. Moreover, the increase in MAFBx mRNA in both ET and ST 
subjects following cycling indicates a response that is independent of training history. 
Myostatin is a transforming growth factor defined as a negative regulator of muscle mass. 
Deletion of Myostatin is associated with gross muscle hypertrophy while over-expression 
results in lower muscle mass and decreased fibre size (McPherron and Lee 1997; Reisz-
Porszasz et al. 2003). In this study an increase in Myostatin mRNA after cycling in ET but not 
ST subjects was observed. These findings are in contrast to recent work in rodents after 
swimming exercise (Matsakas et al. 2005). Differences in muscle sampling time course and 
exercise mode and duration make comparisons difficult to rationalise these discordant 
findings. Previous work involving resistance exercise in humans has shown both decreased 
(Kim et al. 2005) and increased (Willoughby 2004) Myostatin mRNA expression. The 
specific mechanism through which Myostatin gene expression is controlled and how it exerts 
its effect on skeletal muscle is unclear. Nevertheless, the possibility exists that the skeletal 
muscle adaptive state in ST subjects as a result of chronic resistance training inhibits any 
acute up-regulation in Myostatin gene expression regardless of the exercise mode and that its 
regulation following endurance exercise occurs in a phenotype or genotype specific manner. 
The patterns of induction of the two subsets of metabolic and myogenic genes after 
resistance exercise were variable. Considerable changes from rest were observed for PDK4, 
MyoD, MAFBx and Myostatin mRNA abundance in ET but not ST subjects following 3 h 
recovery after resistance exercise. PDK4 phosphorylates and inactivates the pyruvate 
dehydrogenase complex and facilitates movement of glycolytically derived pyruvate toward 
lactate output rather than oxidation (Sugden and Holness 2003). The increase in PDK4 in ET 
subjects following resistance exercise probably corresponds to a requirement for increased 
glycolytic metabolism to supply energy to sustain the repeated high-intensity contractile 
activity, and may also have enhanced muscle glycogen resynthesis during recovery. The 
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present data are in agreement with those of Yang et al. (2005) showing increased PDK4 
mRNA expression following resistance exercise. 
Compatible with its role in muscle hypertrophy and supporting the work of others 
(Willoughby and Nelson 2002; Psilander et al. 2003; Bickel et al. 2005), MyoD mRNA 
increased in ET subjects following resistance exercise. The role of MyoD in satellite cell 
proliferation and differentiation for subsequent muscle regeneration and hypertrophy has been 
previously noted. Resistance training induces muscle overload resulting in local myotrauma 
that stimulates a number of processes including satellite cell activation (Hawke and Garry 
2001). Therefore, unfamiliar resistance exercise in ET subjects might have been expected to 
induce an increase in MyoD expression due to the activation of satellite cells for muscle repair 
/ regeneration and as an adaptation response for greater force production and reduced cellular 
disturbance with subsequent repeated exercise bouts.  MAFBx is a mediator of atrophy 
involved in the breakdown of muscle protein while Myostatin negatively regulates 
hypertrophy processes (Langley et al. 2002; Hoffman and Nader 2004). Few studies have 
investigated the effect of exercise on MAFBx and Myostatin expression in humans and the 
specific response to resistance exercise is still to be determined. Nevertheless, preliminary 
evidence implicates resistance exercise in the down-regulation of the mRNA content of both 
MAFBx and Myostatin, almost certainly reducing their negative affects on subsequent 
hypertrophy processes (Roth et al. 2003; Jones et al. 2004; Kim et al. 2005). The results from 
this study provide evidence in support of such a contention. 
In conclusion, an important component of this work was the elucidation of whether 
familiar / unfamiliar exercise induced a suppressed or amplified acute response in subsets of 
‘metabolic’ and ‘myogenic’ genes that are likely to be fundamental to specific exercise-
induced adaptation. A single endurance exercise bout produced comparative transcriptional 
responses in metabolic genes while training history markedly altered the response of 
myogenic genes. Few differences were evident following resistance exercise, however the 
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magnitude of exercise response was notably larger in endurance-trained subjects. A potential 
limitation with regard to the interpretation of the current data set is the use of a single post-
exercise time point to evaluate the responses of the exercise-induced genes under 
investigation. Muscle samples were collected 3 h after the completion of an exercise bout 
because previous studies have reported that for the genes of interest determined in the present 
investigation, transcriptional activation occurs primarily during the initial few hours of 
recovery (Pilegaard et al. 2000; Psilander et al. 2003; Gavin et al. 2004; Matsakas et al. 2005; 
Yang et al. 2005). The results from the present study indicate that independent of exercise 
mode, the gene responses in skeletal muscle from endurance-trained athletes appears to be 
more sensitive to alterations in the cellular milieu than strength-trained subjects. This may 
indicate that a greater degree of muscle plasticity is conserved with regard to the acute mRNA 
responses compared to their strength-trained counterparts. Alternatively, the chronic adaptive 
state of muscle from strength-trained athletes may require a greater overload stimulus or 
repeated bouts of exercise to increase the transcriptional activity of myogenic genes in 
response to resistance exercise.  
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Chapter Five  
 
 
 
Summary and Conclusions 
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The principle aims of the studies undertaken for this thesis were to enhance our current 
understanding of the molecular responses in skeletal muscle following resistance and 
endurance training overload. Both rodent and human in vivo exercise models were employed 
to elucidate the effect of overload frequency, exercise mode and muscle phenotype on these 
responses. The aims of this thesis were to 1) systematically evaluate the time-course of a 
spectrum of cellular and molecular markers specific to the regulation of muscle contractile 
protein and subsequent hypertrophy, after the imposition of different resistance training protocols 
and 2) to quantify the early response to divergent training stimuli in competitive athletes who 
are highly specialised / adapted to a single discipline, and to establish the degree of 
“signalling specificity” in these athletes. 
The first study (Chapter 2) used a high-frequency model of training and evaluated the 
subsequent time-course of signalling responses. Specifically, this study compared 
conventional-frequency resistance training to a novel high-frequency “stacked” resistance 
training regimen and examined the response of kinases implicated in hypertrophy, 
inflammation and atrophy signalling pathways. Activation of intra-cellular signal transduction 
in skeletal muscle following contractile activity is a transient response that promotes or 
inhibits subsequent gene expression and adaptation. Consequently, the hypothesis of this 
investigation was that if a subsequent exercise bout was performed while the anabolic 
signalling response to an initial bout was still elevated, this could potentially extend the 
duration and / or amplitude of the signal, “stacking” the adaptive response onto that initiated 
previously. Contrary to the original hypothesis that “stacked” training would amplify and 
extend the anabolic signalling response, the first novel finding from this study was an 
extended inflammatory / atrophy signalling response after high-frequency work bouts. 
Moreover, high-frequency work bouts induced a co-ordinated and sustained elevation of 
inflammatory cytokine signalling. The results from this study suggest that in previously 
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untrained muscle high-frequency resistance training does not enhance the activation of 
anabolic pathways and exacerbates inflammation and atrophy signal transduction.  
Study one also provides new information on the effect of conventional resistance 
training on inflammatory responses in skeletal muscle. In contrast to high-frequency 
resistance training, after the initial bout of exercise conventional-frequency resistance training 
induced a suppression of inflammatory signalling responses following subsequent exercise 
bouts. Moreover, the signalling responses of inflammatory cytokines following three training 
bouts were not significantly different to control values and after a further 48 h recovery 
decreased below these levels. Thus, the capacity for exercise to induce a pro- or anti-
inflammatory effect in a frequency-dependent manner highlights the importance of recovery 
in determining subsequent adaptive events and in promoting or inhibiting the specificity of 
training adaptation. In addition, these results indicate a rapid reduction in the inflammatory 
response with repeated bouts of exercise in previously untrained muscle. Such information 
has important implications for disorders characterised by chronic skeletal muscle 
inflammation (e.g. type 2 diabetes). Indeed, the reduction in TNFα signalling observed with 
conventional training provides support for the capacity of habitual exercise to reduce the 
activity of inflammatory pathways in skeletal muscle.  
The second study (Chapter 3 and 4) compared the signalling and mRNA response of 
highly-trained strength and endurance athletes to habitual and unfamiliar exercise. 
Specifically, strength and endurance athletes undertook a bout of resistance or cycling 
exercise, respectively, then “crossed-over” and performed a bout of exercise they do not 
normally incorporate into their habitual training regimen. The distinct molecular events that 
characterise adaptation to divergent exercise such as resistance and endurance training appear 
to be incompatible. Therefore, the hypothesis was that when athletes undertook a training bout 
in an unfamiliar exercise discipline, the adaptive phenotype of the muscle would abolish the 
expected molecular response associated with the specificity of training. In contrast to this 
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hypothesis, the results from this study indicate “cross-over” to an unfamiliar exercise mode 
does not prevent a training-specific adaptive response. However, prior training history had a 
profound effect on signalling and mRNA responses to the habitual training modes. 
AMPK has been implicated in an “aerobic” adaptation pathway resulting in increased 
fat utilisation and mitochondrial biogenesis, while AKT has been identified as an important 
regulator of hypertrophy and cell growth in skeletal muscle. The results from this study 
provide new information demonstrating that when endurance athletes performed cycling there 
was little activation of the AMPK pathway. Likewise, when strength-trained athletes 
undertook resistance exercise there was little up-regulation of the AKT signalling pathways. 
Conversely, when athletes “crossed-over” and performed a bout of unfamiliar exercise, 
strength- and endurance-trained subjects significantly increased AMPK activation. The results 
from this study also demonstrated that strength-trained athletes did not promote / inhibit 
mRNA abundance of genes regulating muscle mass after resistance training but that cycling 
induced a significant increase in the mRNA abundance of genes associated with aerobic 
metabolism. Thus, it appears the adaptive phenotype resulting from chronic resistance training 
retains a capacity to increase metabolic gene expression in response to endurance training. 
Collectively, these findings have a number of important ramifications regarding our current 
understanding of the specificity of exercise-induced adaptation responses.  
Foremost, it appears that a single bout of habitual exercise in a highly adapted 
phenotype is insufficient to induce significant increases in the molecular responses associated 
with the desired exercise-specific adaptation. This highlights the importance of overload in 
initiating mechanotransduction and subsequent primary and secondary messenger activation 
to promote adaptation in elite athletes. Also, the increase in PGC-1α mRNA abundance 
despite the lack of AMPK activation when endurance athletes undertook cycling indicates that 
AMPK activity may not exclusively promote mitochondrial biogenesis but is a consequence 
of intense contraction-induced overload. These findings raise the question of the putative role 
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of AMPK in the adaptation to endurance training. In addition, this study provides novel data 
to show that prolonged cycling increases mRNA abundance of genes implicated in the 
negative regulation of muscle mass. This suggests that endurance training may up-regulate 
proteolysis and suppress hypertrophy thereby impairing the muscles capacity to increase 
protein synthesis and muscle mass. Indeed, Akt has been implicated in down-regulating 
ubiquitin-ligase atrophy processes by inhibiting the FoxO-MAFBx pathway. The lack of Akt 
phosphorylation after cycling exercise was performed by strength-trained athletes likely 
promoted the transcriptional activity of atrophy genes. Equally, the AMPK-mediated 
inhibition of mTOR signalling and subsequent reductions in translational efficiency following 
aerobic exercise may have exacerbated protein degradation and contributed to increased 
MAFBx and Myostatin mRNA abundance in the strength athletes. Collectively, these data 
provide potential mechanisms for adaptation interference, suggesting that the dominant 
mechanism of interference with concurrent training is the negative effect of aerobic 
metabolism on pathways regulating protein synthesis and degradation.  
In conclusion, the aim of training is to provide an overload stimulus that generates 
specific molecular responses to enhance the adaptive phenotype. In this regard, key regulators of 
skeletal muscle adaptation are emerging that are likely to significantly contribute to 
promoting the specificity of training responses, driving the muscle phenotype to either ends of 
an adaptation continuum. Thus, endurance training should activate pathways to promote 
adaptation toward enhanced oxidative capacity and resistance to fatigue during prolonged 
contractile activity. Conversely, resistance training should up-regulate translational machinery 
and satellite cell activity increasing protein synthesis and muscle cross-sectional area.  
The results from the studies undertaken for this thesis provide novel information 
regarding the effect of overload frequency, exercise mode and training history on the 
molecular bases of training adaptation. However, several important questions remain that 
should be addressed in future work. For example, a high-frequency training stimulus suppresses 
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the adaptive response in untrained subjects (Chapter 2), yet a single training bout of habitual 
exercise undertaken by highly-trained athletes was insufficient to generate further adaptation 
responses (Chapter 3). It is unclear how periods of high-frequency training might affect the 
molecular adaptation response in trained athletes. Furthermore, the unique signalling events that 
occur when trained individuals undertake exercise in an “unfamiliar” activity (i.e. “interference”) 
is not well understood (Chapter 4). If “crossing over” to an alternate exercise mode interferes 
with adaptive responses initiated during prior training sessions (i.e. concurrent training), this is 
likely to suppress or limit the specific exercise response and produce a less than optimal 
adaptation. Moreover, the effect of alternating endurance and resistance training sessions on 
the strength-endurance adaptation continuum remains elusive. 
The adaptation continuum provides a framework with which to assess the molecular 
bases of training adaptation. However, this simplistic approach characterising the adaptation 
to endurance and resistance training does not address the multifaceted nature of training 
specificity. This is undoubtedly complicated by the addition of other training modes, 
nutritional interventions and recovery modalities. Nonetheless, continued discovery of 
mechanisms involved in regulating the adaptation response will enhance our understanding of 
the specificity of training adaptation. Greater knowledge regarding exercise-induced 
adaptation in skeletal muscle requires the application of innovative training interventions to 
promote and extend our current understanding of adaptive events that may ultimately translate 
to novel training practices for athletic endeavour. Understanding the specificity of training 
adaptation is not only important for sport and exercise scientists but may also provide 
therapeutic targets for the treatment of acute and chronic skeletal muscle diseases. 
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